SNPS,DISEASE/TRAIT,RISK ALLELE FREQUENCY,P-VALUE,PVALUE_MLOG,OR or BETA,MAPPED_GENE,LOCATION,RISK_ALLELE,Risk_score,risk_cluster,DISEASE/TRAIT_encoded,SNPS_encoded,MAPPED_GENE_encoded,RISK_ALLELE_encoded,interaction_OR_freq,polygenic_score
rs3104373,Multiple sclerosis,0.1808510638297873,1e-234,234.0,0.3392878991802276,HLA-DQA1,6,T,79.39336840817326,Medium Risk,20,433,182,3,0.06136057751131778,79.39336840817326
rs3135388,Multiple sclerosis,0.21276595744680854,4.0000000000000004e-225,224.397940008672,0.3209347852685672,HLA-DRA - HLA-DRB9,6,A,72.01710469139199,Medium Risk,20,444,186,0,0.0682839968656526,72.01710469139198
rs3129889,Multiple sclerosis,0.19148936170212774,1e-206,206.0,0.3478526856723358,HLA-DRA - HLA-DRB9,6,G,71.65765324850118,Medium Risk,20,439,186,2,0.06661008874576646,71.65765324850118
rs9271366,Multiple sclerosis,0.13829787234042556,7e-184,183.154901959986,0.3246054080508993,HLA-DRB1 - HLA-DQA1,6,G,59.453071687243636,Medium Risk,20,773,188,2,0.04489223728363503,59.45307168724372
DRB*15:01,Multiple sclerosis,0.18439716312056748,1e-132,132.0,0.36131163587422,DRB1,6,G,47.69313593539704,Medium Risk,20,4,108,2,0.06662484065765763,47.69313593539704
rs3135388,Multiple sclerosis,0.22340425531914898,9e-81,80.0457574905607,0.22794567478282152,HLA-DRA - HLA-DRB9,6,A,18.246084204687943,High Risk,20,444,186,0,0.050924033728077155,18.24608420468795
chr16:11213951,Multiple sclerosis,0.5638297872340425,4e-71,70.397940008672,0.13069515477792734,CLEC16A,6,C,9.200669665480635,High Risk,20,16,77,1,0.07368982131095902,9.20066966548063
rs10801908,Multiple sclerosis,0.5638297872340425,5e-70,69.301029995664,0.14336229046861618,CD58,1,C,9.935154392012663,High Risk,20,86,64,1,0.08083192973230487,9.935154392012665
rs11256593,Multiple sclerosis,0.5638297872340425,3e-65,64.5228787452803,0.13204453688975895,RPL32P23 - RBM17,10,T,8.519893642714614,High Risk,20,123,470,3,0.07445064313997048,8.519893642714608
rs438613,Multiple sclerosis,0.7943262411347518,2.0000000000000003e-49,48.698970004336,0.12521717851462133,LINC01967,3,C,6.097947620511133,High Risk,20,506,274,1,0.09946329073501836,6.09794762051113
rs2104286,Multiple sclerosis,0.7553191489361702,2e-47,46.698970004336,0.13373302336963172,IL2RA,10,A,6.2451944469275995,High Risk,20,324,220,0,0.1010111133962112,6.245194446927597
rs1800693,Multiple sclerosis,0.7943262411347518,2e-47,46.698970004336,0.12509791998042336,TNFRSF1A,12,C,5.841944012770618,High Risk,20,293,548,1,0.09936856055182565,5.8419440127706155
rs12927355,Multiple sclerosis,0.7127659574468086,6e-46,45.2218487496164,0.13128594151474368,CLEC16A,16,G,5.936992990130718,High Risk,20,207,77,2,0.093576149803062,5.936992990130723
chr3:121765368,Multiple sclerosis,0.7943262411347518,7e-43,42.1549019599857,0.1237489294016885,ILDR1,6,C,5.216623986581376,High Risk,20,34,225,1,0.098297021936093,5.216623986581371
rs6677309,Multiple sclerosis,0.9148936170212767,5e-42,41.301029995664,0.1422978098617399,CD58,1,A,5.877046113417009,High Risk,20,625,64,0,0.1301873579586131,5.877046113417013
rs11621145,Immunoglobulin G index levels in multiple sclerosis,0.6205673758865249,4e-37,36.397940008672,0.012602471552673439,IGHA1,14,G,0.4587040035352038,Low Risk,15,135,210,2,0.007820682701127134,0.4587040035352033
rs6670198,Multiple sclerosis,0.6205673758865249,2e-36,35.698970004336,0.12354719197357152,PRXL2B,1,T,4.410507500384473,High Risk,20,622,425,3,0.076669356721188,4.410507500384471
rs62420820,Multiple sclerosis,0.6205673758865249,8.999999999999999e-36,35.0457574905607,0.12448305395815491,IL20RA - IL22RA2,6,A,4.362602920701876,High Risk,20,597,219,0,0.07725012213715288,4.36260292070188
rs1738074,Multiple sclerosis,0.6205673758865249,3e-35,34.5228787452803,0.12305879114156368,"TAGAP, TAGAP-AS1",6,C,4.248343725120981,High Risk,20,275,525,1,0.0763662710984881,4.248343725120977
rs35540610,Multiple sclerosis,0.45390070921985815,3e-33,32.5228787452803,0.12422611036339168,SP140,2,C,4.040190724346401,High Risk,20,465,511,1,0.056386319597567854,4.040190724346396
rs1323292,Multiple sclerosis,0.45390070921985815,4e-33,32.397940008672,0.1266976630368286,RGS21 - RGS1,1,A,4.104743286306118,High Risk,20,220,446,0,0.057508159108915116,4.104743286306114
rs1077667,Multiple sclerosis,0.45390070921985815,8e-33,32.0969100130081,0.12573106570414783,TNFSF14,19,C,4.035578701745636,High Risk,20,83,549,1,0.057069419894081284,4.035578701745641
rs1813375,Multiple sclerosis,0.5,1.9999999999999998e-32,31.698970004336,0.12516823687752354,LINC01967,3,A,3.967704186276244,High Risk,20,297,274,0,0.06258411843876177,3.967704186276242
rs9281962,Binding antibody response to interferon beta therapy in multiple sclerosis (antibody levels; IFNβ-1a subcutaneous),0.4468085106382979,4.999999999999999e-32,31.301029995664,0.04675181695827725,HLA-DRB1 - HLA-DQA1,6,T,1.4633800249628282,Low Risk,2,788,188,3,0.02088910970476218,1.463380024962829
rs35486093,Multiple sclerosis,0.45390070921985815,2e-31,30.698970004336,0.13239246298788696,C1orf52 - Y_RNA,1,G,4.064312250065308,High Risk,20,464,42,2,0.060093032845565705,4.0643122500653055
rs2150879,Multiple sclerosis,0.45390070921985815,4e-31,30.397940008672,0.12104490395203721,VMP1,17,G,3.6795157286894957,High Risk,20,330,584,2,0.0549423677512793,3.6795157286894913
rs701006,Multiple sclerosis,0.45390070921985815,9.999999999999999e-31,30.0,0.12198703046616911,OS9,12,G,3.659610913985073,High Risk,20,656,395,2,0.055369999644218605,3.659610913985073
chr14:88523488,Multiple sclerosis,0.45390070921985815,1.9999999999999998e-30,29.698970004336,0.14738774011990702,LINC01146,6,C,4.377264072827991,High Risk,20,15,262,1,0.06689939977073793,4.377264072827988
rs11809700,Multiple sclerosis,0.45390070921985815,3e-30,29.5228787452803,0.1227298788694482,EVI5,1,T,3.6233393322856626,High Risk,20,147,132,3,0.05570717906130982,3.6233393322856577
rs9843355,Multiple sclerosis,0.45390070921985815,3.9999999999999996e-30,29.397940008672,0.12547412210938458,TIMMDC1,3,G,3.6886807144124774,High Risk,20,822,538,2,0.05695279301418874,3.6886807144124725
rs4939490,Multiple sclerosis,0.4290780141843972,2.0000000000000002e-29,28.698970004336,0.12195032423834577,CD6 - LINC02954,11,G,3.499848697335337,High Risk,20,549,66,2,0.05232620295333277,3.499848697335335
rs4896153,Multiple sclerosis,0.5035460992907802,3e-29,28.5228787452803,0.12091033892083691,AHI1-DT,6,T,3.448710936089781,High Risk,20,542,10,3,0.06088392952751363,3.4487109360897765
rs3763354,Rheumatoid arthritis or multiple sclerosis,0.5035460992907802,5.0000000000000004e-29,28.301029995664,0.1228530812839023,HLA-DOB,6,G,3.476868738475464,High Risk,54,476,180,2,0.061862189866362154,3.476868738475466
rs72928038,Multiple sclerosis,0.5035460992907802,8.000000000000001e-29,28.0969100130081,0.12569858069252418,BACH2,6,A,3.531741710480684,High Risk,20,687,26,0,0.06329502999410792,3.531741710480689
rs10063294,Multiple sclerosis,0.5035460992907802,2.0000000000000002e-28,27.698970004336,0.12234034014437785,IL7R,5,G,3.3887014119793877,High Risk,20,55,224,2,0.06160400106560871,3.3887014119793855
rs1026916,Multiple sclerosis,0.5035460992907802,2.0000000000000002e-28,27.698970004336,0.12077352257433012,STAT3,17,A,3.345302179104369,High Risk,20,68,516,0,0.060815036189910916,3.3453021791043667
rs1014486,Multiple sclerosis,0.5035460992907802,3e-28,27.5228787452803,0.12027407316774748,IL12A-AS1,3,C,3.3102887319968892,High Risk,20,59,216,1,0.06056354038943314,3.3102887319968843
rs9271673,Neutralising antibody response to interferon beta therapy in multiple sclerosis (antibody titre; IFNβ-1a subcutaneous),0.5035460992907802,2.0000000000000002e-28,27.698970004336,0.029732044536889754,HLA-DRB1 - HLA-DQA1,6,C,0.8235470097948919,Low Risk,38,777,188,1,0.014971455050490587,0.8235470097948914
rs1800693,Multiple sclerosis,0.41489361702127664,7e-28,27.1549019599857,0.12394469595007952,TNFRSF1A,12,G,3.3657060669846515,High Risk,20,293,548,2,0.051423863213330874,3.365706066984646
rs11079784,Multiple sclerosis,0.5035460992907802,2e-27,26.698970004336,0.11995595252661201,KPNB1-DT,17,C,3.2027003783495696,High Risk,20,112,244,1,0.060403351981485484,3.2027003783495673
rs9271700,Neutralising antibody response to interferon beta therapy in multiple sclerosis (presence of antibodies; IFNβ-1a subcutaneous),0.4255319148936171,5e-27,26.301029995664,0.1374036461519638,HLA-DRB1 - HLA-DQA1,6,G,3.6138574189563997,High Risk,46,778,188,2,0.058469636660410135,3.613857418956402
rs41286801,Multiple sclerosis,0.148936170212766,9.999999999999999e-27,26.0,0.13006240058729965,EVI5,1,A,3.3816224152697907,Low Risk,20,496,132,0,0.019370995832151017,3.3816224152697907
rs3748817,Multiple sclerosis,0.6702127659574468,9.999999999999999e-27,26.0,0.12394469595007952,MMEL1,1,A,3.2225620947020674,High Risk,20,472,348,0,0.08306931749845756,3.2225620947020674
rs9275602,Rheumatoid arthritis or multiple sclerosis,0.41489361702127664,1.9999999999999998e-26,25.698970004336,0.12476038990170889,MTCO3P1 - HLA-DQB3,6,G,3.206213517813283,High Risk,54,786,357,2,0.05176228942730476,3.2062135178132807
rs6589706,Multiple sclerosis,0.41489361702127664,4.9999999999999996e-26,25.301029995664,0.12027407316774748,Y_RNA - CXCR5,11,A,3.0430579329178635,High Risk,20,616,594,0,0.04990094525044843,3.0430579329178653
rs3135338,Multiple sclerosis,0.11702127659574474,1.9999999999999998e-25,24.698970004336,0.40413556833476083,TSBP1-AS1 - HLA-DRA,6,A,9.981732279985547,Medium Risk,20,443,566,0,0.047292460124280546,9.98173227998554
rs117518546,Neuromyelitis optica spectrum disorder (AQP4-IgG-positive),0.34574468085106386,1.9999999999999998e-25,24.698970004336,0.341245564664138,IGHG1,14,T,8.428413965752252,Medium Risk,36,142,211,3,0.11798383884664347,8.428413965752247
chr8:129177769,Multiple sclerosis,0.7056737588652482,3e-25,24.5228787452803,0.12207670378074147,MIR1208,6,C,2.993672204438629,High Risk,20,45,339,1,0.08614632642683528,2.993672204438624
rs11749040,Multiple sclerosis,0.7056737588652482,5e-25,24.301029995664,0.12511409519148417,RNU1-150P - TTC33,5,A,3.0404013801286154,High Risk,20,141,457,0,0.0882897338407991,3.0404013801286176
rs631204,Multiple sclerosis,0.7056737588652482,5e-25,24.301029995664,0.12060442921815735,BTF3L4P3 - LINC03004,6,A,2.9308118520403754,High Risk,20,600,39,0,0.08510738090217486,2.9308118520403776
rs4808760,Multiple sclerosis,0.7056737588652482,6e-25,24.2218487496164,0.1214756882417717,IFI30 - MPV17L2,19,C,2.9423657473477443,High Risk,20,535,205,1,0.08572220553231406,2.942365747347749
rs2255214,Multiple sclerosis,0.5319148936170214,1.0000000000000001e-24,24.0,0.1227211550226355,Y_RNA - CD86,3,C,2.9453077205432523,High Risk,20,344,593,1,0.06527721011842315,2.9453077205432523
rs1077667,Multiple sclerosis,0.8191489361702129,2.0000000000000002e-24,23.698970004336,0.12639177780496758,TNFSF14,19,G,2.9953549509946296,High Risk,20,83,549,2,0.10353369032960112,2.9953549509946273
rs11554159,Multiple sclerosis,0.7659574468085106,2.0000000000000002e-24,23.698970004336,0.12516823687752354,IFI30,19,G,2.9663582912560558,High Risk,20,131,204,2,0.09587354314023079,2.9663582912560535
rs12478539,Multiple sclerosis,0.7056737588652482,2.0000000000000002e-24,23.698970004336,0.12106937477058609,LINC02580,2,G,2.869219481131836,High Risk,20,181,286,2,0.08543548077782492,2.8692194811318337
rs77278603,Neutralising antibody response to interferon beta therapy in multiple sclerosis (presence of antibodies; IFNβ-1a subcutaneous and intramuscular),0.7056737588652482,2.0000000000000002e-24,23.698970004336,0.11415636853052735,HLA-DRB9 - HLA-DRB5,6,A,2.705388353608896,High Risk,45,722,193,0,0.08055715367934377,2.705388353608894
rs58166386,Multiple sclerosis,0.8085106382978723,4.0000000000000004e-24,23.397940008672,0.12002936498225868,EPS15L1,19,G,2.808439881133889,High Risk,20,573,122,2,0.09704501849629424,2.808439881133884
rs7977720,Multiple sclerosis,0.8085106382978723,5e-24,23.301029995664,0.11898999143521352,LINC02390 - CLECL1P,12,T,2.7725893596157105,High Risk,20,738,281,3,0.09620467392634284,2.7725893596157127
rs9272775,Neutralising antibody response to interferon beta therapy in multiple sclerosis (antibody titre; IFNβ-1b subcutaneous),0.22340425531914898,3e-24,23.5228787452803,0.03462620824666583,HLA-DQA1,6,C,0.8145080979951465,Low Risk,39,782,182,1,0.007735642267872156,0.8145080979951451
rs1131265,Multiple sclerosis,0.8404255319148938,1.0000000000000001e-23,23.0,0.1276153187324116,TIMMDC1,3,C,2.935152330845467,High Risk,20,127,538,1,0.10725117212617573,2.935152330845467
rs34947566,Multiple sclerosis,0.5177304964539008,1.0000000000000001e-23,23.0,0.12471552673436928,RMI2,16,C,2.8684571148904934,High Risk,20,460,448,1,0.06456903157169475,2.8684571148904934
rs17066096,Multiple sclerosis,0.24468085106382984,2.0000000000000002e-23,22.698970004336,0.12394469595007952,IL20RA - IL22RA2,6,G,2.8134169355674032,Low Risk,20,261,219,2,0.030326893689913082,2.813416935567401
rs8070345,Multiple sclerosis,0.4680851063829788,2.0000000000000002e-23,22.698970004336,0.1214976140951915,VMP1,17,A,2.757870697945145,High Risk,20,749,584,0,0.056871223619025815,2.7578706979451426
rs1250551,Multiple sclerosis,0.36879432624113484,2.0000000000000002e-23,22.698970004336,0.11916773522574331,ZMIZ1,10,T,2.704984847373804,Low Risk,20,185,604,3,0.04394838462225995,2.704984847373802
rs9989735,Multiple sclerosis,0.1808510638297873,4.0000000000000004e-23,22.397940008672,0.12639177780496758,SP140,2,C,2.83091545686507,Low Risk,20,833,511,1,0.022858087475366485,2.830915456865065
rs34383631,Multiple sclerosis,0.3936170212765958,4.0000000000000004e-23,22.397940008672,0.1227211550226355,CD6 - LINC02954,11,A,2.7487010679919313,High Risk,20,455,66,0,0.048305135487633134,2.7487010679919264
A*02:01,Multiple sclerosis,0.2730496453900709,9.000000000000001e-23,22.0457574905607,0.15208613728129208,HLA,6,G,3.352854100179484,High Risk,20,0,174,2,0.04152706585340245,3.352854100179488
rs34723276,Multiple sclerosis,0.34751773049645396,1e-22,22.0,0.11872017618989356,VCAM1,6,A,2.6118438761776583,Low Risk,20,459,581,0,0.04125736619365096,2.6118438761776583
rs28703878,Multiple sclerosis,0.5815602836879434,5e-22,21.301029995664,0.12001841429095804,PKIA-AS1,8,G,2.556515842843724,High Risk,20,414,410,2,0.06979794306282668,2.556515842843726
rs1920296,Multiple sclerosis,0.6595744680851064,7e-22,21.1549019599857,0.1214976140951915,IQCB1,3,C,2.570270114555958,High Risk,20,308,229,1,0.08013672419044546,2.570270114555953
rs2269423,Rheumatoid arthritis or multiple sclerosis,0.6702127659574468,6e-22,21.2218487496164,0.0887639275663771,AGPAT1,6,G,1.8837346452355568,High Risk,54,346,8,2,0.05949071741150806,1.8837346452355606
rs201202118,Multiple sclerosis,0.6914893617021278,9e-22,21.0457574905607,0.1227211550226355,TSFM,12,A,2.5827596675678888,High Risk,20,310,568,0,0.0848603731539501,2.582759667567892
rs140522,Multiple sclerosis,0.6702127659574468,1e-21,21.0,0.1209864554019332,CIMAP1B - KLHDC7B-DT,22,T,2.5407155634405973,High Risk,20,240,76,3,0.08108666691831694,2.5407155634405973
rs3809627,Multiple sclerosis,0.6702127659574468,1e-21,21.0,0.11835695583017251,TBX6,16,C,2.4854960724336226,High Risk,20,481,527,1,0.07932434273724329,2.4854960724336226
rs9271721,Binding antibody response to interferon beta therapy in multiple sclerosis (antibody levels; IFNβ-1a subcutaneous and intramuscular),0.5815602836879434,5e-22,21.301029995664,0.024775754312981776,HLA-DRB1 - HLA-DQA1,6,G,0.5277490857860261,Low Risk,1,779,188,2,0.01440859470684047,0.5277490857860265
rs2284178,Rheumatoid arthritis or multiple sclerosis,0.6702127659574468,2e-21,20.698970004336,0.11963186508422041,HCP5,6,G,2.476256386941052,High Risk,54,352,173,2,0.08017880319474346,2.4762563869410497
rs67111717,Multiple sclerosis,0.47517730496453914,3e-21,20.5228787452803,0.11955218402055551,RGS14,5,G,2.453554976387302,High Risk,20,630,445,2,0.05680848460551221,2.4535549763872977
rs2040406,Multiple sclerosis,0.25531914893617025,1e-20,20.0,0.2352869203474856,HLA-DQA1,6,G,4.705738406949712,High Risk,20,315,182,2,0.060073256258932506,4.705738406949712
rs59655222,Multiple sclerosis,0.36879432624113484,6e-21,20.2218487496164,0.11965006729475101,INAVA,1,T,2.419545563715874,High Risk,20,576,226,3,0.044126265952674146,2.4195455637158787
rs212405,Multiple sclerosis,0.6595744680851064,8e-21,20.0969100130081,0.1214976140951915,"TAGAP, TAGAP-AS1",6,T,2.4417266172662426,High Risk,20,327,525,3,0.08013672419044546,2.441726617266248
rs12087340,Multiple sclerosis,0.07446808510638303,1e-20,20.0,0.1325094824421877,BCL10-AS1,1,A,2.650189648843754,Low Risk,20,164,31,0,0.0098677274159076,2.650189648843754
rs9271640,Multiple sclerosis (OCB status),0.43971631205673767,2e-20,19.698970004336,0.2744402300256944,HLA-DRB1 - HLA-DQA1,6,G,5.406189859259231,Medium Risk,21,774,188,2,0.12067584582690111,5.406189859259226
rs74796499,Multiple sclerosis,0.9893617021276595,2e-20,19.698970004336,0.14596843264407194,GALC,14,C,2.8754277762355156,High Risk,20,701,151,1,0.14441557697764565,2.8754277762355134
rs11154801,Multiple sclerosis,0.37234042553191493,2e-20,19.698970004336,0.1214976140951915,AHI1,6,A,2.3933778556595704,High Risk,20,120,9,0,0.04523847333331599,2.393377855659568
rs2364485,Multiple sclerosis,0.574468085106383,2e-20,19.698970004336,0.1209864554019332,LTBR - RPL31P10,12,A,2.3833085558936196,High Risk,20,368,317,0,0.06950285735855738,2.3833085558936173
rs3749981,Rheumatoid arthritis or multiple sclerosis,0.6170212765957448,4e-20,19.397940008672,0.12557608385333824,PPP1R2P1 - HLA-Z,6,G,2.4359173411110246,High Risk,54,473,420,2,0.07748311556908105,2.4359173411110198
rs4796791,Multiple sclerosis,0.3617021276595745,4e-20,19.397940008672,0.1214976140951915,STAT3,17,A,2.3568034294153106,High Risk,20,534,516,0,0.04394594552379267,2.356803429415306
rs7090512,Multiple sclerosis,0.6170212765957448,5e-20,19.301029995664,0.13006240058729965,IL2RA - RPL32P23,10,G,2.5103382950435353,High Risk,20,660,221,2,0.08025126844748277,2.5103382950435376
rs1359062,Multiple sclerosis,0.8617021276595744,5e-20,19.301029995664,0.12516823687752354,RGS21 - RGS1,1,C,2.4158758944774563,High Risk,20,234,446,1,0.10785773603275964,2.4158758944774585
rs2331964,Multiple sclerosis,0.6170212765957448,5e-20,19.301029995664,0.11841429095803255,IQCB1,3,C,2.285517781696268,High Risk,20,366,229,1,0.0730641369741052,2.2855177816962704
rs6990534,Multiple sclerosis,0.6170212765957448,6e-20,19.2218487496164,0.11930133365961093,PVT1,8,G,2.293192191232556,High Risk,20,655,429,2,0.07361146119422804,2.2931921912325612
rs9368737,Rheumatoid arthritis or multiple sclerosis,0.6170212765957448,8e-20,19.0969100130081,0.1252865125005098,HLA-DQB1 - MTCO3P1,6,G,2.3925852550658444,High Risk,54,800,185,2,0.07730444388329329,2.3925852550658497
rs6880778,Multiple sclerosis,0.6276595744680852,8e-20,19.0969100130081,0.1214976140951915,RNU1-150P - TTC33,5,G,2.3202290031710513,High Risk,20,642,457,2,0.07625914076187552,2.3202290031710566
rs2327586,Multiple sclerosis,0.6170212765957448,9e-20,19.0457574905607,0.11969900893184877,HBS1L - MYB,6,T,2.279758295976448,High Risk,20,364,171,3,0.07385683529837479,2.279758295976451
rs9591325,Multiple sclerosis,0.6170212765957448,1e-19,19.0,0.1346629144744892,DLEU1,13,T,2.5585953750152948,High Risk,20,810,101,3,0.08308988339915292,2.5585953750152948
rs12925972,Multiple sclerosis,0.6170212765957448,1e-19,19.0,0.11990701088951426,WWOX,16,C,2.278233206900771,High Risk,20,206,590,1,0.07398517693182796,2.278233206900771
rs9610458,Multiple sclerosis,0.6170212765957448,1e-19,19.0,0.11774134344793832,MAPK1,22,T,2.237085525510828,High Risk,20,812,323,3,0.07264891404234494,2.237085525510828
rs12365699,Multiple sclerosis,0.5141843971631206,2e-19,18.698970004336,0.12195032423834577,Y_RNA - CXCR5,11,G,2.2803454549518793,High Risk,20,176,594,2,0.06270495395234091,2.280345454951877
rs1177228,Multiple sclerosis,0.5141843971631206,2e-19,18.698970004336,0.11847546800440474,PUS10,2,G,2.215369222464036,High Risk,20,145,428,2,0.06091823709446343,2.215369222464034
rs2248137,Multiple sclerosis,0.5141843971631206,2e-19,18.698970004336,0.11806454178392267,CYP24A1,20,C,2.2076853253932467,High Risk,20,341,96,1,0.06070694524350634,2.2076853253932445
rs9275698,Rheumatoid arthritis or multiple sclerosis,0.4645390070921986,2e-19,18.698970004336,0.09156782209714914,MTCO3P1 - HLA-DQB3,6,G,1.7122239587569688,Low Risk,54,787,357,2,0.04253682515860474,1.712223958756967
rs6679677,Rheumatoid arthritis or multiple sclerosis,0.4645390070921986,2e-19,18.698970004336,0.09156782209714914,PHTF1 - RSBN1,1,G,1.7122239587569688,Low Risk,54,626,407,2,0.04253682515860474,1.712223958756967
rs1076928,Multiple sclerosis,0.45390070921985815,3e-19,18.5228787452803,0.12271424201639546,ETV7,6,T,2.2730210251886787,High Risk,20,82,131,3,0.055700081482619214,2.2730210251886738
rs1087056,Multiple sclerosis,0.45390070921985815,3e-19,18.5228787452803,0.11755587911415637,LINC02664,10,A,2.1774732946263518,High Risk,20,90,292,0,0.053358696902879484,2.1774732946263473
rs55838263,Multiple sclerosis,0.7340425531914894,4e-19,18.397940008672,0.1227211550226355,INAVA,1,A,2.257816447901389,High Risk,20,561,226,0,0.09008254996342394,2.2578164479013845
rs28834106,Multiple sclerosis,0.45390070921985815,4e-19,18.397940008672,0.12114278722623271,PDE4A - KEAP1,19,T,2.228777731871551,High Risk,20,417,400,3,0.0549867970388574,2.228777731871546
rs60600003,Multiple sclerosis,0.45390070921985815,5e-19,18.301029995664,0.12467886944818304,ELMO1,7,G,2.2817517295966714,High Risk,20,581,117,2,0.056591827267260385,2.2817517295966736
rs6032662,Multiple sclerosis,0.45390070921985815,5e-19,18.301029995664,0.11898935519393124,RPL13P2 - CD40,20,C,2.1776277585688515,High Risk,20,580,467,1,0.054009352712139,2.1776277585688533
rs2546890,Multiple sclerosis,0.45390070921985815,5e-19,18.301029995664,0.11755781230882174,IL12B - LINC01845,5,A,2.151429049288383,High Risk,20,385,218,0,0.05335957438130916,2.151429049288385
rs9272775,Binding antibody response to interferon beta therapy in multiple sclerosis (antibody levels; IFNβ-1b subcutaneous),0.29078014184397166,2e-19,18.698970004336,0.034277674048696916,HLA-DQA1,6,C,0.6409571988549908,Low Risk,3,782,182,1,0.009967266921961515,0.6409571988549901
rs28366299,Neutralising antibody response to interferon beta therapy in multiple sclerosis (presence of antibodies; IFNβ-1b subcutaneous),0.1808510638297873,7e-19,18.1549019599857,0.13985072800685183,HLA-DRB1 - HLA-DQA1,6,A,2.5389762559970275,Low Risk,47,409,188,0,0.025292152937409385,2.5389762559970213
rs1014486,Multiple sclerosis,0.4468085106382979,1e-18,18.0,0.12027407316774748,IL12A-AS1,3,G,2.1649333170194547,High Risk,20,59,216,2,0.05373947950048292,2.1649333170194547
rs10951042,Multiple sclerosis,0.45390070921985815,1e-18,18.0,0.11930747583506669,CARD11 - SDK1-AS1,7,C,2.1475345650312003,High Risk,20,100,49,1,0.054153747896767856,2.1475345650312003
rs2454138,Neutralising antibody response to interferon beta therapy in multiple sclerosis (mean antibody levels),0.21276595744680854,5e-19,18.301029995664,0.03462620824666583,HLA-DRB1 - HLA-DQA1,6,A,0.633695275758339,Low Risk,43,374,188,0,0.0073672783503544335,0.6336952757583395
rs3129783,Binding antibody response to interferon beta therapy in multiple sclerosis (antibody levels; IFNβ-1a subcutaneous and intramuscular),0.4468085106382979,4e-19,18.397940008672,0.02116725804478159,HLA-DQB1 - MTCO3P1,6,G,0.3894339436559722,Low Risk,1,437,185,2,0.009457711041285392,0.38943394365597145
rs9878602,Multiple sclerosis,0.3297872340425533,2e-18,17.698970004336,0.11907500305885232,FOXP1,3,T,2.107504907404847,Low Risk,20,826,145,3,0.03926941590238748,2.1075049074048446
rs2454138,Neutralising antibody response to interferon beta therapy in multiple sclerosis (area under the curve for the first two years),0.21276595744680854,8e-19,18.0969100130081,0.03462620824666583,HLA-DRB1 - HLA-DQA1,6,A,0.626627374731589,Low Risk,41,374,188,0,0.0073672783503544335,0.6266273747315905
rs2454138,Neutralising antibody response to interferon beta therapy in multiple sclerosis (maximum antibody levels),0.21276595744680854,1e-18,18.0,0.03462620824666583,HLA-DRB1 - HLA-DQA1,6,A,0.623271748439985,Low Risk,42,374,188,0,0.0073672783503544335,0.623271748439985
rs1465697,Multiple sclerosis,0.553191489361702,3e-18,17.5228787452803,0.11872426281659121,SLC6A16 - CD37,19,T,2.0803908614579227,High Risk,20,246,500,3,0.06567725177088023,2.0803908614579183
rs4976646,Multiple sclerosis,0.3617021276595745,4e-18,17.397940008672,0.1214976140951915,RGS14,5,G,2.113808201224928,High Risk,20,553,445,2,0.04394594552379267,2.113808201224923
rs6498184,Multiple sclerosis,0.8510638297872342,7e-18,17.1549019599857,0.12516823687752354,RMI2,16,G,2.1472488321381884,High Risk,20,611,448,2,0.1065261590447009,2.147248832138183
rs2523393,Multiple sclerosis,0.6063829787234043,1e-17,17.0,0.14107426893429587,"HLA-F-AS1, HLA-F",6,A,2.3982625718830297,High Risk,20,380,194,0,0.08554503541760494,2.3982625718830297
chr6:14691215,Multiple sclerosis,0.6063829787234043,1e-17,17.0,0.12037195644194298,LINC01108,6,C,2.0463232595130307,High Risk,20,42,261,1,0.07299150550202926,2.0463232595130307
rs483180,Multiple sclerosis,0.6063829787234043,1e-17,17.0,0.11732462987886946,PHGDH,1,C,1.994518707940781,High Risk,20,540,404,1,0.07114365854356978,1.994518707940781
rs9271366,Multiple sclerosis,0.4822695035460993,4e-17,16.397940008672,0.30502875321179496,HLA-DRB1 - HLA-DQA1,6,G,5.001843196087042,Medium Risk,20,773,188,2,0.147106065378738,5.00184319608703
rs1112718,Multiple sclerosis,0.6666666666666667,2e-17,16.698970004336,0.11733757494188182,Y_RNA - EXOC6,10,A,1.9594166443360141,High Risk,20,116,595,0,0.07822504996125455,1.9594166443360121
rs9272071,Binding antibody response to interferon beta therapy in multiple sclerosis (antibody levels; all treatment preparations),0.31914893617021284,5e-18,17.301029995664,0.012131748439985324,HLA-DQA1,6,C,0.2098917436600358,Low Risk,4,780,182,1,0.003871834608505955,0.20989174366003602
rs440841,Rheumatoid arthritis or multiple sclerosis,0.5851063829787234,4e-17,16.397940008672,0.18113299889881318,HLA-DOA - HLA-DPA1,6,G,2.9702080495335967,High Risk,54,508,179,2,0.10598207382377367,2.9702080495335896
rs35703946,Multiple sclerosis,0.5496453900709222,3e-17,16.5228787452803,0.12290468616175211,LINC02132 - LINC01082,16,G,2.0307392266773645,High Risk,20,466,280,2,0.06755399416692051,2.0307392266773596
rs9281971,Neutralising antibody response to interferon beta therapy in multiple sclerosis (presence of antibodies; all treatment preparations),0.3617021276595745,2e-17,16.698970004336,0.05787348586810229,HLA-DQA1,6,G,0.9664276045578045,Low Risk,48,789,182,2,0.020932962973568912,0.9664276045578035
rs6881706,Multiple sclerosis,0.7553191489361702,4e-17,16.397940008672,0.1214976140951915,IL7R,5,C,1.9923105871297364,High Risk,20,643,224,1,0.09176947447615529,1.9923105871297315
rs7923837,Multiple sclerosis,0.6382978723404256,4e-17,16.397940008672,0.12027407316774748,Y_RNA - EXOC6,10,G,1.9722470364033544,High Risk,20,732,595,2,0.07677068500068988,1.9722470364033498
rs12434551,Multiple sclerosis,0.5496453900709222,4e-17,16.397940008672,0.11687262938945309,RNU6-921P - ZFP36L1,14,A,1.9164703653840123,High Risk,20,178,463,0,0.06423850196938026,1.9164703653840076
rs9268633,Neutralising antibody response to interferon beta therapy in multiple sclerosis (antibody titre; IFNβ-1a subcutaneous and intramuscular),0.3936170212765958,1e-17,17.0,0.008931848770341366,TSBP1-AS1 - HLA-DRA,6,A,0.15184142909580323,Low Risk,37,772,566,0,0.0035157277074747938,0.15184142909580323
rs3129871,Multiple sclerosis (OCB status),0.3652482269503547,1e-16,16.0,0.22672213385537748,TSBP1-AS1 - HLA-DRA,6,G,3.6275541416860397,High Risk,21,438,566,2,0.08280985740107762,3.6275541416860397
rs1150757,Neuromyelitis optica (AQP4-IgG-positive),0.08510638297872347,3e-16,15.5228787452803,0.5546311024103756,TNXB,6,A,8.609471351077422,Medium Risk,35,128,554,0,0.04720264701364903,8.609471351077401
rs34026809,Multiple sclerosis,0.549645390070922,8e-17,16.0969100130081,0.11788969778539092,PHLDB1,11,G,1.8976598567121528,High Risk,20,452,406,2,0.0647975289245943,1.8976598567121579
rs7200786,Multiple sclerosis,0.4822695035460993,9e-17,16.0457574905607,0.12516823687752354,CLEC16A,16,A,2.008419174457796,High Risk,20,672,77,0,0.06036482345866384,2.0084191744577993
rs2986736,Multiple sclerosis,0.4822695035460993,9e-17,16.0457574905607,0.12150639911905055,ESPN,1,C,1.9496622138155604,High Risk,20,426,125,1,0.058598830780818706,1.9496622138155633
chr13:100026952,Multiple sclerosis,0.4822695035460993,9e-17,16.0457574905607,0.12027407316774748,MIR548AN,6,A,1.9298886104516269,High Risk,20,14,344,0,0.0580045175560768,1.9298886104516297
rs1021156,Multiple sclerosis,0.25531914893617025,9e-17,16.0457574905607,0.12027407316774748,PKIA - ZC2HC1A,8,A,1.9298886104516269,Low Risk,20,63,409,0,0.030708274000275957,1.9298886104516297
rs62013236,Multiple sclerosis,0.4822695035460993,9e-17,16.0457574905607,0.11978465679676986,CTSH - RASGRF1,15,C,1.9220355540510097,High Risk,20,592,92,1,0.05776848696581809,1.9220355540510126
rs9909593,Multiple sclerosis,0.4822695035460993,9e-17,16.0457574905607,0.11675003058852321,IKZF3,17,G,1.8733426778389841,High Risk,20,829,213,2,0.056304979290918995,1.873342677838987
rs465151,Rheumatoid arthritis or multiple sclerosis,0.549645390070922,7e-17,16.1549019599857,0.07979869896814715,WDR46,6,G,1.2891401583648325,Low Risk,54,517,587,2,0.04386098702149931,1.2891401583648292
HLA-DRB1*03:01,Neuromyelitis optica (AQP4-IgG-positive),0.1063829787234043,4e-16,15.397940008672,0.4848892695460663,HLA-DRB1,6,G,7.466295883319134,Medium Risk,35,9,187,2,0.05158396484532622,7.466295883319116
rs9281971,Neutralising antibody response to interferon beta therapy in multiple sclerosis (antibody titre; all treatment preparations),0.3581560283687944,2e-17,16.698970004336,0.00403768506056526,HLA-DQA1,6,G,0.06742518171333495,Low Risk,40,789,182,2,0.0014461212450960687,0.06742518171333488
HLA-B*08:01,Neuromyelitis optica (AQP4-IgG-positive),0.09574468085106386,6e-16,15.2218487496164,0.5020188425302827,HLA-B,6,G,7.6416548904534345,Medium Risk,35,5,175,2,0.048065633859282406,7.641654890453457
rs12133753,Multiple sclerosis,0.6453900709219857,2e-16,15.698970004336,0.12284350911537992,TGFBR3,1,C,1.9285165648297276,High Risk,20,166,535,1,0.07928198106028064,1.928516564829725
rs2163226,Multiple sclerosis,0.7553191489361702,2e-16,15.698970004336,0.1214976140951915,LINC02580,2,A,1.9073873992788044,High Risk,20,332,286,0,0.09176947447615529,1.907387399278802
rs7552544,Multiple sclerosis,0.4361702127659575,2e-16,15.698970004336,0.11905053224030346,VCAM1 - EXTL2,1,A,1.868970734640762,High Risk,20,705,582,0,0.05192629597715365,1.8689707346407598
rs13327021,Multiple sclerosis,0.6453900709219857,2e-16,15.698970004336,0.11699362535176801,EOMES - LINC01980,3,T,1.836679415095932,High Risk,20,226,119,3,0.07550652416319778,1.8366794150959296
rs9273529,Rheumatoid arthritis or multiple sclerosis,0.3120567375886525,4e-16,15.397940008672,0.24100085647864924,HLA-DQB1,6,G,3.710916730096821,High Risk,54,784,184,2,0.07520594102879835,3.710916730096812
rs2975043,Rheumatoid arthritis or multiple sclerosis,0.4609929078014185,5e-16,15.301029995664,0.24592077572494805,POLR1HASP,6,G,3.762841165924385,High Risk,54,425,416,2,0.11336773349022429,3.7628411659243897
rs1335532,Multiple sclerosis,0.6453900709219857,3e-16,15.5228787452803,0.13373302336963172,CD58,1,A,2.075921506006535,High Risk,20,229,64,0,0.08630996543713819,2.0759215060065297
rs4613763,Multiple sclerosis,0.6453900709219857,3e-16,15.5228787452803,0.13128594151474368,RNU1-150P - TTC33,5,G,2.037935751093332,High Risk,20,515,457,2,0.0847306431052601,2.037935751093327
rs115277907,Rheumatoid arthritis or multiple sclerosis,0.3120567375886525,3e-16,15.5228787452803,0.12232554345609528,C2,6,G,1.8988445785194876,Low Risk,54,130,43,2,0.03817251001466803,1.8988445785194832
chr7:50328339,Multiple sclerosis,0.6453900709219857,3e-16,15.5228787452803,0.11797381622415269,C7orf72,6,A,1.8312932443655086,High Risk,20,43,45,0,0.07613912961984322,1.8312932443655041
rs61863928,Multiple sclerosis,0.6453900709219857,3e-16,15.5228787452803,0.11771687262938946,LINC02929 - ALDH7A1P4,10,G,1.8273047400996223,High Risk,20,589,299,2,0.07597330077499602,1.8273047400996179
rs2317231,Multiple sclerosis,0.6453900709219857,3e-16,15.5228787452803,0.11665239202251315,FCRL3 - VDAC1P9,1,G,1.810780936712379,High Risk,20,363,141,2,0.07528629556062905,1.8107809367123746
rs3129934,Multiple sclerosis,0.08510638297872347,7e-16,15.1549019599857,0.2707696072433623,"TSBP1, TSBP1-AS1",6,T,4.103486851517001,Medium Risk,20,440,564,3,0.02304422189305213,4.1034868515169896
rs4410871,Multiple sclerosis,0.7446808510638299,4e-16,15.397940008672,0.12027407316774748,PVT1,8,G,1.8519729632356068,High Risk,20,510,429,2,0.08956579916747154,1.8519729632356023
chr16:11353879,Multiple sclerosis,0.5106382978723405,5e-16,15.301029995664,0.11790425792242751,SOCS1,6,T,1.804056587087566,High Risk,20,17,509,3,0.0602064295774098,1.8040565870875682
rs12622670,Multiple sclerosis,0.5106382978723405,5e-16,15.301029995664,0.11783922672213387,PLEK - WDR4P2,2,T,1.8030615427412189,High Risk,20,191,412,3,0.06017322215598326,1.8030615427412213
rs9266658,Rheumatoid arthritis or multiple sclerosis,0.1418439716312057,7e-16,15.1549019599857,0.16973367592479302,FGFR3P1 - ZDHHC20P2,6,G,2.572297217948231,High Risk,54,770,142,2,0.024075698712736605,2.5722972179482233
rs2283792,Multiple sclerosis,0.5425531914893618,6e-16,15.2218487496164,0.11905053224030346,MAPK1,22,C,1.8121691953232248,High Risk,20,351,323,1,0.0645912462154838,1.8121691953232302
rs6457617,Immunoglobulin G index levels in multiple sclerosis,0.3368794326241135,7e-17,16.1549019599857,0.0,HLA-DQB1 - MTCO3P1,6,A,0.0,Low Risk,15,604,185,0,0.0,0.0
rs983494,Multiple sclerosis,0.5106382978723405,6e-16,15.2218487496164,0.1175211060809984,CD48 - SLAMF7,1,G,1.7888885016525766,High Risk,20,821,63,2,0.06001077757327579,1.788888501652582
rs6533052,Multiple sclerosis,0.5106382978723405,7e-16,15.1549019599857,0.1181573473632693,SLC9B1,4,A,1.7906630151423262,High Risk,20,614,504,0,0.060335666738690716,1.790663015142321
rs4810485,Multiple sclerosis,0.24468085106382984,8e-16,15.0969100130081,0.12027407316774748,CD40,20,A,1.8157668595114305,Low Risk,20,536,62,0,0.029428762583597792,1.8157668595114358
rs522308,Neutralising antibody response to interferon beta therapy in multiple sclerosis (presence of antibodies),0.24468085106382984,2e-15,14.698970004336,0.3025816713569069,HLA-DRB1 - HLA-DQA1,6,T,4.447638911137034,Medium Risk,44,555,188,3,0.07403594086392404,4.447638911137028
rs72922276,Multiple sclerosis,0.32269503546099293,1e-15,15.0,0.12690566499449407,JAK1,1,G,1.9035849749174112,High Risk,20,686,235,2,0.040951828065599154,1.9035849749174112
chr1:32738415,Multiple sclerosis,0.32269503546099293,1e-15,15.0,0.12294896610791632,LCK,6,A,1.8442344916187448,Low Risk,20,27,248,0,0.03967502097808648,1.8442344916187448
rs2239707,Rheumatoid arthritis or multiple sclerosis,0.1418439716312057,1e-15,15.0,0.12262513560911947,NFKBIL1,6,G,1.839377034136792,Low Risk,54,338,384,2,0.017393636256612697,1.839377034136792
rs4796224,Multiple sclerosis,0.36170212765957455,1e-15,15.0,0.118020775724948,ZNHIT3,17,G,1.77031163587422,Low Risk,20,533,611,2,0.04268836568774716,1.77031163587422
HLA-DQB1*02:01,Neuromyelitis optica (AQP4-IgG-positive),0.11702127659574474,4e-15,14.397940008672,0.44818304172274565,HLA-DQB1,6,G,6.452912547628249,Medium Risk,35,8,184,2,0.05244695169095962,6.452912547628232
rs7535818,Multiple sclerosis,0.29078014184397166,2e-15,14.698970004336,0.14545326073657164,RGS1,1,G,2.1380131165997325,High Risk,20,704,443,2,0.042294919788648494,2.13801311659973
rs72928038,Multiple sclerosis,0.1808510638297873,2e-15,14.698970004336,0.12394469595007952,BACH2,6,A,1.821859367966767,Low Risk,20,687,26,0,0.02241553011863141,1.8218593679667645
rs12722559,Multiple sclerosis,0.29078014184397166,2e-15,14.698970004336,0.1236021044903952,IL2RA,10,C,1.8168236263771254,Low Risk,20,198,220,1,0.035941037475930526,1.816823626377123
rs669607,Multiple sclerosis,0.29078014184397166,2e-15,14.698970004336,0.1227211550226355,LINC01967,3,C,1.8038745765751898,Low Risk,20,629,274,1,0.03568487486473799,1.8038745765751873
rs9271640; rs3135388; rs3957148,Oligoclonal band status in multiple sclerosis,0.27659574468085113,4e-15,14.397940008672,0.25731065704147804,HLA-DRB1 - HLA-DQA1; HLA-DRA - HLA-DRB9; MTCO3P1 - HLA-DQB3,6,G,3.704743403675186,High Risk,50,775,190,2,0.07117103279870671,3.7047434036751765
rs1801133,Multiple sclerosis,0.2907801418439716,2e-15,14.698970004336,0.11991337330233695,MTHFR,1,G,1.7626030772897985,Low Risk,20,294,360,2,0.03486842769784266,1.762603077289796
rs2371108,Multiple sclerosis,0.3936170212765958,2e-15,14.698970004336,0.11905053224030346,LINC02084 - EOMES,3,A,1.7499202024004588,High Risk,20,369,278,0,0.04686031588182158,1.7499202024004563
rs1870071,Multiple sclerosis,0.29787234042553196,2e-15,14.698970004336,0.11905053224030346,EPS15L1,19,G,1.7499202024004588,Low Risk,20,303,122,2,0.03546186066732444,1.7499202024004563
rs12147246,Multiple sclerosis,0.2907801418439716,2e-15,14.698970004336,0.11835695583017251,TRAF3,14,A,1.7397253435522289,Low Risk,20,167,557,0,0.03441585240451825,1.7397253435522266
rs3828840,Multiple sclerosis (OCB status),0.25886524822695045,5e-15,14.301029995664,0.22182797014560135,"HLA-DRB6, HLA-DRB6",6,G,3.172368454929499,High Risk,21,484,191,2,0.05742355255542165,3.1723684549295035
rs3129720,Multiple sclerosis (OCB status),0.25886524822695045,5e-15,14.301029995664,0.2181573473632693,HLA-DQB1 - MTCO3P1,6,G,3.119874768416601,High Risk,21,436,185,2,0.05647335587772576,3.1198747684166053
rs405343,Multiple sclerosis,0.45390070921985826,3e-15,14.5228787452803,0.11918255230637465,SOX8 - SSTR5,16,T,1.7308737556985103,High Risk,20,493,510,3,0.054097045018496305,1.7308737556985059
rs8283,Rheumatoid arthritis or multiple sclerosis,0.4468085106382979,3e-15,14.5228787452803,0.11909453892899384,ATF6B,6,G,1.7295955480908463,High Risk,54,755,21,2,0.053212453564018526,1.7295955480908418
rs9736016,Multiple sclerosis,0.6489361702127661,3e-15,14.5228787452803,0.11905053224030346,Y_RNA - CXCR5,11,T,1.7289564442870147,High Risk,20,816,594,3,0.07725619645381396,1.7289564442870102
rs1782645,Multiple sclerosis,0.41489361702127664,3e-15,14.5228787452803,0.11905053224030346,ZMIZ1,10,A,1.7289564442870147,High Risk,20,291,604,0,0.04939330592948761,1.7289564442870102
rs3129871,Multiple sclerosis (OCB status),0.36170212765957455,6e-15,14.2218487496164,0.19491006974183286,TSBP1-AS1 - HLA-DRA,6,G,2.7719815316455225,High Risk,21,438,566,2,0.070499386927897,2.771981531645531
rs7731626,Multiple sclerosis,0.5390070921985817,4e-15,14.397940008672,0.11836534932093479,ANKRD55,5,G,1.7042171986283285,High Risk,20,723,14,2,0.06379976275454642,1.704217198628324
rs11810217,Multiple sclerosis,0.40780141843971635,6e-15,14.2218487496164,0.12516823687752354,EVI5,1,A,1.780123733128292,High Risk,20,149,132,0,0.051043784542252515,1.7801237331282975
rs8107548,Multiple sclerosis,0.25531914893617025,6e-15,14.2218487496164,0.12027407316774748,DKKL1,19,G,1.7105196770919957,Low Risk,20,753,100,2,0.030708274000275957,1.710519677092001
rs523604,Multiple sclerosis,0.5531914893617023,6e-15,14.2218487496164,0.11905053224030346,CXCR5,11,A,1.6931186630829214,High Risk,20,556,95,0,0.06585774123931683,1.6931186630829267
rs1738074,Multiple sclerosis,0.40780141843971635,7e-15,14.1549019599857,0.1227211550226355,"TAGAP, TAGAP-AS1",6,G,1.7371059177616175,High Risk,20,275,525,2,0.05004586109079108,1.7371059177616122
rs4648356,Multiple sclerosis,0.5000000000000001,1e-14,14.0,0.12394469595007952,TTC34,1,C,1.7352257433011133,High Risk,20,516,570,1,0.061972347975039775,1.7352257433011133
rs58394161,Multiple sclerosis,0.5000000000000001,1e-14,14.0,0.12304308087605531,GFI1,1,C,1.7226031322647744,High Risk,20,575,156,1,0.06152154043802767,1.7226031322647744
rs34536443,Multiple sclerosis,1.0,2e-14,13.698970004336,0.1422978098617399,TYK2,19,C,1.949333428978685,High Risk,20,456,572,1,0.1422978098617399,1.9493334289786821
rs2534671,Rheumatoid arthritis or multiple sclerosis,0.5921985815602837,2e-14,13.698970004336,0.1272727272727273,MICB,6,G,1.7435052732791299,High Risk,54,384,337,2,0.07537072856221794,1.7435052732791274
rs842639,Multiple sclerosis,0.6914893617021278,2e-14,13.698970004336,0.11905053224030346,REL-DT,2,A,1.6308696701601553,High Risk,20,756,438,0,0.08232217654914603,1.6308696701601528
rs244656,Multiple sclerosis,0.5921985815602837,3e-14,13.5228787452803,0.1204698397161385,VDAC1 - TCF7,5,A,1.6290990349446983,High Risk,20,373,583,0,0.07134206820069196,1.6290990349446939
rs9863496,Multiple sclerosis,0.5921985815602837,3e-14,13.5228787452803,0.11605286920347485,SATB1-AS1,3,C,1.5693688782804691,High Risk,20,825,481,1,0.06872634452829894,1.5693688782804647
rs6742,Multiple sclerosis,0.3262411347517731,4e-14,13.397940008672,0.12507035360332802,SLC2A4RG,20,C,1.6756850944407875,High Risk,20,635,497,1,0.040803094083355244,1.6756850944407828
rs1800693,Multiple sclerosis,0.3262411347517731,4e-14,13.397940008672,0.1214976140951915,TNFRSF1A,12,G,1.6278177448441618,Low Risk,20,293,548,2,0.039637519492048294,1.6278177448441573
rs6564681,Multiple sclerosis,0.3262411347517731,4e-14,13.397940008672,0.11670713324360699,MAFTRR,16,C,1.5636351697819404,Low Risk,20,615,319,1,0.03807466758302072,1.5636351697819362
rs3737798,Multiple sclerosis,0.3262411347517731,4e-14,13.397940008672,0.11588156123822344,VANGL2,1,A,1.5525742055809726,Low Risk,20,469,578,0,0.0378053320351651,1.5525742055809681
rs60600003,Multiple sclerosis,0.08510638297872347,6e-14,13.2218487496164,0.12516823687752354,ELMO1,7,C,1.6549554962507684,Low Risk,20,581,117,1,0.010652615904470097,1.654955496250774
rs17724508,Multiple sclerosis,0.1879432624113476,6e-14,13.2218487496164,0.12432399363758719,RNA5SP431 - MAF,16,T,1.643793039824444,Low Risk,20,285,454,3,0.023365856960255758,1.6437930398244494
rs12296430,Multiple sclerosis,0.20212765957446813,7e-14,13.1549019599857,0.1214976140951915,LTBR - RPL31P10,12,C,1.5982892017944261,Low Risk,20,175,317,1,0.024558028380942967,1.5982892017944208
rs9271640; rs6457617; rs3957148,Immunoglobulin G index levels in multiple sclerosis,0.27659574468085113,8e-14,13.0969100130081,0.12241945022227661,HLA-DRB1 - HLA-DQA1; HLA-DQB1 - MTCO3P1; MTCO3P1 - HLA-DQB3,6,G,1.603316523403076,Low Risk,15,776,189,2,0.033860698997650984,1.6033165234030813
rs2523589,Rheumatoid arthritis or multiple sclerosis,0.3368794326241135,8e-14,13.0969100130081,0.12241945022227661,HLA-B,6,G,1.603316523403076,Low Risk,54,382,175,2,0.04124059493303645,1.6033165234030813
rs1077667,Multiple sclerosis,0.3581560283687944,9e-14,13.0457574905607,0.12639177780496758,TNFSF14,19,G,1.6488764820444362,High Risk,20,83,549,2,0.04526797715709833,1.6488764820444393
rs883871,Multiple sclerosis,0.3581560283687944,9e-14,13.0457574905607,0.12248031322647743,NR1D1,17,A,1.5978484637205357,High Risk,20,759,392,0,0.043867062538561076,1.5978484637205386
rs9308424,Multiple sclerosis,0.3581560283687944,9e-14,13.0457574905607,0.1183862596353848,BATF3 - NSL1,1,G,1.544438433417782,Low Risk,20,795,29,2,0.04240075256444634,1.544438433417785
rs11154801,Multiple sclerosis,0.3581560283687944,1e-13,13.0,0.1227211550226355,AHI1,6,A,1.5953750152942616,High Risk,20,120,9,0,0.04395332147973826,1.5953750152942616
rs7595717,Multiple sclerosis,0.2659574468085107,1e-13,13.0,0.11905053224030346,CNRIP1 - PLEK,2,A,1.5476569191239449,Low Risk,20,713,82,0,0.031662375595825396,1.5476569191239449
rs3873444,Rheumatoid arthritis or multiple sclerosis,0.3581560283687944,1e-13,13.0,0.1182605938251968,MTCO3P1 - HLA-DQB3,6,G,1.5373877197275583,Low Risk,54,488,357,2,0.04235574459696766,1.5373877197275583
rs2269434,Multiple sclerosis,0.3581560283687944,1e-13,13.0,0.11790425792242751,MYBPC3,11,C,1.5327553529915576,Low Risk,20,347,365,1,0.0422281207452666,1.5327553529915576
rs4794058,Multiple sclerosis,0.5319148936170214,1e-13,13.0,0.11782699131285942,EFCAB13-DT - NPEPPS,17,A,1.5317508870671726,High Risk,20,532,112,0,0.06267393154939332,1.5317508870671726
HLA-C*07:01,Neuromyelitis optica (AQP4-IgG-positive),0.13829787234042556,5e-13,12.301029995664,0.38333537256821243,HLA-C,6,G,4.7154199163606085,Medium Risk,35,6,177,2,0.053014466419008116,4.7154199163606165
rs7132277,Multiple sclerosis,0.1808510638297873,2e-13,12.698970004336,0.1214976140951915,PITPNM2,12,A,1.54289455699323,Low Risk,20,663,408,0,0.02197297276189634,1.5428945569932275
rs2248359,Multiple sclerosis,0.6382978723404256,2e-13,12.698970004336,0.11782699131285942,CYP24A1 - PFDN4,20,G,1.4962814283831625,High Risk,20,342,97,2,0.07520871785927198,1.4962814283831603
rs2084007,Multiple sclerosis,0.5354609929078015,2e-13,12.698970004336,0.11703168971002079,JADE2,5,C,1.4861819171843142,High Risk,20,322,234,1,0.06266590477380546,1.486181917184312
rs7385730,B-cell lymphoblastic leukemia or multiple sclerosis (pleiotropy),0.4361702127659575,2e-13,12.698970004336,0.11684000163138791,SPMIP7 - IKZF1,7,G,1.4837476760235666,High Risk,0,698,513,2,0.05096212837113729,1.4837476760235644
rs6738544,Multiple sclerosis,0.5354609929078015,2e-13,12.698970004336,0.11588156123822344,STAT4,2,C,1.4715764702198268,High Risk,20,634,517,1,0.06205005584032532,1.4715764702198246
rs719316,Multiple sclerosis,0.5354609929078015,2e-13,12.698970004336,0.1156613238712835,ATXN1,6,T,1.4687796825032227,High Risk,20,670,23,3,0.061932127321148264,1.4687796825032204
rs17208314,Rheumatoid arthritis or multiple sclerosis,0.4290780141843972,4e-13,12.397940008672,0.20613830090949875,TSBP1-AS1,6,G,2.55569028816555,High Risk,54,272,565,2,0.08844941280159345,2.5556902881655423
rs71624119,Multiple sclerosis,0.7872340425531916,3e-13,12.5228787452803,0.12027407316774748,ANKRD55,5,G,1.506177634480677,High Risk,20,666,14,2,0.0946838448341842,1.5061776344806725
rs7975763,Multiple sclerosis,0.5354609929078015,3e-13,12.5228787452803,0.11725253884742445,PITPNM2,12,T,1.4683393265625688,High Risk,20,737,408,3,0.06278416087220245,1.4683393265625644
rs12148050,Multiple sclerosis,0.3617021276595745,5e-13,12.301029995664,0.11782699131285942,TRAF3,14,A,1.449393354438323,Low Risk,20,168,557,0,0.04261827345358746,1.4493933544383255
rs17066096,Multiple sclerosis,0.5248226950354611,6e-13,12.2218487496164,0.12394469595007952,IL20RA - IL22RA2,6,G,1.5148333272190588,High Risk,20,261,219,2,0.06504898936387153,1.5148333272190644
rs67297943,Multiple sclerosis,0.8297872340425533,6e-13,12.2218487496164,0.12027407316774748,LINC02865,6,A,1.4699715307565007,High Risk,20,633,296,0,0.09980189050089686,1.469971530756506
rs11052877,Multiple sclerosis,0.3829787234042554,6e-13,12.2218487496164,0.11782699131285942,CD69,12,G,1.440063666448128,High Risk,20,108,67,2,0.04512523071556319,1.4400636664481334
rs34695601,Multiple sclerosis,0.5248226950354611,6e-13,12.2218487496164,0.11699498348219747,BATF - FLVCR2-AS1,14,T,1.4298949925832813,High Risk,20,458,28,3,0.06140162253675613,1.4298949925832867
rs249677,Multiple sclerosis,0.5248226950354611,6e-13,12.2218487496164,0.11584092744402301,NDFIP1 - SPRY4,5,A,1.4157902942361316,High Risk,20,377,381,0,0.06079594773657946,1.415790294236137
rs735542,Multiple sclerosis,0.5248226950354611,6e-13,12.2218487496164,0.1157225009176557,"CASC19, PCAT1",8,A,1.4143429031429278,High Risk,20,697,51,0,0.06073379480784768,1.414342903142933
HLA-DRB1*03:01,Neuromyelitis optica,0.1063829787234043,2e-12,11.698970004336,0.31604062155879115,HLA-DRB1,6,G,3.6973497517680087,Medium Risk,34,9,187,2,0.03362134271902035,3.697349751768003
rs3218816,Rheumatoid arthritis or multiple sclerosis,0.4397163120567377,1e-12,12.0,0.118629662710551,GTF2H4,6,G,1.4235559525266122,High Risk,54,446,168,2,0.052163397787618186,1.4235559525266122
rs3819715,Rheumatoid arthritis or multiple sclerosis,0.4397163120567377,1e-12,12.0,0.118629662710551,TAP2,6,G,1.4235559525266122,High Risk,54,483,526,2,0.052163397787618186,1.4235559525266122
rs7743807,Rheumatoid arthritis or multiple sclerosis,0.4397163120567377,1e-12,12.0,0.118629662710551,EHMT2,6,G,1.4235559525266122,High Risk,54,724,114,2,0.052163397787618186,1.4235559525266122
rs144595899,Rheumatoid arthritis or multiple sclerosis,0.4397163120567377,1e-12,12.0,0.118629662710551,ATF6B,6,G,1.4235559525266122,High Risk,54,244,21,2,0.052163397787618186,1.4235559525266122
rs6496663,Multiple sclerosis,0.5248226950354611,1e-12,12.0,0.11778792365104612,GOLGA2P8 - GABARAPL3,15,C,1.4134550838125535,High Risk,20,607,162,1,0.06181777553317315,1.4134550838125535
rs2523608,Binding antibody response to interferon beta therapy in multiple sclerosis (antibody levels; all treatment preparations),0.4893617021276596,2e-13,12.698970004336,0.0066991912394469555,HLA-B,6,G,0.08507282860304752,Low Risk,4,383,175,2,0.0032783276278144677,0.08507282860304739
rs9267821,Rheumatoid arthritis or multiple sclerosis,0.4255319148936171,2e-12,11.698970004336,0.1827894082140381,NOTCH4,6,G,2.138447803806364,High Risk,54,771,389,2,0.07778272689959069,2.13844780380636
rs2859448,Rheumatoid arthritis or multiple sclerosis,0.4255319148936171,2e-12,11.698970004336,0.1827894082140381,HCP5,6,G,2.138447803806364,High Risk,54,413,173,2,0.07778272689959069,2.13844780380636
rs2300747,Multiple sclerosis,0.6950354609929079,2e-12,11.698970004336,0.1475998164688609,CD58,1,G,1.7267658255147051,High Risk,20,361,64,2,0.10258710648190333,1.7267658255147023
rs6589939,Multiple sclerosis,0.5709219858156029,2e-12,11.698970004336,0.11695058118194056,GLULP3 - UBASH3B,11,G,1.368201341237187,High Risk,20,617,159,2,0.06676965805068238,1.3682013412371847
chr2:112492986,Multiple sclerosis,0.5709219858156029,2e-12,11.698970004336,0.1153770219013826,MIR4435-1HG,6,C,1.349792318413895,High Risk,20,30,342,1,0.06587127846142767,1.3497923184138927
HLA-B*08:01,Neuromyelitis optica,0.09574468085106386,6e-12,11.2218487496164,0.3172641624862352,HLA-B,6,G,3.5602904450942385,Medium Risk,34,5,175,2,0.030376355982724652,3.5602904450942527
rs1150757,Neuromyelitis optica,0.08510638297872347,7e-12,11.1549019599857,0.3343937354704515,TNXB,6,A,3.730129335206293,Medium Risk,34,128,554,0,0.028459041316634192,3.730129335206279
rs28383224,Neuromyelitis optica,0.4255319148936171,6e-12,11.2218487496164,0.2585341979689221,HLA-DRB1 - HLA-DQA1,6,A,2.9012316662106157,High Risk,34,410,188,0,0.11001455232720089,2.9012316662106272
rs2236262,Multiple sclerosis,0.5106382978723405,3e-12,11.5228787452803,0.1166034503854154,ZFP36L1,14,A,1.3436074200724535,High Risk,20,336,602,0,0.05954218743085043,1.3436074200724493
rs2157338,Rheumatoid arthritis or multiple sclerosis,0.4255319148936172,3e-12,11.5228787452803,0.1165093070679881,HLA-DRB9,6,G,1.34252261804106,High Risk,54,331,192,2,0.049578428539569425,1.3425226180410559
rs9461856,Rheumatoid arthritis or multiple sclerosis,0.4255319148936172,3e-12,11.5228787452803,0.1165093070679881,SYNGAP1,6,G,1.34252261804106,High Risk,54,804,522,2,0.049578428539569425,1.3425226180410559
rs9271640,Oligoclonal band status in multiple sclerosis,0.6773049645390072,5e-12,11.301029995664,0.17533341490272852,HLA-DRB1 - HLA-DQA1,6,A,1.9814481810579332,High Risk,50,774,188,0,0.11875419236319558,1.9814481810579365
HLA-DQA1*05:01,Neuromyelitis optica (AQP4-IgG-positive),0.22340425531914898,1e-11,11.0,0.3392878991802276,HLA-DQA1,6,G,3.7321668909825036,Medium Risk,35,7,182,2,0.07579836045515725,3.7321668909825036
rs9967792,Multiple sclerosis,0.6595744680851064,4e-12,11.397940008672,0.11782699131285942,STAT4,2,G,1.342984978386293,High Risk,20,831,517,2,0.07771567512124772,1.3429849783862886
rs4262739,Multiple sclerosis,0.5709219858156029,4e-12,11.397940008672,0.11509747950568947,ETS1,11,G,1.3118741665552078,High Risk,20,500,126,2,0.0657116815617589,1.3118741665552036
HLA-DQB1*02:01,Neuromyelitis optica,0.11702127659574474,1e-11,11.0,0.3001345895020189,HLA-DQB1,6,G,3.301480484522208,Medium Risk,34,8,184,2,0.03512213281406606,3.301480484522208
DRB*13:03,Multiple sclerosis,0.21276595744680854,1e-11,11.0,0.28178147559035854,DRB1,6,G,3.099596231493944,Medium Risk,20,3,108,2,0.059953505444757145,3.099596231493944
rs17780048,Multiple sclerosis,0.6595744680851064,5e-12,11.301029995664,0.11914841551449896,WAKMAR2,6,C,1.3464998176651886,High Risk,20,288,586,1,0.0785872527861589,1.3464998176651908
rs2289746,Multiple sclerosis,0.574468085106383,5e-12,11.301029995664,0.11716627921203965,CBLB,3,C,1.3240996358556012,High Risk,20,356,54,1,0.06730828805798023,1.3240996358556034
rs9265549,Rheumatoid arthritis or multiple sclerosis,0.421985815602837,4e-12,11.397940008672,0.08252007504384357,LINC02571 - HLA-B,6,G,0.9405588648608435,Low Risk,54,768,285,2,0.034822301170983644,0.9405588648608404
rs35929052,Multiple sclerosis,0.9148936170212767,6e-12,11.2218487496164,0.12516823687752354,LINC02132 - LINC01082,16,G,1.4046190224957213,High Risk,20,467,280,2,0.11451562097305347,1.404619022495727
rs793108,Multiple sclerosis,0.5212765957446809,6e-12,11.2218487496164,0.1166034503854154,LINC02664,10,A,1.3085062839085266,High Risk,20,734,292,0,0.06078264966899314,1.308506283908532
rs666930,Multiple sclerosis,0.5425531914893618,6e-12,11.2218487496164,0.1166034503854154,PHGDH,1,G,1.3085062839085266,High Risk,20,621,404,2,0.06326357414527858,1.308506283908532
rs12614091,Multiple sclerosis,0.6595744680851064,6e-12,11.2218487496164,0.11611403401443779,KRT18P39 - NPM1P33,2,A,1.3030141274178297,High Risk,20,190,245,0,0.07658585222228877,1.3030141274178348
rs4925166,Multiple sclerosis,0.6595744680851064,7e-12,11.1549019599857,0.12673323137158937,TOP3A,17,G,1.413696771022269,High Risk,20,548,555,2,0.08359000367062279,1.4136967710222637
rs4409785,Multiple sclerosis,0.6595744680851064,7e-12,11.1549019599857,0.11751245564664137,LNCRNA-IUR - FAM76B,11,C,1.3108399218154574,High Risk,20,509,309,1,0.07750821542650814,1.3108399218154525
rs3830041,Rheumatoid arthritis or multiple sclerosis,0.3439716312056738,8e-12,11.0969100130081,0.12655897059423304,NOTCH4,6,G,1.4044135080231368,High Risk,54,485,389,2,0.043532695559009245,1.4044135080231424
chr11:14868316,Multiple sclerosis,0.698581560283688,9e-12,11.0457574905607,0.1418903829683103,PDE3B,6,G,1.5672867605107363,High Risk,20,13,399,2,0.09912200512325224,1.56728676051074
rs4902647,Multiple sclerosis,0.574468085106383,9e-12,11.0457574905607,0.12027407316774748,RNU6-921P - ZFP36L1,14,G,1.3285182446128894,High Risk,20,544,463,2,0.0690936165006209,1.3285182446128923
rs9260489,Multiple sclerosis,0.45744680851063835,1e-11,11.0,0.1325094824421877,POLR1HASP,6,T,1.4576043068640645,High Risk,20,764,416,3,0.060616039840575224,1.4576043068640645
rs9282641,Multiple sclerosis,0.698581560283688,1e-11,11.0,0.1325094824421877,CD86,3,G,1.4576043068640645,High Risk,20,790,68,2,0.09256868099684744,1.4576043068640645
rs1891621,Multiple sclerosis,0.698581560283688,1e-11,11.0,0.12509791998042336,LINC02664,10,G,1.3760771197846569,High Risk,20,307,292,2,0.0873911001281681,1.3760771197846569
rs2546890,Multiple sclerosis,0.574468085106383,1e-11,11.0,0.12027407316774748,IL12B - LINC01845,5,A,1.3230148048452222,High Risk,20,385,218,0,0.0690936165006209,1.3230148048452222
rs201847125,Multiple sclerosis,0.723404255319149,1e-11,11.0,0.11905053224030346,SPMIP7 - IKZF1,7,G,1.3095558546433381,High Risk,20,311,513,2,0.08612166162064507,1.3095558546433381
rs57116599,Multiple sclerosis,0.574468085106383,1e-11,11.0,0.1183716138504833,MERTK,2,G,1.3020877523553163,High Risk,20,570,333,2,0.06800071433963935,1.3020877523553163
rs2705616,Multiple sclerosis,0.574468085106383,1e-11,11.0,0.11626550838125535,AFF1,4,C,1.278920592193809,High Risk,20,394,5,1,0.06679082396369988,1.278920592193809
chr5:40429250,Multiple sclerosis,0.574468085106383,1e-11,11.0,0.11558748317631226,LINC00603,6,T,1.2714623149394348,High Risk,20,39,258,3,0.06640132012256236,1.2714623149394348
rs10245867,Multiple sclerosis,0.574468085106383,1e-11,11.0,0.11533501774134344,JAZF1,7,T,1.268685195154778,High Risk,20,66,236,3,0.06625628678758028,1.268685195154778
rs11231749,Multiple sclerosis,0.574468085106383,1e-11,11.0,0.11514743668175702,PRDX5 - CCDC88B,11,C,1.2666218034993273,High Risk,20,122,421,1,0.06614852745547745,1.2666218034993273
rs6837324,Multiple sclerosis,0.574468085106383,1e-11,11.0,0.11495814266487214,TXK,4,G,1.2645395693135937,High Risk,20,640,571,2,0.06603978408407549,1.2645395693135937
rs886401,Binding antibody response to interferon beta therapy in multiple sclerosis (antibody levels; IFNβ-1a subcutaneous and intramuscular),0.4007092198581561,4e-12,11.397940008672,0.014635754312981752,CCHCR1,6,A,0.16681744964102904,Low Risk,1,760,56,0,0.005864681692790562,0.1668174496410285
rs1800693,Multiple sclerosis,0.45744680851063835,2e-11,10.698970004336,0.13128594151474368,TNFRSF1A,12,C,1.4046243502572555,High Risk,20,293,548,1,0.06005633494823382,1.4046243502572529
rs650258,Multiple sclerosis,0.5886524822695036,2e-11,10.698970004336,0.1214976140951915,LINC02954,11,G,1.2998993288028469,High Risk,20,612,301,2,0.07151987212695671,1.2998993288028444
rs2288904,Multiple sclerosis,0.8085106382978724,2e-11,10.698970004336,0.11905053224030346,SLC44A2,19,G,1.2737180734392448,High Risk,20,355,499,2,0.09625362181130918,1.2737180734392426
rs7204270,Multiple sclerosis,0.5,2e-11,10.698970004336,0.11782699131285942,MAPK3 - CORO1A,16,G,1.2606274457574436,High Risk,20,673,326,2,0.05891349565642971,1.2606274457574413
rs34681760,Multiple sclerosis,0.5886524822695036,2e-11,10.698970004336,0.11683592316162977,LINC02102 - TENT4A,5,C,1.2500240373351847,High Risk,20,457,279,1,0.06877575618734236,1.2500240373351825
rs10936602,Multiple sclerosis,0.5886524822695036,2e-11,10.698970004336,0.11618744647008443,LRRIQ4,3,T,1.2430860046638301,High Risk,20,99,316,3,0.06839402877317027,1.243086004663828
rs9992763,Multiple sclerosis,0.5886524822695036,2e-11,10.698970004336,0.11484689832374895,LEF1,4,G,1.2287435202568187,High Risk,20,834,251,2,0.06760491177922812,1.2287435202568164
rs34536443,Multiple sclerosis,0.5460992907801419,3e-11,10.5228787452803,0.13177535788572128,TYK2,19,G,1.3866561126473662,High Risk,20,456,572,2,0.07196242948369176,1.3866561126473613
rs3118470,Multiple sclerosis,0.6631205673758865,3e-11,10.5228787452803,0.1214976140951915,IL2RA,10,G,1.2785046609645634,High Risk,20,434,220,2,0.0805675667936199,1.2785046609645587
rs2248359,Multiple sclerosis,0.6631205673758865,3e-11,10.5228787452803,0.1214976140951915,CYP24A1 - PFDN4,20,G,1.2785046609645634,High Risk,20,342,97,2,0.0805675667936199,1.2785046609645587
rs3129934,Multiple sclerosis,0.26241134751773054,9e-11,10.0457574905607,0.3882295362779885,"TSBP1, TSBP1-AS1",6,T,3.9000597721215002,Medium Risk,20,440,564,3,0.10187583576089061,3.90005977212151
rs7731626,Rheumatoid arthritis or multiple sclerosis,0.4042553191489362,3e-11,10.5228787452803,0.11774134344793832,ANKRD55,5,G,1.2389778804090625,High Risk,54,723,14,2,0.047597564372570816,1.238977880409058
rs12149527,Multiple sclerosis,0.4787234042553192,3e-11,10.5228787452803,0.1166034503854154,WWOX,16,A,1.227003969687038,High Risk,20,169,590,0,0.05582080071642227,1.2270039696870338
rs13385171,Multiple sclerosis,0.5602836879432624,3e-11,10.5228787452803,0.11512296586320814,SPRED2 - LINC02934,2,C,1.2114250105755868,High Risk,20,230,514,1,0.06450151988080456,1.2114250105755824
rs28383224,Neuromyelitis optica (AQP4-IgG-positive),0.4255319148936171,8e-11,10.0969100130081,0.30992291692157103,HLA-DRB1 - HLA-DQA1,6,A,3.1292638031260744,Medium Risk,35,410,188,0,0.13188209230705153,3.129263803126088
rs17205731,Binding antibody response to interferon beta therapy in multiple sclerosis (antibody levels; IFNβ-1b subcutaneous),0.03191489361702132,2e-11,10.698970004336,0.06035238712834945,HLA-DQB1 - MTCO3P1,6,T,0.645708379576286,Low Risk,3,271,185,3,0.0019261400147345597,0.6457083795762848
rs9275563,Multiple sclerosis (OCB status),0.8212765957446808,6e-11,10.2218487496164,0.19858069252416494,MTCO3P1 - HLA-DQB3,6,G,2.0298618035760856,High Risk,21,785,357,2,0.16308967513686737,2.0298618035760945
rs35967351,Multiple sclerosis,0.7021276595744682,4e-11,10.397940008672,0.11782699131285942,SLAMF7,1,A,1.2251579870734337,High Risk,20,468,494,0,0.08272958964519919,1.2251579870734293
rs4711253,Rheumatoid arthritis or multiple sclerosis,0.4858156028368796,4e-11,10.397940008672,0.11585968432644073,MUC22 - HCG22,6,G,1.2047020470500107,High Risk,54,524,362,2,0.05628644238554037,1.2047020470500063
rs2726479,Multiple sclerosis,0.624113475177305,4e-11,10.397940008672,0.11506957053713447,TET2-AS1,4,C,1.1964864912687796,High Risk,20,397,534,1,0.07181646955509102,1.1964864912687754
rs3184504,Multiple sclerosis,0.624113475177305,4e-11,10.397940008672,0.11468249112932828,"ATXN2, SH2B3",12,T,1.1924616628078186,High Risk,20,445,24,3,0.07157488808071552,1.1924616628078144
rs703842,Multiple sclerosis,0.6914893617021278,5e-11,10.301029995664,0.13495656429707575,"METTL1, CYP27B1",12,A,1.390191616935932,High Risk,20,657,335,0,0.09332102850329708,1.3901916169359347
HLA-C*07:01,Neuromyelitis optica,0.13829787234042556,1e-10,10.0,0.2756637709531384,HLA-C,6,G,2.756637709531384,Medium Risk,34,6,177,2,0.03812371300415744,2.756637709531384
rs7595037,Multiple sclerosis,0.6985815602836881,5e-11,10.301029995664,0.12027407316774748,PLEK - WDR4P2,2,A,1.238946835401651,High Risk,20,712,412,0,0.0840212496951995,1.2389468354016535
rs9955954,Multiple sclerosis,0.6985815602836881,5e-11,10.301029995664,0.11774435335861987,MALT1,18,A,1.2128881157672022,High Risk,20,830,320,0,0.08225403408385858,1.2128881157672047
rs760517,Multiple sclerosis,0.6985815602836881,5e-11,10.301029995664,0.11537990945797139,"NCF4-AS1, NCF4",22,C,1.1885319082235575,High Risk,20,715,374,1,0.08060227717454031,1.1885319082235597
rs5756405,Multiple sclerosis,0.6985815602836881,5e-11,10.301029995664,0.11470696194787716,CSF2RB,22,A,1.1815998557365694,High Risk,20,572,88,0,0.08013216845294967,1.181599855736572
chr3:100848597,Multiple sclerosis,0.7695035460992907,6e-11,10.2218487496164,0.12586565520616663,ABI3BP,6,C,1.2865796902887978,High Risk,20,32,0,1,0.09685406801325587,1.2865796902888034
rs140522,Chronic lymphocytic leukemia or multiple sclerosis,0.7695035460992907,6e-11,10.2218487496164,0.12007852685672336,CIMAP1B - KLHDC7B-DT,22,G,1.2274245396061718,High Risk,6,240,76,2,0.09240085222662754,1.2274245396061771
rs1399180,Multiple sclerosis,0.5957446808510638,7e-11,10.1549019599857,0.11924191851217425,"GATA3, GATA3-AS1",10,C,1.2108899920117386,High Risk,20,239,154,1,0.0710377386881038,1.2108899920117335
rs17413179,B-cell lymphoblastic leukemia or multiple sclerosis (pleiotropy),0.6099290780141845,1e-10,10.0,0.17359598678575797,ADIPOR1P1 - EBLN1,10,G,1.7359598678575796,High Risk,0,277,4,2,0.10588124016719991,1.7359598678575796
chr11:118783424,Multiple sclerosis,0.6382978723404256,9e-11,10.0457574905607,0.13934907622659978,BCL9L,6,G,1.3998670263060753,High Risk,20,12,34,2,0.08894621886804242,1.3998670263060786
rs533646,Multiple sclerosis,0.7021276595744682,8e-11,10.0969100130081,0.11782699131285942,TREHP1 - RNU6-376P,11,G,1.1896885283894236,High Risk,20,559,558,2,0.08272958964519919,1.1896885283894287
rs10230723,Multiple sclerosis,0.6382978723404256,8e-11,10.0969100130081,0.11753334149027284,SPMIP7 - IKZF1,7,A,1.186723572555431,High Risk,20,64,513,0,0.07502128180230182,1.1867235725554361
rs756699,Multiple sclerosis,0.9148936170212767,9e-11,10.0457574905607,0.1214976140951915,VDAC1 - TCF7,5,A,1.2205355668820201,High Risk,20,708,583,0,0.111157391619005,1.2205355668820232
rs669607,Multiple sclerosis,0.6382978723404256,1e-10,10.0,0.12883885965985561,LINC01967,3,C,1.2883885965985562,High Risk,20,629,274,1,0.08223756999565253,1.2883885965985562
rs6911131,Multiple sclerosis,0.6205673758865249,1e-10,10.0,0.12164468371467027,PHACTR2,6,G,1.2164468371467028,High Risk,20,646,403,2,0.07548872216335922,1.2164468371467028
rs706015,Multiple sclerosis,0.17021276595744683,1e-10,10.0,0.11905053224030346,SKAP2,7,C,1.1905053224030346,Low Risk,20,658,491,1,0.02026392038132825,1.1905053224030346
rs17119,Multiple sclerosis,0.8297872340425533,1e-10,10.0,0.11905053224030346,RNU6-793P - RPL6P17,6,A,1.1905053224030346,High Risk,20,265,461,0,0.09878661185897522,1.1905053224030346
rs4772201,Multiple sclerosis,0.8617021276595744,1e-10,10.0,0.11905053224030346,LNCARGI - TM9SF2,13,A,1.1905053224030346,High Risk,20,529,308,0,0.10258609693047425,1.1905053224030346
rs7196953,Multiple sclerosis,0.29787234042553196,1e-10,10.0,0.11782699131285942,MAFTRR,16,A,1.1782699131285943,Low Risk,20,671,319,0,0.03509740166766026,1.1782699131285943
rs17051321,Multiple sclerosis,0.3049645390070922,1e-10,10.0,0.1171373424691056,TNIP3,4,T,1.1713734246910559,Low Risk,20,260,552,3,0.03572273564660667,1.1713734246910559
rs1843938,Multiple sclerosis,0.4468085106382979,1e-10,10.0,0.1166034503854154,CARD11 - SDK1-AS1,7,A,1.166034503854154,High Risk,20,301,49,0,0.052099414001994124,1.166034503854154
rs7855251,Multiple sclerosis,0.3049645390070922,1e-10,10.0,0.11628532974427994,TRIM14,9,T,1.1628532974427994,Low Risk,20,731,559,3,0.035462901978752036,1.1628532974427994
rs11871306,Relapse in treatment-naive multiple sclerosis (time to event),0.0,2e-10,9.69897000433602,0.24752232962192586,WNT9B,17,C,2.4007116504064316,High Risk,52,155,588,1,0.0,2.400711650406432
rs9657904,Multiple sclerosis,0.8574468085106384,2e-10,9.69897000433602,0.15575676006362413,CBLB,3,T,1.5106801438296527,High Risk,20,815,54,3,0.13355313682051176,1.510680143829653
rs3095350,Rheumatoid arthritis or multiple sclerosis,0.6900709219858157,2e-10,9.69897000433602,0.13461805130714957,LINC02570 - RN7SKP186,6,G,1.3056564416702108,High Risk,54,432,284,2,0.09289600278145854,1.3056564416702112
rs3134931,Rheumatoid arthritis or multiple sclerosis,0.6900709219858157,2e-10,9.69897000433602,0.13461805130714957,NOTCH4,6,G,1.3056564416702108,High Risk,54,442,389,2,0.09289600278145854,1.3056564416702112
rs2119704,Multiple sclerosis,0.6900709219858157,2e-10,9.69897000433602,0.13373302336963172,LINC01147,14,C,1.297072582251226,High Risk,20,326,263,1,0.0922852707366324,1.2970725822512261
rs10797431,Multiple sclerosis,0.5425531914893618,2e-10,9.69897000433602,0.13012066560626454,TNFRSF14 - PRXL2B,1,G,1.2620364326593971,High Risk,20,85,547,2,0.07059738240339886,1.2620364326593974
rs10201872,Multiple sclerosis,0.5425531914893618,2e-10,9.69897000433602,0.12394469595007952,SP140,2,A,1.2021358882163693,High Risk,20,62,511,0,0.06724659035589421,1.2021358882163695
rs9891119,Multiple sclerosis,0.47163120567375894,2e-10,9.69897000433602,0.12027407316774748,STAT3,17,C,1.1665346279532984,High Risk,20,827,516,1,0.05672500613939864,1.1665346279532987
rs28746882,Binding antibody response to interferon beta therapy in multiple sclerosis (antibody levels; all treatment preparations),0.06382978723404259,5e-11,10.301029995664,0.018326401566132397,HLA-DQB1 - MTCO3P1,6,A,0.18878081224531318,Low Risk,4,415,185,0,0.0011697703127318557,0.18878081224531354
rs9828629,Multiple sclerosis,0.6595744680851064,2e-10,9.69897000433602,0.1166034503854154,FOXP1,3,G,1.1309333676902271,High Risk,20,820,145,2,0.07690865876484847,1.1309333676902273
rs2050568,Multiple sclerosis,0.5531914893617023,2e-10,9.69897000433602,0.1166034503854154,FCRL1,1,G,1.1309333676902271,High Risk,20,317,139,2,0.06450403638342131,1.1309333676902273
rs7222450,Multiple sclerosis,0.47163120567375894,2e-10,9.69897000433602,0.11436437048819284,RNA5SP443 - ARHGAP27,17,A,1.1092165989297538,High Risk,20,674,455,0,0.05393780593946684,1.109216598929754
rs10492972,Multiple sclerosis,0.2659574468085107,3e-10,9.52287874528034,0.14841551449896,KIF1B,1,C,1.413342948491992,High Risk,20,74,240,1,0.0394722113029149,1.4133429484919924
HLA-DQA1*05:01,Neuromyelitis optica,0.22340425531914898,5e-10,9.30102999566398,0.253640034259146,HLA-DQA1,6,G,2.359113566745557,High Risk,34,7,182,2,0.05666426297278795,2.3591135667455565
rs2300747,Multiple sclerosis,0.9148936170212767,3e-10,9.52287874528034,0.1435213507891839,CD58,1,A,1.3667364209242427,High Risk,20,361,64,0,0.13130676774329592,1.366736420924243
rs2523545,Rheumatoid arthritis or multiple sclerosis,0.4609929078014185,3e-10,9.52287874528034,0.13901159508952243,HLA-B,6,G,1.3237905642255297,High Risk,54,381,175,2,0.06408335943843234,1.3237905642255299
rs6662618,Multiple sclerosis and type 2 diabetes (pleiotropy),0.4609929078014185,3e-10,9.52287874528034,0.13901159508952243,RN7SL824P - GFI1,1,G,1.3237905642255297,High Risk,30,620,451,2,0.06408335943843234,1.3237905642255299
chr8:95851818,Multiple sclerosis,0.26950354609929084,3e-10,9.52287874528034,0.1255194787715649,INTS8,6,G,1.195306776512402,Low Risk,20,46,227,2,0.0338279446334714,1.1953067765124024
rs744166,Multiple sclerosis,0.41489361702127664,3e-10,9.52287874528034,0.12516823687752354,STAT3,17,G,1.1919619425451835,High Risk,20,699,516,2,0.051931502534291685,1.1919619425451837
rs2812197,Multiple sclerosis,0.26950354609929084,3e-10,9.52287874528034,0.12509791998042336,DLEU1,13,G,1.191292323260354,Low Risk,20,405,101,2,0.033714333044369424,1.1912923232603543
rs11581062,Multiple sclerosis,0.26950354609929084,3e-10,9.52287874528034,0.1214976140951915,"HNRNPA1P68, SLC30A7",1,G,1.1570070468693718,Low Risk,20,133,198,2,0.03274403784125729,1.157007046869372
rs2836438,Multiple sclerosis,0.26950354609929084,3e-10,9.52287874528034,0.1198084791386272,ERG,21,A,1.1409216194935956,Low Risk,20,408,123,0,0.03228880998062294,1.1409216194935958
rs917116,Multiple sclerosis,0.20212765957446813,3e-10,9.52287874528034,0.11782699131285942,JAZF1,7,C,1.12205215119356,Low Risk,20,763,236,1,0.023816093988769462,1.1220521511935602
rs2585447,Multiple sclerosis,0.2872340425531915,3e-10,9.52287874528034,0.11757035360332804,BCAS1 - CYP24A1,20,C,1.1196082214042262,Low Risk,20,386,30,1,0.0337702079498921,1.1196082214042264
rs10951154,Multiple sclerosis,0.2872340425531915,3e-10,9.52287874528034,0.11659287899180229,"HOXA1, HOTAIRM1",7,C,1.1102998492020764,Low Risk,20,101,201,1,0.03348944396573045,1.1102998492020766
chr6:119215402,Multiple sclerosis,0.2872340425531915,3e-10,9.52287874528034,0.11630980056282882,ASF1A,6,A,1.1076041276475577,Low Risk,20,40,19,0,0.03340813420421679,1.1076041276475577
rs9260765,Binding antibody response to interferon beta therapy in multiple sclerosis (antibody levels; all treatment preparations),0.45744680851063835,5e-11,10.301029995664,0.005717172396916659,POLR1HASP,6,C,0.05889276435102064,Low Risk,4,765,416,1,0.002615302266674642,0.058892764351020754
DRB*03:01,Multiple sclerosis,0.4574468085106383,4e-10,9.39794000867204,0.13862718707940783,DRB1,6,G,1.3028099877432302,High Risk,20,1,108,2,0.0634145643022823,1.3028099877432304
rs6689470,Multiple sclerosis,0.4503546099290781,4e-10,9.39794000867204,0.13618010522451976,GFI1,1,A,1.2798124592746822,High Risk,20,627,156,0,0.06132933816848941,1.2798124592746825
rs9272219,Neuromyelitis optica,0.4255319148936171,8e-10,9.09691001300806,0.28789918022757865,HLA-DQA1,6,A,2.618992935349071,Medium Risk,34,781,182,0,0.12251028945854413,2.6189929353490724
rs12832171,Multiple sclerosis,0.18439716312056748,4e-10,9.39794000867204,0.12712590236143398,TNFRSF1A,12,C,1.1947216039410555,Low Risk,20,203,548,1,0.023441655754590677,1.1947216039410558
rs9261269,Rheumatoid arthritis or multiple sclerosis,0.24822695035461,4e-10,9.39794000867204,0.12592683225253884,"POLR1H, POLR1HASP",6,G,1.1834528149914672,Low Risk,54,766,415,2,0.03125843353786426,1.1834528149914674
rs941816,Multiple sclerosis,0.19148936170212774,4e-10,9.39794000867204,0.12027407316774748,PXT1,6,G,1.1303285242291221,Low Risk,20,802,430,2,0.023031205500206972,1.1303285242291221
rs4780346,Multiple sclerosis,0.24468085106382984,4e-10,9.39794000867204,0.11782699131285942,CLEC16A - HNRNPCP4,16,A,1.1073309957605741,Low Risk,20,530,78,0,0.02883000851272093,1.1073309957605744
rs10191360,Multiple sclerosis,0.24822695035461,4e-10,9.39794000867204,0.11704392511929523,CXCR4 - HNRNPKP2,2,T,1.0999717866506387,Low Risk,20,61,94,3,0.029053456589895988,1.0999717866506389
rs3817963,Multiple sclerosis (OCB status),0.5705673758865248,6e-10,9.22184874961636,0.18145111953994864,"TSBP1-AS1, BTNL2",6,G,1.6733147798459633,High Risk,21,482,567,2,0.10353008912758063,1.673314779845964
rs4940730,Multiple sclerosis,0.24822695035461,4e-10,9.39794000867204,0.1144744891716628,ALPK2,18,A,1.0758243817586637,Low Risk,20,550,12,0,0.028415653340483682,1.075824381758664
rs2425752,Multiple sclerosis,0.20567375886524827,5e-10,9.30102999566398,0.12027407316774748,NCOA5,20,A,1.1186727622339037,Low Risk,20,372,378,0,0.02473722072244452,1.1186727622339034
rs3007421,Multiple sclerosis,0.11702127659574474,5e-10,9.30102999566398,0.12027407316774748,PLEKHG5,1,A,1.1186727622339037,Low Risk,20,430,413,0,0.014074625583459819,1.1186727622339034
rs759648,Multiple sclerosis,0.3085106382978724,5e-10,9.30102999566398,0.1166034503854154,PVT1,8,C,1.0845321896326654,Low Risk,20,714,429,1,0.0359734049061388,1.0845321896326654
rs11125803,Multiple sclerosis,0.22340425531914895,5e-10,9.30102999566398,0.11548919613361067,ADCY3,2,C,1.0741684774138336,Low Risk,20,115,2,1,0.02580077785963643,1.0741684774138334
rs9273011,Rheumatoid arthritis or multiple sclerosis,0.21631205673758871,6e-10,9.22184874961636,0.1414087034544639,HLA-DQA1,6,G,1.3040496751364181,High Risk,54,783,182,2,0.030588407484830854,1.3040496751364186
rs73414214,Multiple sclerosis,0.20567375886524827,6e-10,9.22184874961636,0.1225009176556956,CDHR3 - SYPL1,7,C,1.1296849343100326,Low Risk,20,696,71,1,0.02519522419868917,1.129684934310033
rs12466022,Multiple sclerosis,0.20567375886524827,6e-10,9.22184874961636,0.12027407316774748,LINC02580,2,C,1.1091493112532582,Low Risk,20,180,286,1,0.02473722072244452,1.1091493112532587
rs13414105,Multiple sclerosis,0.18794326241134757,7e-10,9.15490195998574,0.11797381622415269,LBH,2,C,1.0800387213774933,Low Risk,20,231,247,1,0.02217238390028402,1.080038721377493
rs11079784,Multiple sclerosis,0.26205673758865256,8e-10,9.09691001300806,0.12639177780496758,KPNB1-DT,17,C,1.149774629075899,Low Risk,20,112,244,1,0.03312181694959967,1.1497746290758994
chr3:121783015,Multiple sclerosis,0.1879432624113476,8e-10,9.09691001300806,0.12148537868591704,CD86,6,T,1.105141557801994,Low Risk,20,35,68,3,0.02283235840550924,1.1051415578019945
rs16870908,Rheumatoid arthritis or multiple sclerosis,0.36489361702127665,8e-10,9.09691001300806,0.11732533953260735,TAP2,6,G,1.0672980559737457,Low Risk,54,255,526,2,0.042811267510302474,1.0672980559737462
rs354033,Multiple sclerosis,0.18794326241134757,8e-10,9.09691001300806,0.1167625107059831,ZNF767P,7,G,1.062178052785218,Low Risk,20,463,610,2,0.021944727189422364,1.0621780527852185
rs13136820,Multiple sclerosis,0.18794326241134757,8e-10,9.09691001300806,0.11629756515355438,RHOH - LINC02265,4,C,1.0579484849338257,Low Risk,20,216,447,1,0.021857343805455263,1.057948484933826
rs11919880,Multiple sclerosis,0.18794326241134757,8e-10,9.09691001300806,0.11419307475835067,TRIM71 - CCR4,3,A,1.0388041251854176,Low Risk,20,157,563,0,0.02146181901486733,1.038804125185418
rs12253981,Multiple sclerosis,0.5308510638297873,1e-09,9.0,0.14474489171662794,IL2RA,10,G,1.3027040254496514,High Risk,20,174,220,2,0.07683797975169931,1.3027040254496514
rs4939490,Multiple sclerosis,0.26205673758865256,1e-09,9.0,0.1435213507891839,CD6 - LINC02954,11,G,1.2916921571026552,High Risk,20,549,66,2,0.03761073696213012,1.2916921571026552
rs6498168,Multiple sclerosis,0.26205673758865256,1e-09,9.0,0.13495656429707575,CLEC16A,16,T,1.2146090786736818,High Risk,20,609,77,3,0.035366276955864896,1.2146090786736818
rs3781092,B-cell lymphoblastic leukemia or multiple sclerosis (pleiotropy),0.36489361702127665,9e-10,9.04575749056068,0.11743343121660756,GATA3,10,G,1.0622743400698695,Low Risk,0,478,153,2,0.04285070947584723,1.0622743400698702
rs9292777,Multiple sclerosis,0.26205673758865256,1e-09,9.0,0.13006240058729965,RNU1-150P - TTC33,5,T,1.1705616052856969,Low Risk,20,792,457,3,0.034083728380856194,1.1705616052856969
rs2681424,Multiple sclerosis,0.26205673758865256,1e-09,9.0,0.12673323137158937,Y_RNA - CD86,3,G,1.1405990823443044,Low Risk,20,391,593,2,0.033211297157306585,1.1405990823443044
rs41288889,Rheumatoid arthritis or multiple sclerosis,0.36489361702127665,1e-09,9.0,0.1241404624984706,HLA-DQA2,6,G,1.1172641624862354,High Risk,54,497,183,2,0.04529806237976109,1.1172641624862354
rs1264372,Rheumatoid arthritis or multiple sclerosis,0.36489361702127665,1e-09,9.0,0.1241404624984706,LINC00243,6,G,1.1172641624862354,High Risk,54,193,255,2,0.04529806237976109,1.1172641624862354
rs3132131,Rheumatoid arthritis or multiple sclerosis,0.36489361702127665,1e-09,9.0,0.1241404624984706,HLA-Z - HLA-DMB,6,G,1.1172641624862354,High Risk,54,441,195,2,0.04529806237976109,1.1172641624862354
rs9261425,Rheumatoid arthritis or multiple sclerosis,0.36489361702127665,1e-09,9.0,0.1241404624984706,TRIM31-AS1,6,G,1.1172641624862354,High Risk,54,767,561,2,0.04529806237976109,1.1172641624862354
rs11129295,Multiple sclerosis,0.26205673758865256,1e-09,9.0,0.12027407316774748,EOMES - LINC01980,3,A,1.0824666585097273,Low Risk,20,117,119,0,0.0315186312308388,1.0824666585097273
rs56095240,Multiple sclerosis,0.26205673758865256,1e-09,9.0,0.12004845222072677,LNCRNA-IUR - FAM76B,11,A,1.080436069986541,Low Risk,20,565,309,0,0.03145950574153089,1.080436069986541
rs6427540,Multiple sclerosis,0.26205673758865256,1e-09,9.0,0.11978465679676986,SLAMF1 - SETP9,1,C,1.0780619111709289,Low Risk,20,601,493,1,0.03139037637333793,1.0780619111709289
rs7120737,Multiple sclerosis,0.13829787234042556,1e-09,9.0,0.11905053224030346,AGBL2,11,G,1.0714547901627312,Low Risk,20,661,7,2,0.016464435309829207,1.0714547901627312
rs11852059,Multiple sclerosis,0.26205673758865256,1e-09,9.0,0.11844491618744649,GNG2,14,C,1.0660042456870185,Low Risk,20,151,160,1,0.031039288320043608,1.0660042456870185
rs7260482,Multiple sclerosis,0.3258865248226951,1e-09,9.0,0.11633653493209348,CEACAM16-AS1,19,C,1.0470288143888413,Low Risk,20,678,73,1,0.037912509078934016,1.0470288143888413
rs531612,Multiple sclerosis,0.41099290780141856,1e-09,9.0,0.11525108283372079,DRAP1 - TSGA10IP,11,T,1.037259745503487,High Risk,20,557,107,3,0.047367377661093064,1.037259745503487
rs802730,Multiple sclerosis,0.41099290780141856,1e-09,9.0,0.11480484522207268,THEMIS - PTPRK,6,T,1.0332436069986541,High Risk,20,742,536,3,0.047183977167511444,1.0332436069986541
rs6672420,Multiple sclerosis,0.41099290780141856,1e-09,9.0,0.11456959500795302,RUNX3,1,A,1.0311263550715772,Low Risk,20,623,478,0,0.0470872909979495,1.0311263550715772
rs6789653,Multiple sclerosis,0.41099290780141856,1e-09,9.0,0.11409519148415516,ZBTB38,3,G,1.0268567233573964,Low Risk,20,637,597,2,0.04689231451423258,1.0268567233573964
rs559242105,Neutralising antibody response to interferon beta therapy in multiple sclerosis (antibody titre; IFNβ-1b subcutaneous),0.17021276595744683,5e-10,9.30102999566398,0.01872017618989355,HLA-DPA2 - COL11A2P1,6,G,0.17411692026631456,Low Risk,39,563,181,2,0.0031864129684925197,0.17411692026631453
rs7522462,Multiple sclerosis,0.5248226950354611,2e-09,8.69897000433602,0.12027407316774748,INAVA,1,G,1.046260554785551,High Risk,20,702,226,2,0.06312256322278947,1.046260554785551
rs6793295,Chronic lymphocytic leukemia or multiple sclerosis,0.5248226950354611,2e-09,8.69897000433602,0.11994336229046862,LRRC34,3,G,1.0433837107839945,High Risk,6,638,315,2,0.06294899864889844,1.0433837107839947
rs12368653,Multiple sclerosis,0.5248226950354611,2e-09,8.69897000433602,0.11905053224030346,"AGAP2, TSPAN31",12,A,1.0356170089586378,High Risk,20,177,6,0,0.06248042117576211,1.035617008958638
rs10102877,B-cell lymphoblastic leukemia or multiple sclerosis (pleiotropy),0.5248226950354611,2e-09,8.69897000433602,0.11840601574289326,"IL7, ZC2HC1A",8,G,1.030010379280367,High Risk,0,58,223,2,0.06214216429059648,1.0300103792803672
rs112586220,Rheumatoid arthritis or multiple sclerosis,0.5248226950354611,2e-09,8.69897000433602,0.11840601574289326,H2BC15,6,G,1.030010379280367,High Risk,54,124,169,2,0.06214216429059648,1.0300103792803672
rs9808753,Multiple sclerosis,0.5248226950354611,2e-09,8.69897000433602,0.1168481585709042,IFNGR2,21,G,1.0164586264701945,High Risk,20,818,208,2,0.061324565491112856,1.0164586264701945
rs2456449,Multiple sclerosis,0.37234042553191493,2e-09,8.69897000433602,0.1166034503854154,"CASC19, PCAT1",8,G,1.0143299173048117,Low Risk,20,375,51,2,0.0434161783349951,1.014329917304812
rs11083862,Multiple sclerosis,0.5248226950354611,2e-09,8.69897000433602,0.11622415269790774,SAE1,19,A,1.0110304180984686,High Risk,20,113,479,0,0.0609970730471289,1.0110304180984688
rs12588969,Multiple sclerosis,0.5248226950354611,2e-09,8.69897000433602,0.11619455524287287,RCOR1 - TRAF3,14,G,1.0107729507249155,High Risk,20,187,436,2,0.0609815396310113,1.0107729507249157
rs4325907,Multiple sclerosis,0.5248226950354611,2e-09,8.69897000433602,0.11601042456870182,RDUR - ZPLD1,3,C,1.0091712035134235,High Risk,20,504,437,1,0.06088490367435416,1.0091712035134237
rs8042861,Multiple sclerosis,0.45744680851063835,2e-09,8.69897000433602,0.11537990945797139,IQGAP1,15,A,1.0036863714778987,High Risk,20,744,230,0,0.052780171347795425,1.003686371477899
rs694739,Multiple sclerosis,0.6382978723404256,2e-09,8.69897000433602,0.11537990945797139,PRDX5 - CCDC88B,11,A,1.0036863714778987,High Risk,20,651,421,0,0.07364675071785408,1.003686371477899
rs4679081,Multiple sclerosis,0.5638297872340426,2e-09,8.69897000433602,0.11537990945797139,CCR4 - GLB1,3,G,1.0036863714778987,High Risk,20,521,57,2,0.0650546298007711,1.003686371477899
rs11161550,Multiple sclerosis,0.553191489361702,2e-09,8.69897000433602,0.11427970145601371,SYDE2 - C1orf52,1,G,0.9941156950703385,High Risk,20,121,521,2,0.0632185582522629,0.9941156950703387
chr3:112693983,Multiple sclerosis,0.4432624113475178,3e-09,8.52287874528034,0.15097271503731802,CD200R1,6,T,1.286722144108823,High Risk,20,33,58,3,0.06692052971512324,1.2867221441088232
rs2205986,Drug-induced liver injury in interferon-beta-treated multiple sclerosis,0.31914893617021284,2e-08,7.69897000433602,1.0,SYT14,1,G,7.698970004336019,Medium Risk,12,335,523,2,0.31914893617021284,7.69897000433602
rs2281816,Rheumatoid arthritis or multiple sclerosis,0.4290780141843972,3e-09,8.52287874528034,0.1292146090786737,MLN - LINC01016,6,G,1.1012804452963356,High Risk,54,350,347,2,0.05544314786709049,1.1012804452963358
rs1055569,Rheumatoid arthritis or multiple sclerosis,0.4290780141843972,3e-09,8.52287874528034,0.1292146090786737,HCP5,6,G,1.1012804452963356,High Risk,54,78,173,2,0.05544314786709049,1.1012804452963358
rs13190937,Rheumatoid arthritis or multiple sclerosis,0.4290780141843972,3e-09,8.52287874528034,0.1292146090786737,ZSCAN23,6,G,1.1012804452963356,High Risk,54,217,612,2,0.05544314786709049,1.1012804452963358
rs2293370,Multiple sclerosis,0.4290780141843972,3e-09,8.52287874528034,0.1227211550226355,TIMMDC1,3,G,1.0459375237386734,High Risk,20,358,538,2,0.05265694949552801,1.0459375237386737
rs7238078,Multiple sclerosis,0.4290780141843972,3e-09,8.52287874528034,0.1214976140951915,MALT1,18,A,1.0355094327741803,High Risk,20,675,320,0,0.052131954984107,1.0355094327741805
rs6072343,Multiple sclerosis,0.4290780141843972,3e-09,8.52287874528034,0.11679295240425792,ADI1P1 - LPIN3,20,A,0.9954121716447879,High Risk,20,584,3,0,0.05011328808835181,0.9954121716447881
rs7769192,Multiple sclerosis,0.5531914893617023,3e-09,8.52287874528034,0.1166034503854154,BTF3L4P3 - LINC03004,6,G,0.9937970689162073,High Risk,20,726,39,2,0.06450403638342131,0.9937970689162076
rs4665719,Multiple sclerosis,0.24468085106382984,3e-09,8.52287874528034,0.1166034503854154,CENPO,2,G,0.9937970689162073,Low Risk,20,519,74,2,0.0285306314772825,0.9937970689162076
rs12946510,Multiple sclerosis,0.4893617021276596,3e-09,8.52287874528034,0.11537990945797139,GRB7 - IKZF3,17,A,0.9833689779517141,High Risk,20,208,165,0,0.05646250888368813,0.9833689779517143
rs4728142,Multiple sclerosis,0.4290780141843972,3e-09,8.52287874528034,0.11394995717606755,KCP - IRF5,7,A,0.9711816680415108,High Risk,20,526,239,0,0.04889342134150417,0.9711816680415111
rs10271373,Multiple sclerosis,0.4290780141843972,3e-09,8.52287874528034,0.11381306741710512,ZC3HAV1,7,A,0.9700149732244033,High Risk,20,69,600,0,0.048834684955566386,0.9700149732244036
rs17445836,Multiple sclerosis,0.8404255319148938,4e-09,8.39794000867204,0.1374036461519638,LINC02132 - LINC01082,16,G,1.1539075773569925,High Risk,20,279,280,2,0.11547753240431002,1.1539075773569927
rs2182410,Multiple sclerosis,0.4290780141843972,4e-09,8.39794000867204,0.13012066560626454,RPL32P23 - RBM17,10,G,1.0927455436498845,High Risk,20,333,470,2,0.05583191680268798,1.0927455436498847
rs17824933,Multiple sclerosis,0.24468085106382984,4e-09,8.39794000867204,0.12883885965985561,CD6,11,G,1.0819810142091832,Low Risk,20,290,65,2,0.031524401831666805,1.0819810142091835
rs213204,Rheumatoid arthritis or multiple sclerosis,0.4290780141843972,4e-09,8.39794000867204,0.12018434683306826,RPS18,6,G,1.0093009346855404,High Risk,54,328,473,2,0.05156846087518178,1.0093009346855406
rs669607,Epstein Barr virus nuclear antigen 1 IgG levels or multiple sclerosis,0.4290780141843972,4e-09,8.39794000867204,0.12018434683306826,LINC01967,3,A,1.0093009346855404,High Risk,13,629,274,0,0.05156846087518178,1.0093009346855406
rs2286974,Multiple sclerosis,0.5602836879432626,4e-09,8.39794000867204,0.11915289367429341,CLEC16A,16,A,1.0006388529363939,High Risk,20,354,77,0,0.06675942269694456,1.000638852936394
rs11587876,Multiple sclerosis,0.8404255319148938,4e-09,8.39794000867204,0.11782699131285942,DDAH1,1,A,0.9895040044477148,High Risk,20,134,98,0,0.09902481184804145,0.989504004447715
rs2256814,Multiple sclerosis,0.20212765957446813,4e-09,8.39794000867204,0.11782699131285942,SLC2A4RG,20,A,0.9895040044477148,Low Risk,20,345,497,0,0.023816093988769462,0.989504004447715
rs8062446,Multiple sclerosis,0.5602836879432626,4e-09,8.39794000867204,0.11755781230882174,NLRC5,16,T,0.9872434553202122,High Risk,20,746,387,3,0.06586572462692851,0.9872434553202124
rs1036207,Multiple sclerosis,0.6382978723404256,4e-09,8.39794000867204,0.11537990945797139,NDFIP1,5,C,0.9689535578340551,High Risk,20,70,380,1,0.07364675071785408,0.9689535578340553
rs11256593,Multiple sclerosis,0.5602836879432626,4e-09,8.39794000867204,0.11415636853052735,RPL32P23 - RBM17,10,T,0.9586783345272252,High Risk,20,123,470,3,0.06395995116249406,0.9586783345272254
rs2300747,Multiple sclerosis,0.946808510638298,6e-09,8.22184874961636,0.15208613728129208,CD58,1,A,1.2504292176401728,High Risk,20,361,64,0,0.1439964491280319,1.2504292176401732
rs2019960,Multiple sclerosis,0.5602836879432626,5e-09,8.30102999566398,0.1214976140951915,PVT1,8,G,1.0085553390057915,High Risk,20,312,429,2,0.06807313130156122,1.0085553390057913
rs2303759,Multiple sclerosis,0.5602836879432626,5e-09,8.30102999566398,0.12027407316774748,DKKL1,19,C,0.9983986890661563,High Risk,20,362,100,1,0.06738760127838335,0.998398689066156
rs354033,Multiple sclerosis,0.5602836879432626,5e-09,8.30102999566398,0.12027407316774748,ZNF767P,7,G,0.9983986890661563,High Risk,20,463,610,2,0.06738760127838335,0.998398689066156
rs2283792,Multiple sclerosis,0.5602836879432626,5e-09,8.30102999566398,0.11905053224030346,MAPK1,22,C,0.9882420391265209,High Risk,20,351,323,1,0.0667020712552055,0.9882420391265206
rs7923837,Multiple sclerosis,0.5602836879432626,5e-09,8.30102999566398,0.11905053224030346,Y_RNA - EXOC6,10,G,0.9882420391265209,High Risk,20,732,595,2,0.0667020712552055,0.9882420391265206
rs2425752,Diffuse large B-cell lymphoma or multiple sclerosis,0.5602836879432626,5e-09,8.30102999566398,0.11891606509237733,NCOA5,20,G,0.9871258232981547,High Risk,11,372,378,2,0.06662673150565823,0.9871258232981545
rs9568402,Multiple sclerosis,0.5602836879432626,5e-09,8.30102999566398,0.11781699498348219,DLEU1,13,T,0.9780024093568784,High Risk,20,809,101,3,0.06601094045173826,0.9780024093568783
rs2590438,Multiple sclerosis,0.5602836879432626,5e-09,8.30102999566398,0.11522313715893798,BCL6-AS1 - LINC01991,3,G,0.9564707177508492,High Risk,20,387,33,2,0.06455764422380214,0.956470717750849
rs12609500,Multiple sclerosis,0.5602836879432626,5e-09,8.30102999566398,0.113923895754313,SMARCA4,19,C,0.9456856758794486,High Risk,20,188,505,1,0.06382970045809028,0.9456856758794485
rs533259,Multiple sclerosis,0.5248226950354611,6e-09,8.22184874961636,0.12882254578082303,RNASEL,1,G,1.0591594869504557,High Risk,20,558,456,2,0.0676089956580206,1.0591594869504561
rs417812,Rheumatoid arthritis or multiple sclerosis,0.5248226950354611,6e-09,8.22184874961636,0.12882254578082303,HLA-DOA,6,G,1.0591594869504557,High Risk,54,499,178,2,0.0676089956580206,1.0591594869504561
rs9266380,Rheumatoid arthritis or multiple sclerosis,0.5248226950354611,6e-09,8.22184874961636,0.12882254578082303,"HLA-B, DHFRP2",6,G,1.0591594869504557,High Risk,54,769,176,2,0.0676089956580206,1.0591594869504561
rs1250550,Multiple sclerosis,0.5602836879432626,6e-09,8.22184874961636,0.11905053224030346,ZMIZ1,10,A,0.9788154696411007,High Risk,20,184,604,0,0.0667020712552055,0.9788154696411011
rs802734,Multiple sclerosis,0.5602836879432626,6e-09,8.22184874961636,0.11905053224030346,THEMIS - PTPRK,6,A,0.9788154696411007,High Risk,20,743,536,0,0.0667020712552055,0.9788154696411011
rs61884005,Multiple sclerosis,0.5602836879432626,6e-09,8.22184874961636,0.11847546800440474,RRAS2 - COPB1,11,C,0.9740873784722277,High Risk,20,590,476,1,0.06637987214431189,0.9740873784722281
rs4812772,Multiple sclerosis,0.5602836879432626,6e-09,8.22184874961636,0.1159060320567723,TOX2,20,C,0.9529618647389666,High Risk,20,538,556,1,0.0649402590956384,0.952961864738967
rs12971909,Multiple sclerosis,0.5602836879432626,6e-09,8.22184874961636,0.1156859292793344,UBXN6 - HDGFL2,19,A,0.9511522129935017,High Risk,20,211,573,0,0.06481693909976893,0.9511522129935022
rs72989863,Multiple sclerosis,0.5602836879432626,6e-09,8.22184874961636,0.11489049308699377,MARCHF1,4,G,0.9446122569301063,High Risk,20,689,327,2,0.06437126917640078,0.9446122569301068
rs3763308,Rheumatoid arthritis or multiple sclerosis,0.4858156028368796,7e-09,8.15490195998574,0.12163123292140789,"BTNL2, TSBP1-AS1",6,G,0.9918907797462716,High Risk,54,475,40,2,0.059090350745506684,0.9918907797462712
rs2836438,B-cell lymphoblastic leukemia or multiple sclerosis (pleiotropy),0.5248226950354611,5e-09,8.30102999566398,0.07864689506097311,ERG,21,G,0.6528502349669753,Low Risk,0,408,123,2,0.041275675422071,0.652850234966975
rs9296088,Rheumatoid arthritis or multiple sclerosis,0.5248226950354611,5e-09,8.30102999566398,0.07864689506097311,HCG24 - COL11A2,6,G,0.6528502349669753,Low Risk,54,794,172,2,0.041275675422071,0.652850234966975
rs6859219,Multiple sclerosis,0.5106382978723405,8e-09,8.09691001300806,0.13012066560626454,ANKRD55,5,G,1.0535753202466362,High Risk,20,641,14,2,0.06644459520319893,1.0535753202466367
rs4410871,Multiple sclerosis,0.5106382978723405,8e-09,8.09691001300806,0.12027407316774748,PVT1,8,G,0.9738483473371982,High Risk,20,510,429,2,0.061416548000551914,0.9738483473371986
rs962052,Multiple sclerosis,0.5602836879432626,8e-09,8.09691001300806,0.11449895999021167,LINC02612 - FABP5P10,2,C,0.9270877756237537,High Risk,20,813,287,1,0.06415189956898386,0.9270877756237541
rs6065926,Multiple sclerosis,0.5106382978723405,9e-09,8.04575749056068,0.12639177780496758,RPL13P2 - CD40,20,A,1.0169175930195984,High Risk,20,583,467,0,0.06454048228338771,1.016917593019599
rs771767,Multiple sclerosis,0.5106382978723405,9e-09,8.04575749056068,0.11905053224030346,RDUR - ZPLD1,3,A,0.9578517115276567,High Risk,20,721,437,0,0.060791761143984754,0.9578517115276572
rs802734,Chronic lymphocytic leukemia or multiple sclerosis,0.5106382978723405,9e-09,8.04575749056068,0.11825445980668053,THEMIS - PTPRK,6,G,0.9514467057818061,High Risk,6,743,536,2,0.06038525607149645,0.9514467057818068
rs17174870,Multiple sclerosis,0.5106382978723405,1e-08,8.0,0.12027407316774748,MERTK,2,G,0.9621925853419798,High Risk,20,270,333,2,0.061416548000551914,0.9621925853419798
rs874628,Multiple sclerosis,0.5106382978723405,1e-08,8.0,0.12027407316774748,MPV17L2,19,A,0.9621925853419798,High Risk,20,757,354,0,0.061416548000551914,0.9621925853419798
rs13333054,Multiple sclerosis,0.5106382978723405,1e-08,8.0,0.12027407316774748,LINC02132 - LINC01082,16,A,0.9621925853419798,High Risk,20,228,280,0,0.061416548000551914,0.9621925853419798
rs1886700,Multiple sclerosis,0.12765957446808512,1e-08,8.0,0.11905053224030346,CDH3,16,A,0.9524042579224277,Low Risk,20,305,70,0,0.015197940285996189,0.9524042579224277
rs13192841,Multiple sclerosis,0.5106382978723405,1e-08,8.0,0.11905053224030346,BTF3L4P3 - LINC03004,6,A,0.9524042579224277,High Risk,20,218,39,0,0.060791761143984754,0.9524042579224277
rs11755724,Chronic lymphocytic leukemia or multiple sclerosis,0.5106382978723405,1e-08,8.0,0.11799161874464702,RREB1,6,G,0.9439329499571761,High Risk,6,143,477,2,0.0602510393589687,0.9439329499571761
rs59772922,Multiple sclerosis,0.8617021276595744,1e-08,8.0,0.11782699131285942,MORF4L1 - CTSH,15,A,0.9426159305028754,High Risk,20,577,351,0,0.10153176911001716,0.9426159305028754
rs10466829,Multiple sclerosis,0.5106382978723405,1e-08,8.0,0.11782699131285942,CLECL1P,12,A,0.9426159305028754,High Risk,20,73,79,0,0.06016697428741759,0.9426159305028754
rs7665090,Multiple sclerosis,0.5425531914893618,1e-08,8.0,0.11782699131285942,NFKB1 - MANBA,4,G,0.9426159305028754,High Risk,20,717,383,2,0.06392741018038119,0.9426159305028754
rs11719975,Multiple sclerosis,0.27659574468085113,1e-08,8.0,0.1166034503854154,SATB1-AS1,3,C,0.9328276030833232,Low Risk,20,140,481,1,0.032252018191710655,0.9328276030833232
rs35218683,Multiple sclerosis,0.5602836879432626,1e-08,8.0,0.11650731677474613,IFITM3,11,T,0.932058534197969,High Risk,20,461,206,3,0.0652771491149287,0.932058534197969
rs13066789,Multiple sclerosis,0.5602836879432626,1e-08,8.0,0.11496390554264041,LPP,3,C,0.9197112443411233,High Risk,20,214,313,1,0.06441240097779145,0.9197112443411233
rs4820955,Multiple sclerosis,0.5602836879432626,1e-08,8.0,0.11479260981279824,LIMK2,22,A,0.9183408785023859,High Risk,20,539,253,0,0.06431642677454655,0.9183408785023859
rs137955,Multiple sclerosis,0.5602836879432626,1e-08,8.0,0.11376483543374526,ENTHD1 - GRAP2,22,T,0.910118683469962,High Risk,20,236,118,3,0.06374058155507714,0.910118683469962
rs9494168,B-cell lymphoblastic leukemia or multiple sclerosis (pleiotropy),0.19148936170212774,1e-08,8.0,0.10673948774419839,HBS1L - MYB,6,G,0.8539159019535871,Low Risk,0,806,171,2,0.020439476376548638,0.8539159019535871
rs1398607,Multiple sclerosis and triglyceride levels (pleiotropy),0.19148936170212774,1e-08,8.0,0.10673948774419839,RDUR - ZPLD1,3,G,0.8539159019535871,Low Risk,29,238,437,2,0.020439476376548638,0.8539159019535871
rs771767,Multiple sclerosis and C-reactive protein levels (pleiotropy),0.19148936170212774,1e-08,8.0,0.10673948774419839,RDUR - ZPLD1,3,G,0.8539159019535871,Low Risk,24,721,437,2,0.020439476376548638,0.8539159019535871
rs6911639,Rheumatoid arthritis or multiple sclerosis,0.19148936170212774,1e-08,8.0,0.10673948774419839,HLA-DOA - HLA-DPA1,6,G,0.8539159019535871,Low Risk,54,647,179,2,0.020439476376548638,0.8539159019535871
rs559242105,Neutralising antibody response to interferon beta therapy in multiple sclerosis (presence of antibodies; IFNβ-1b subcutaneous),0.17021276595744683,1e-08,8.0,0.08846200905420286,HLA-DPA2 - COL11A2P1,6,G,0.7076960724336229,Low Risk,47,563,181,2,0.015057363243268574,0.7076960724336229
rs12988804,Relapse in multiple sclerosis,0.3262411347517731,3e-08,7.52287874528034,0.251192952404258,LRP2,2,T,1.8896941226062078,High Risk,51,213,314,3,0.08194947383401326,1.8896941226062085
chr1:154983036,Multiple sclerosis,0.49290780141843976,2e-08,7.69897000433602,0.1292930502875321,ZBTB7B,6,G,0.9954233159328181,High Risk,20,23,599,2,0.06372955315591122,0.9954233159328182
rs170934,Multiple sclerosis,0.4893617021276596,2e-08,7.69897000433602,0.1276153187324116,LINC01967,3,T,0.9825065110146174,High Risk,20,264,274,3,0.06245004959245675,0.9825065110146175
rs6062314,Marginal zone lymphoma or multiple sclerosis,0.49290780141843976,2e-08,7.69897000433602,0.1265844977364493,ZBTB46,20,G,0.9745702510868639,High Risk,16,582,598,2,0.062394486472930694,0.974570251086864
rs394199,Multiple sclerosis and systolic blood pressure (pleiotropy),0.49290780141843976,2e-08,7.69897000433602,0.12227573310493903,GGNBP1,6,G,0.9413972014331223,High Risk,28,491,157,2,0.060270662771583425,0.9413972014331224
rs76864766,Rheumatoid arthritis or multiple sclerosis,0.49290780141843976,2e-08,7.69897000433602,0.12227573310493903,HMGN4 - ABT1,6,G,0.9413972014331223,High Risk,54,719,196,2,0.060270662771583425,0.9413972014331224
rs11808092,Epstein Barr virus nuclear antigen 1 IgG levels or multiple sclerosis,0.49290780141843976,2e-08,7.69897000433602,0.12227573310493903,EVI5,1,A,0.9413972014331223,High Risk,13,146,132,0,0.060270662771583425,0.9413972014331224
rs210131,Multiple sclerosis and systolic blood pressure (pleiotropy),0.49290780141843976,2e-08,7.69897000433602,0.12227573310493903,Metazoa_SRP - BAK1,6,G,0.9413972014331223,High Risk,28,323,368,2,0.060270662771583425,0.9413972014331224
rs72830848,Decreased low contrast letter acuity in multiple sclerosis,0.04255319148936171,4e-08,7.39794000867204,0.2597577388963661,MSI2,17,T,1.9216721691436116,High Risk,7,683,356,3,0.011053520804100688,1.9216721691436123
rs1323292,Marginal zone lymphoma or multiple sclerosis,0.49290780141843976,2e-08,7.69897000433602,0.12182949957176067,RGS21 - RGS1,1,G,0.9379616628462533,High Risk,16,220,446,2,0.0600507107818253,0.9379616628462534
rs1323292,Multiple sclerosis,0.49290780141843976,2e-08,7.69897000433602,0.1214976140951915,RGS21 - RGS1,1,A,0.9354064865172724,High Risk,20,220,446,0,0.05988712184124688,0.9354064865172725
rs6897932,Multiple sclerosis,0.49290780141843976,2e-08,7.69897000433602,0.12027407316774748,IL7R,5,G,0.9259864816178034,High Risk,20,645,224,2,0.05928402897275497,0.9259864816178035
rs2300603,Multiple sclerosis,0.49290780141843976,2e-08,7.69897000433602,0.12027407316774748,BATF,14,A,0.9259864816178034,High Risk,20,360,27,0,0.05928402897275497,0.9259864816178035
rs4285028,Multiple sclerosis,0.49290780141843976,2e-08,7.69897000433602,0.11905053224030346,SLC15A2,3,A,0.9165664767183345,High Risk,20,502,495,0,0.05868093610426306,0.9165664767183346
rs140522,Multiple sclerosis,0.49290780141843976,2e-08,7.69897000433602,0.11905053224030346,CIMAP1B - KLHDC7B-DT,22,A,0.9165664767183345,High Risk,20,240,76,0,0.05868093610426306,0.9165664767183346
rs8021741,Marginal zone lymphoma or multiple sclerosis,0.49290780141843976,2e-08,7.69897000433602,0.11840091765569558,BATF - FLVCR2-AS1,14,G,0.9115651135170592,High Risk,16,741,28,2,0.05836073600759463,0.9115651135170593
rs2777899,Marginal zone lymphoma or multiple sclerosis,0.49290780141843976,2e-08,7.69897000433602,0.11822520494310536,VMP1,17,G,0.9102123066134465,High Risk,16,403,584,2,0.05827412584075052,0.9102123066134467
rs140522,Diffuse large B-cell lymphoma or multiple sclerosis,0.49290780141843976,2e-08,7.69897000433602,0.11745460663159185,CIMAP1B - KLHDC7B-DT,22,G,0.9042794933277121,High Risk,11,240,76,2,0.057894291921245636,0.9042794933277122
rs806321,Chronic lymphocytic leukemia or multiple sclerosis,0.49290780141843976,2e-08,7.69897000433602,0.11738238101064483,DLEU1,13,G,0.9037234304384965,High Risk,6,747,101,2,0.057858691349218554,0.9037234304384965
rs61708525,Multiple sclerosis,0.49290780141843976,2e-08,7.69897000433602,0.11540438027652025,PLXNC1,12,G,0.8884948621179167,High Risk,20,588,414,2,0.05688371935615715,0.8884948621179167
rs12211604,Multiple sclerosis,0.49290780141843976,2e-08,7.69897000433602,0.11481911170928669,RN7SL554P - RREB1,6,G,0.8839888969743047,High Risk,20,171,450,2,0.05659523591344273,0.8839888969743048
rs3923387,Multiple sclerosis,0.49290780141843976,2e-08,7.69897000433602,0.11463354949223054,EPPK1 - PLEC,8,T,0.8825602590312513,High Risk,20,490,121,3,0.056503770849007255,0.8825602590312515
rs11899404,Multiple sclerosis,0.49290780141843976,2e-08,7.69897000433602,0.11349930258167137,MIR3681HG,2,C,0.8738277260893456,High Risk,20,156,341,1,0.05594469169805788,0.8738277260893457
rs12722489,Multiple sclerosis,0.8829787234042554,3e-08,7.52287874528034,0.1374036461519638,IL2RA,10,C,1.033670969160629,High Risk,20,197,220,1,0.12132449607035102,1.0336709691606292
rs12025416,B-cell lymphoblastic leukemia or multiple sclerosis (pleiotropy),0.624113475177305,3e-08,7.52287874528034,0.13006240058729968,LINC01762 - CD58,1,G,0.9784436689383336,High Risk,0,160,269,2,0.08117369682044236,0.9784436689383339
rs6718520,Multiple sclerosis,0.4893617021276596,3e-08,7.52287874528034,0.1276153187324116,LINC02580,2,A,0.960034568864235,High Risk,20,632,286,0,0.06245004959245675,0.9600345688642353
rs1800693,Multiple sclerosis,0.624113475177305,3e-08,7.52287874528034,0.1276153187324116,TNFRSF1A,12,C,0.960034568864235,High Risk,20,293,548,1,0.07964644005994484,0.9600345688642353
rs2150702,Multiple sclerosis,0.5,3e-08,7.52287874528034,0.12639177780496758,"BRD10, MLANA",9,G,0.9508300188271857,High Risk,20,329,37,2,0.06319588890248379,0.950830018827186
rs1870071,Multiple sclerosis,0.624113475177305,3e-08,7.52287874528034,0.12639177780496758,EPS15L1,19,C,0.9508300188271857,High Risk,20,303,122,1,0.07888281167969607,0.950830018827186
rs698805,Median relapse-independent longitudinal Multiple Sclerosis Severity Scale score in relapse-onset multiple sclerosis,0.05319148936170215,4e-08,7.39794000867204,0.17288633304784046,CAMKMT,2,G,1.2790027202072176,High Risk,17,654,48,2,0.009196081545097901,1.279002720207218
rs1107345,Marginal zone lymphoma or multiple sclerosis,0.4432624113475178,3e-08,7.52287874528034,0.11971870794078063,IL2RA,10,G,0.9006293233801229,High Risk,16,111,220,2,0.05306680316523965,0.9006293233801232
rs11578655,Multiple sclerosis,0.4432624113475178,3e-08,7.52287874528034,0.11741125657653248,SLC30A7,1,G,0.8832706465562524,High Risk,20,132,498,2,0.0520439967094559,0.8832706465562528
rs1292034,Chronic lymphocytic leukemia or multiple sclerosis,0.4432624113475178,3e-08,7.52287874528034,0.11735348097393859,RPS6KB1,17,G,0.8828360077035031,High Risk,6,205,475,2,0.052018386956533075,0.8828360077035035
rs2777899,Chronic lymphocytic leukemia or multiple sclerosis,0.4432624113475178,3e-08,7.52287874528034,0.11731020433133489,VMP1,17,G,0.8825104427686926,High Risk,6,403,584,2,0.05199920404757753,0.882510442768693
rs1415069,Multiple sclerosis,0.4432624113475178,3e-08,7.52287874528034,0.11588324972470328,DIPK1A,1,G,0.8717756362879838,High Risk,20,241,99,2,0.051366688707758554,0.8717756362879842
rs55858457,Multiple sclerosis,0.4432624113475178,3e-08,7.52287874528034,0.11495814266487214,CHST12,7,T,0.8648161680504713,High Risk,20,562,75,3,0.05095662352166319,0.8648161680504717
rs32658,Multiple sclerosis,0.4432624113475178,3e-08,7.52287874528034,0.11454191851217424,TNFAIP8,5,T,0.861684964218868,High Risk,20,447,546,3,0.050772127000077244,0.8616849642188683
rs2469434,Multiple sclerosis,0.4432624113475178,3e-08,7.52287874528034,0.11349930258167137,CD226,18,C,0.8538414909957973,High Risk,20,376,59,1,0.05030997454861321,0.8538414909957976
rs12722489,Multiple sclerosis,0.8829787234042554,4e-08,7.39794000867204,0.13495656429707575,IL2RA,10,C,0.998400566446257,High Risk,20,197,220,1,0.11916377485805627,0.9984005664462573
rs2293152,Multiple sclerosis,0.6382978723404256,4e-08,7.39794000867204,0.13373302336963172,STAT3,17,C,0.989348884066871,High Risk,20,357,516,1,0.08536150427848833,0.9893488840668715
rs1265086,Binding antibody response to interferon beta therapy in multiple sclerosis (antibody levels; all treatment preparations),0.3829787234042554,5e-09,8.30102999566398,0.0031007243362290438,POLR2LP1 - CCHCR1,6,T,0.02573920572332258,Low Risk,4,195,417,3,0.0011875114479175063,0.025739205723322573
rs4285028,Multiple sclerosis and HDL levels (pleiotropy),0.26950354609929084,4e-08,7.39794000867204,0.13087809453892899,SLC15A2,3,G,0.9682282918483041,High Risk,25,502,495,2,0.03527211058495959,0.9682282918483044
rs1365120,Multiple sclerosis,0.5035460992907802,4e-08,7.39794000867204,0.1185330233696317,PRR5L,11,C,0.876900195935056,High Risk,20,235,424,1,0.05968684155492093,0.8769001959350563
rs12212193,Multiple sclerosis,0.5035460992907802,4e-08,7.39794000867204,0.11782699131285942,BACH2,6,G,0.8716770131348553,High Risk,20,172,26,2,0.05933132186675901,0.8716770131348557
rs12048904,Multiple sclerosis,0.5035460992907802,4e-08,7.39794000867204,0.11782699131285942,VCAM1 - EXTL2,1,A,0.8716770131348553,High Risk,20,162,582,0,0.05933132186675901,0.8716770131348557
rs12048904,Multiple sclerosis,0.5035460992907802,4e-08,7.39794000867204,0.11782699131285942,VCAM1 - EXTL2,1,A,0.8716770131348553,High Risk,20,162,582,0,0.05933132186675901,0.8716770131348557
rs2688608,Multiple sclerosis,0.574468085106383,4e-08,7.39794000867204,0.11537990945797139,CAMK2G - C10orf55,10,A,0.8535736483760837,High Risk,20,392,47,0,0.06628207564606868,0.8535736483760841
rs2726518,Multiple sclerosis,0.5957446808510638,4e-08,7.39794000867204,0.11537990945797139,"TET2, TET2-AS1",4,C,0.8535736483760837,High Risk,20,398,533,1,0.0687369673366638,0.8535736483760841
rs17785991,Multiple sclerosis,0.34042553191489366,4e-08,7.39794000867204,0.11537990945797139,SLC9A8,20,A,0.8535736483760837,Low Risk,20,289,503,0,0.03927826704952218,0.8535736483760841
rs67934705,Multiple sclerosis,0.5035460992907802,4e-08,7.39794000867204,0.11519519148415513,CNR2,6,G,0.8522071158872676,High Risk,20,639,81,2,0.05800608932890082,0.8522071158872679
rs1323292,Diffuse large B-cell lymphoma or multiple sclerosis,0.5035460992907802,5e-08,7.30102999566398,0.12041003303560506,RGS21 - RGS1,1,G,0.8791172629718434,High Risk,11,220,446,2,0.06063200245055291,0.8791172629718433
rs10936182,Multiple sclerosis,0.5035460992907802,5e-08,7.30102999566398,0.11869570537134468,"IL12A, IL12A-AS1",3,T,0.8666009052726819,High Risk,20,97,215,3,0.05976875944230832,0.8666009052726817
rs806321,Diffuse large B-cell lymphoma or multiple sclerosis,0.5035460992907802,5e-08,7.30102999566398,0.11745460663159185,DLEU1,13,G,0.8575396061461656,High Risk,11,747,101,2,0.059143809013071084,0.8575396061461655
rs2255214,Epstein Barr virus nuclear antigen 1 IgG levels or multiple sclerosis,0.42198581560283693,5e-08,7.30102999566398,0.11730353195481057,Y_RNA - CD86,3,T,0.8564366053994003,High Risk,13,344,593,3,0.04950042660504418,0.8564366053994001
rs17741873,Multiple sclerosis,0.5035460992907802,5e-08,7.30102999566398,0.11508625963538482,CAMK2G - C10orf55,10,G,0.8402482336867175,High Risk,20,286,47,2,0.057951237121364,0.8402482336867174
rs9900529,Multiple sclerosis,0.5035460992907802,5e-08,7.30102999566398,0.11474366817570048,GRB2,17,C,0.8377469631633038,High Risk,20,828,164,1,0.057778726528189606,0.8377469631633037
rs6020055,Multiple sclerosis,0.5035460992907802,5e-08,7.30102999566398,0.11404595619723482,RNU6-919P - SLC9A8,20,A,0.8326529470801919,High Risk,20,579,462,0,0.05742739638300477,0.8326529470801918
rs10967273,Median relapse-independent longitudinal Multiple Sclerosis Severity Scale score in relapse-onset multiple sclerosis,0.11702127659574474,4e-08,7.39794000867204,0.08601492719931482,LINC03106 - CAAP1,9,T,0.6363332712708237,Low Risk,17,103,304,3,0.010065576587153867,0.636333271270824
rs4560284,Multiple sclerosis,0.4184397163120568,6e-08,7.22184874961636,0.12073901872017619,ITPR1 - BHLHE40-AS1,3,A,0.8719589313742102,High Risk,20,513,232,0,0.050522000741066636,0.8719589313742107
rs4308217,Multiple sclerosis,0.4184397163120568,6e-08,7.22184874961636,0.11905053224030346,CD86,3,C,0.8597649374007972,High Risk,20,503,68,1,0.04981547093743195,0.8597649374007976
rs6498160,Multiple sclerosis,0.3617021276595745,7e-08,7.15490195998574,0.13985072800685183,CLEC16A,16,T,1.0006182479216572,High Risk,20,608,77,3,0.05058430587481875,1.0006182479216568
rs12755416,Multiple sclerosis,0.31914893617021284,6e-08,7.22184874961636,0.11690754924752232,HORMAD1 - CTSS,1,G,0.8442886383539316,Low Risk,20,201,200,2,0.037310919972613515,0.8442886383539321
rs10891261,Multiple sclerosis,0.31914893617021284,6e-08,7.22184874961636,0.1150138382478894,POU2AF1,11,C,0.8306125439390979,Low Risk,20,91,419,1,0.03670654412166684,0.8306125439390983
rs13254990,Multiple sclerosis,0.31914893617021284,6e-08,7.22184874961636,0.11455574452465436,PVT1,8,T,0.8273042603567459,Low Risk,20,222,429,3,0.03656034399723013,0.8273042603567462
rs71545193,Multiple sclerosis,0.31914893617021284,6e-08,7.22184874961636,0.11376483543374526,EXOC2,6,A,0.8215924345275037,Low Risk,20,665,133,0,0.03630792620225913,0.8215924345275041
rs6072343,Multiple sclerosis,0.13829787234042556,7e-08,7.15490195998574,0.11782699131285942,ADI1P1 - LPIN3,20,A,0.843040571083601,Low Risk,20,584,3,0,0.016295222202842265,0.8430405710836008
rs56376240,Multiple sclerosis,0.31914893617021284,7e-08,7.15490195998574,0.11723812553529916,HTR3A,11,A,0.8388272941775666,Low Risk,20,568,203,0,0.037416423043180595,0.8388272941775663
rs12722561,Epstein Barr virus nuclear antigen 1 IgG levels or multiple sclerosis,0.2836879432624114,6e-08,7.22184874961636,0.09661112198703048,IL2RA,10,C,0.6977109105210694,Low Risk,13,199,220,1,0.027407410492774613,0.6977109105210697
chr8:129011095,Multiple sclerosis,0.31914893617021284,7e-08,7.15490195998574,0.11454790162730943,PVT1,6,C,0.8195790058654904,Low Risk,20,44,429,1,0.036557840944886,0.81957900586549
rs16978630,Diffuse large B-cell lymphoma or multiple sclerosis,0.5035460992907802,9e-08,7.04575749056068,0.1475998164688609,TNPO2,19,G,1.0399525124908575,High Risk,11,259,553,2,0.07432331183892996,1.0399525124908582
rs12025416,Multiple sclerosis,0.5035460992907802,1e-07,7.0,0.16187446470084424,LINC01762 - CD58,1,G,1.1331212529059096,High Risk,20,160,269,2,0.08151125527489321,1.1331212529059096
rs2546890,Multiple sclerosis,0.5319148936170214,8e-08,7.09691001300806,0.12639177780496758,IL12B - LINC01845,5,A,0.8969910734659637,High Risk,20,385,218,0,0.06722966904519553,0.8969910734659643
rs1920296,Multiple sclerosis and triglyceride levels (pleiotropy),0.2517730496453901,7e-08,7.15490195998574,0.10644806068763003,IQCB1,3,G,0.7616254380506055,Low Risk,29,308,229,2,0.026800752868162175,0.7616254380506051
rs2744148,Multiple sclerosis,0.6347517730496454,8e-08,7.09691001300806,0.1214976140951915,SOX8 - SSTR5,16,G,0.8622576340287533,High Risk,20,401,510,2,0.0771208259682244,0.8622576340287538
rs9846396,Multiple sclerosis,0.5851063829787234,8e-08,7.09691001300806,0.11537990945797139,ZBTB38,3,G,0.81884083473224,High Risk,20,824,597,2,0.06750952149136624,0.8188408347322405
rs17519972,Multiple sclerosis and C-reactive protein levels (pleiotropy),0.5141843971631206,9e-08,7.04575749056068,0.13019834821974793,RPAP2,1,G,0.917345987227916,High Risk,24,281,465,2,0.06694595919100514,0.9173459872279168
rs4896477,Multiple sclerosis,0.31914893617021284,8e-08,7.09691001300806,0.1135946408907378,LINC01625 - ATP5PBP6,6,G,0.8061709443615315,Low Risk,20,543,268,2,0.03625360879491633,0.8061709443615319
rs1335532,Multiple sclerosis,0.9042553191489362,1e-07,7.0,0.14107426893429587,CD58,1,A,0.9875198825400711,High Risk,20,229,64,0,0.12756715807888455,0.9875198825400711
rs2104286,Multiple sclerosis,0.7872340425531916,9e-08,7.04575749056068,0.12516823687752354,IL2RA,10,T,0.8819050425600844,High Risk,20,324,220,3,0.09853669711634834,0.8819050425600851
rs7315384,Median relapse-independent longitudinal Multiple Sclerosis Severity Scale score in relapse-onset multiple sclerosis,0.2340425531914894,8e-08,7.09691001300806,0.10926220482075126,STAB2,12,C,0.7754240354357267,Low Risk,17,693,515,1,0.025572005383580086,0.7754240354357271
rs1250550,Marginal zone lymphoma or multiple sclerosis,0.4893617021276596,9e-08,7.04575749056068,0.1182105836290224,ZMIZ1,10,G,0.8328831050677337,High Risk,16,184,604,2,0.057847732414202456,0.8328831050677342
rs180515,Multiple sclerosis,0.4893617021276596,9e-08,7.04575749056068,0.11782699131285942,RPS6KB1,17,G,0.8301804066328069,High Risk,20,296,475,2,0.05766001702544185,0.8301804066328075
rs7595037,Follicular lymphoma or multiple sclerosis,0.4893617021276596,9e-08,7.04575749056068,0.11700798972225622,PLEK - WDR4P2,2,G,0.8244099200410332,High Risk,14,712,412,2,0.057259229013019004,0.8244099200410339
rs6074022,Multiple sclerosis,0.24468085106382984,1e-07,7.0,0.13128594151474368,RPL13P2 - CD40,20,G,0.9190015906032057,Low Risk,20,586,467,2,0.03212315590254367,0.9190015906032057
rs882300,Multiple sclerosis,0.6276595744680852,1e-07,7.0,0.13006240058729965,HNRNPKP2 - UBBP1,2,C,0.9104368041110975,High Risk,20,758,199,1,0.08163491100692213,0.9104368041110975
rs2618101,Multiple sclerosis,0.4893617021276596,9e-08,7.04575749056068,0.11506957053713447,LINC01980,3,G,0.8107522885476152,High Risk,20,389,275,2,0.05631064090115091,0.8107522885476157
rs7830997,Multiple sclerosis,0.5248226950354611,9e-08,7.04575749056068,0.11447281292059219,LINC03020 - TRAM1,8,A,0.8065476791008133,High Risk,20,730,303,0,0.060077930185275345,0.8065476791008138
rs6062314,Multiple sclerosis,0.4609929078014185,1e-07,7.0,0.12639177780496758,ZBTB46,20,A,0.884742444634773,High Risk,20,582,598,0,0.05826571317250279,0.884742444634773
rs8070463,Multiple sclerosis,0.5106382978723405,1e-07,7.0,0.12516823687752354,KPNB1 - TBKBP1,17,T,0.8761776581426648,High Risk,20,750,243,3,0.06391569542682055,0.8761776581426648
rs134490,Multiple sclerosis,0.4645390070921987,1e-07,7.0,0.11874464700844242,TTC28,22,T,0.8312125290590969,High Risk,20,233,569,3,0.05516152041881547,0.8312125290590969
rs2425752,Marginal zone lymphoma or multiple sclerosis,0.4645390070921987,1e-07,7.0,0.1185330233696317,NCOA5,20,G,0.8297311635874219,High Risk,16,372,378,2,0.0550632129837651,0.8297311635874219
rs9808753,Multiple sclerosis,0.12765957446808512,1e-07,7.0,0.11782699131285942,IFNGR2,21,G,0.824788939190016,Low Risk,20,818,208,2,0.015041743571854397,0.824788939190016
rs228614,Multiple sclerosis,0.3723404255319149,1e-07,7.0,0.11782699131285942,MANBA,4,G,0.824788939190016,Low Risk,20,353,321,2,0.04387175208457532,0.824788939190016
rs2425752,Follicular lymphoma or multiple sclerosis,0.3723404255319149,1e-07,7.0,0.11781699498348219,NCOA5,20,G,0.8247189648843753,Low Risk,14,372,378,2,0.04386803004704124,0.8247189648843753
rs4392367,Multiple sclerosis,0.3723404255319149,1e-07,7.0,0.11539214486724582,CRTAP,3,G,0.8077450140707207,Low Risk,20,507,87,2,0.04296516032291067,0.8077450140707207
rs6435203,Multiple sclerosis,0.7553191489361702,1e-07,7.0,0.11537990945797139,CD28 - KRT18P39,2,A,0.8076593662057997,High Risk,20,603,61,0,0.08714865501612733,0.8076593662057997
rs7525478,Multiple sclerosis,0.3723404255319149,1e-07,7.0,0.11534320323014806,CR1L,1,T,0.8074024226110365,Low Risk,20,703,86,3,0.042946937372927464,0.8074024226110365
rs1819577,Multiple sclerosis,0.3723404255319149,1e-07,7.0,0.11423839471430319,MED6P1 - RNLS,10,A,0.7996687630001224,Low Risk,20,298,330,0,0.04253557250000651,0.7996687630001224
rs10904115,Multiple sclerosis,0.3723404255319149,1e-07,7.0,0.11410088094946776,LINC02639 - LINC02660,10,T,0.7987061666462743,Low Risk,20,93,290,3,0.04248437056629118,0.7987061666462743
rs9977672,Multiple sclerosis,0.3723404255319149,1e-07,7.0,0.11409519148415516,LINC02940 - RPL23AP12,21,G,0.7986663403890861,Low Risk,20,832,300,2,0.042482252148355645,0.7986663403890861
rs3783196,Multiple sclerosis,0.3723404255319149,1e-07,7.0,0.11400954361923407,RGCC,13,C,0.7980668053346385,Low Risk,20,479,441,1,0.042450361985885025,0.7980668053346385
rs13428812,Multiple sclerosis,0.3723404255319149,1e-07,7.0,0.11345849749174111,DNMT3A,2,G,0.7942094824421878,Low Risk,20,232,104,2,0.042245185236286585,0.7942094824421878
rs7315384,Median relapse-independent longitudinal age-related multiple sclerosis severity score in relapse-onset multiple sclerosis,0.2340425531914894,1e-07,7.0,0.1118316407683837,STAB2,12,C,0.7828214853786859,Low Risk,18,693,515,1,0.026173362733025975,0.7828214853786859
rs1219732,Median relapse-independent longitudinal age-related multiple sclerosis severity score in relapse-onset multiple sclerosis,0.35106382978723405,6e-08,7.22184874961636,0.054080508993025814,CPXM2,10,T,0.39056125624989957,Low Risk,18,170,85,3,0.018985710603934596,0.3905612562498998
rs9643199,Median relapse-independent longitudinal Multiple Sclerosis Severity Scale score in relapse-onset multiple sclerosis,0.25531914893617025,7e-08,7.15490195998574,0.06166646274317876,MTSS1,8,A,0.4412174951465575,Low Risk,17,814,361,0,0.015744628785492452,0.44121749514655734
rs2503875,Multiple sclerosis,0.42269503546099296,2e-07,6.69897000433602,0.18756882417716872,LINC02633,10,A,1.25651792691143,High Risk,20,378,289,0,0.07928441078694509,1.25651792691143
rs10967273,Median relapse-independent longitudinal age-related multiple sclerosis severity score in relapse-onset multiple sclerosis,0.11702127659574474,1e-07,7.0,0.08222195032423835,LINC03106 - CAAP1,9,T,0.5755536522696685,Low Risk,18,103,304,3,0.009621717591134279,0.5755536522696685
rs3745672,Multiple sclerosis,0.21276595744680854,1e-06,6.0,0.888657775602594,"ZNF433, ZNF433-AS1",19,G,5.331946653615564,Medium Risk,20,470,606,2,0.18907612246863703,5.331946653615564
rs9657904,Multiple sclerosis,0.8638297872340426,2e-07,6.69897000433602,0.15208613728129208,CBLB,3,T,1.0188204717227056,High Risk,20,815,54,3,0.13137653560894594,1.0188204717227056
rs17169210,Median relapse-independent longitudinal Multiple Sclerosis Severity Scale score in relapse-onset multiple sclerosis,0.22340425531914898,1e-07,7.0,0.06044292181573474,SLC25A48,5,C,0.4231004527101432,Low Risk,17,269,496,1,0.013503205937557763,0.4231004527101432
chr1:198573373,Multiple sclerosis,0.35460992907801425,2e-07,6.69897000433602,0.1336963171418084,ATP6V1G3,6,C,0.89562761822317,High Risk,20,25,22,1,0.04741004153964838,0.8956276182231702
DRB*08:01,Multiple sclerosis,0.35460992907801425,2e-07,6.69897000433602,0.12883885965985561,DRB1,6,G,0.8630876562542307,High Risk,20,2,108,2,0.04568753888647363,0.8630876562542308
rs2836425,Multiple sclerosis,0.35460992907801425,2e-07,6.69897000433602,0.12883885965985561,ERG,21,T,0.8630876562542307,High Risk,20,407,123,3,0.04568753888647363,0.8630876562542308
rs10411936,Multiple sclerosis,0.29787234042553196,2e-07,6.69897000433602,0.12639177780496758,EPS15L1,19,A,0.8466947283101808,Low Risk,20,71,122,0,0.0376486146653095,0.8466947283101809
rs2681424,Multiple sclerosis,0.40425531914893625,2e-07,6.69897000433602,0.12639177780496758,Y_RNA - CD86,3,T,0.8466947283101808,High Risk,20,391,593,3,0.051094548474348606,0.8466947283101809
rs7592330,Multiple sclerosis,0.574468085106383,2e-07,6.69897000433602,0.12516823687752354,PLEK - WDR4P2,2,A,0.8384982643381557,High Risk,20,711,412,0,0.07190515735517311,0.8384982643381558
rs11865121,Multiple sclerosis,0.7127659574468086,2e-07,6.69897000433602,0.12516823687752354,CLEC16A,16,C,0.8384982643381557,High Risk,20,154,77,1,0.089215658199937,0.8384982643381558
rs72855540,Multiple sclerosis,0.549645390070922,2e-07,6.69897000433602,0.12510705983115136,GTDC1,2,G,0.8380884411395546,High Risk,20,684,167,2,0.06876451870151937,0.8380884411395547
rs1520333,Multiple sclerosis,0.3971631205673759,2e-07,6.69897000433602,0.11905053224030346,PKIA-AS1,8,G,0.797515944478031,High Risk,20,249,410,2,0.047282480889765915,0.7975159444780311
rs6896969,Multiple sclerosis,0.6382978723404256,2e-07,6.69897000433602,0.11905053224030346,RNU1-150P - TTC33,5,C,0.797515944478031,High Risk,20,644,457,1,0.07598970142998093,0.7975159444780311
rs942637,Multiple sclerosis and body mass index (pleiotropy),0.5283687943262413,2e-07,6.69897000433602,0.11820775317101025,ITPR3,6,G,0.7918701927725535,High Risk,27,803,233,2,0.06245728802298061,0.7918701927725537
rs4765569,Multiple sclerosis,0.39716312056737596,2e-07,6.69897000433602,0.11767179738162242,NCOR2,12,C,0.7882798410157943,High Risk,20,528,379,1,0.046734898250857144,0.7882798410157944
rs11859008,Multiple sclerosis,0.39716312056737596,2e-07,6.69897000433602,0.11737428116970514,WWOX - RNA5SP431,16,C,0.7862867888363567,High Risk,20,152,591,1,0.046616735783712684,0.7862867888363568
rs4903324,Multiple sclerosis,0.19148936170212774,2e-07,6.69897000433602,0.1166034503854154,JDP2 - BATF,14,A,0.781123016533981,Low Risk,20,545,237,0,0.022328320286568917,0.7811230165339811
rs3845959,Multiple sclerosis,0.33333333333333337,2e-07,6.69897000433602,0.11644439006484768,ALDH1L1,3,T,0.7800574762176177,Low Risk,20,486,11,3,0.03881479668828256,0.7800574762176178
rs9283487,Multiple sclerosis (OCB status),0.42269503546099296,3e-07,6.52287874528034,0.18145111953994864,PRKRA,6,G,1.1835836509544526,High Risk,21,791,423,2,0.07669848740837547,1.183583650954453
rs4953911,Multiple sclerosis (severity),0.3617021276595745,2e-07,6.69897000433602,0.11529980423345161,MGAT5,2,T,0.7723899300657074,Low Risk,23,552,336,3,0.04170418450997186,0.7723899300657076
rs12456021,Multiple sclerosis,0.4255319148936171,2e-07,6.69897000433602,0.1152371099963294,ALPK2,18,A,0.771969943251781,High Risk,20,179,12,0,0.04903706808354443,0.7719699432517811
rs2052401,Multiple sclerosis,0.4255319148936171,2e-07,6.69897000433602,0.11500061177046372,EIF3EP2 - GCG,2,C,0.7703856487306282,High Risk,20,318,115,1,0.04893643054062287,0.7703856487306283
rs4834222,Multiple sclerosis,0.4255319148936171,2e-07,6.69897000433602,0.11473582527835557,FAM241A,4,T,0.7686118519624423,High Risk,20,541,138,3,0.04882375543759812,0.7686118519624424
chr20:52210360,Multiple sclerosis,0.4255319148936171,2e-07,6.69897000433602,0.11471919735715161,ZNF217,6,G,0.7685004620170625,High Risk,20,28,605,2,0.0488166797264475,0.7685004620170626
rs175126,Multiple sclerosis,0.4680851063829788,2e-07,6.69897000433602,0.11415636853052735,LINC02954,11,G,0.764730088589931,High Risk,20,280,301,2,0.05343489590790643,0.7647300885899311
rs66756607,Multiple sclerosis,0.4468085106382979,2e-07,6.69897000433602,0.11415636853052735,LPP,3,G,0.764730088589931,High Risk,20,624,313,2,0.05100603700300159,0.7647300885899311
rs17591266,Multiple sclerosis,0.4255319148936171,2e-07,6.69897000433602,0.11398507280068519,COG6,13,G,0.7635825836338475,High Risk,20,283,83,2,0.04850428629816392,0.7635825836338476
rs6921288,Multiple sclerosis,0.4255319148936171,2e-07,6.69897000433602,0.11398507280068519,TMEM244 - L3MBTL3,6,A,0.7635825836338475,High Risk,20,649,542,0,0.04850428629816392,0.7635825836338476
rs10513196,Depression in multiple sclerosis,0.5003546099290781,4e-07,6.39794000867204,0.21693380643582527,LINC01990 - BBX,3,A,1.387929479429282,High Risk,8,75,276,0,0.10854383009962748,1.3879294794292827
rs6897932,Multiple sclerosis,0.7765957446808511,3e-07,6.52287874528034,0.12883885965985561,IL7R,5,C,0.8404002592414285,High Risk,20,645,224,1,0.10005571016137724,0.8404002592414288
rs630923,Multiple sclerosis,0.6666666666666667,3e-07,6.52287874528034,0.1214976140951915,Y_RNA - CXCR5,11,C,0.7925142045837974,High Risk,20,599,594,1,0.08099840939679434,0.7925142045837976
rs3761959,Multiple sclerosis and LDL levels (pleiotropy),0.19503546099290786,1e-06,6.0,0.4244871324279131,FCRL3,1,G,2.5469227945674784,Medium Risk,26,474,140,2,0.08279004355863556,2.5469227945674784
rs307896,Multiple sclerosis and triglyceride levels (pleiotropy),0.19503546099290786,1e-06,6.0,0.4244871324279131,SAE1,19,G,2.5469227945674784,Medium Risk,29,431,479,2,0.08279004355863556,2.5469227945674784
rs13279485,Multiple sclerosis,0.19503546099290786,1e-06,6.0,0.4244871324279131,"ARHGEF10, KBTBD11-OT1",8,G,2.5469227945674784,Medium Risk,20,225,16,2,0.08279004355863556,2.5469227945674784
rs290986,Multiple sclerosis and HDL levels (pleiotropy),0.19503546099290786,1e-06,6.0,0.4244871324279131,OR7E108P - SYK,9,G,2.5469227945674784,Medium Risk,25,420,394,2,0.08279004355863556,2.5469227945674784
rs2920001,Multiple sclerosis,0.19503546099290786,1e-06,6.0,0.4244871324279131,DSCAS,18,G,2.5469227945674784,Medium Risk,20,421,109,2,0.08279004355863556,2.5469227945674784
rs7924357,Multiple sclerosis,0.19503546099290786,1e-06,6.0,0.4244871324279131,"WTAPP1, WTAPP1",11,G,2.5469227945674784,Medium Risk,20,733,589,2,0.08279004355863556,2.5469227945674784
rs3004212,Multiple sclerosis,0.7553191489361702,3e-07,6.52287874528034,0.11537990945797139,CSGALNACT2,10,G,0.7526091590357713,High Risk,20,429,89,2,0.08714865501612733,0.7526091590357716
rs10066308,Multiple sclerosis,0.6666666666666667,3e-07,6.52287874528034,0.11441758228312737,"CARINH, IRF1",5,A,0.7463320155609756,High Risk,20,56,50,0,0.07627838818875159,0.746332015560976
rs10758669,Multiple sclerosis,0.6666666666666667,3e-07,6.52287874528034,0.11422461764346017,HNRNPA1P41 - JAK2,9,C,0.7450733306142998,High Risk,20,81,197,1,0.07614974509564013,0.7450733306143001
rs1534422,Multiple sclerosis,0.4680851063829788,3e-07,6.52287874528034,0.11415636853052735,MIR3681HG,2,G,0.744628149926166,High Risk,20,251,341,2,0.05343489590790643,0.7446281499261663
rs2242508,Multiple sclerosis,0.6666666666666667,3e-07,6.52287874528034,0.11403224030343814,PHKG1,7,A,0.7438184765519965,High Risk,20,339,405,0,0.07602149353562544,0.7438184765519968
rs408667,Multiple sclerosis,0.4645390070921986,3e-07,6.52287874528034,0.1132548146335495,GALC,14,A,0.7387474231738446,High Risk,20,495,151,0,0.052611279138280086,0.7387474231738449
rs6495124,Multiple sclerosis,0.4645390070921986,3e-07,6.52287874528034,0.11322770096659734,SCAMP2,15,C,0.7385705640119757,High Risk,20,606,482,1,0.05259868378235551,0.7385705640119761
rs3885012,Median relapse-independent longitudinal Multiple Sclerosis Severity Scale score in relapse-onset multiple sclerosis,0.04255319148936171,4e-07,6.39794000867204,0.14498959990211674,SNORA70 - RN7SL734P,12,G,0.927634762055104,Low Risk,17,489,508,2,0.006169770208600713,0.9276347620551044
rs931555,Multiple sclerosis,0.3368794326241135,4e-07,6.39794000867204,0.1374036461519638,SPEF2,5,G,0.8791002850530648,High Risk,20,796,512,2,0.04628846235615802,0.8791002850530651
rs1738074,Multiple sclerosis,0.5957446808510638,4e-07,6.39794000867204,0.12516823687752354,"TAGAP, TAGAP-AS1",6,C,0.8008188705336466,High Risk,20,275,525,1,0.07456831133129062,0.800818870533647
rs1250542,Multiple sclerosis,0.37234042553191493,4e-07,6.39794000867204,0.12516823687752354,ZMIZ1,10,A,0.8008188705336466,High Risk,20,183,604,0,0.04660519458205664,0.800818870533647
rs6659742,Multiple sclerosis (OCB status),0.39397163120567386,7e-07,6.15490195998574,0.22794567478282152,SNHG28,1,G,1.402983280491061,High Risk,21,619,507,2,0.08980412932046623,1.4029832804910602
rs7070182,Median relapse-independent longitudinal age-related multiple sclerosis severity score in relapse-onset multiple sclerosis,0.17021276595744683,4e-07,6.39794000867204,0.12051878135323628,TCF7L2,10,C,0.7710719330162679,Low Risk,18,659,528,1,0.020513835123955115,0.7710719330162682
rs12722574,Multiple sclerosis,0.34751773049645396,4e-07,6.39794000867204,0.11953952037195645,IL2RA,10,A,0.7648066800052062,Low Risk,20,200,220,0,0.04154210282429693,0.7648066800052066
rs1219732,Median relapse-independent longitudinal Multiple Sclerosis Severity Scale score in relapse-onset multiple sclerosis,0.35106382978723405,2e-07,6.69897000433602,0.05175578123088219,CPXM2,10,T,0.3467104260166569,Low Risk,17,170,85,3,0.018169582772543748,0.3467104260166569
rs2187163,Multiple sclerosis,0.2801418439716312,4e-07,6.39794000867204,0.1165178025204943,BCL2,18,G,0.745473910468418,Low Risk,20,334,32,2,0.03264151205361365,0.7454739104684184
rs1129183,Multiple sclerosis,0.2801418439716312,4e-07,6.39794000867204,0.11618036216811452,LZTFL1,3,T,0.7433149873373871,Low Risk,20,125,318,3,0.03254698089106754,0.7433149873373873
rs10965250,Multiple sclerosis,0.2801418439716312,4e-07,6.39794000867204,0.11458343325584242,CDKN2B-AS1,9,A,0.7330979319585562,Low Risk,20,102,72,0,0.03209961428089202,0.7330979319585565
rs28512338,Multiple sclerosis,0.2801418439716312,4e-07,6.39794000867204,0.1142664872139973,LIPG - SMUG1P1,18,A,0.7310701301968452,Low Risk,20,412,305,0,0.03201082443229003,0.7310701301968455
rs3809006,Multiple sclerosis,0.5,4e-07,6.39794000867204,0.11415636853052735,ETS1,11,G,0.7303655974661705,High Risk,20,480,126,2,0.057078184265263676,0.7303655974661708
chr3:47005668,Multiple sclerosis,0.2801418439716312,4e-07,6.39794000867204,0.11393613116358743,CCDC12,6,G,0.728956532004821,Low Risk,20,36,55,2,0.03191827787916102,0.7289565320048212
rs7070182,Median relapse-independent longitudinal Multiple Sclerosis Severity Scale score in relapse-onset multiple sclerosis,0.17021276595744683,4e-07,6.39794000867204,0.11342224397406094,TCF7L2,10,C,0.7256687125950053,Low Risk,17,659,528,1,0.019305913867925267,0.7256687125950056
rs13241771,Decreased low contrast letter acuity in multiple sclerosis,0.148936170212766,7e-07,6.15490195998574,0.201027774379053,RNU6-393P - TMEM130,7,A,1.237306242537205,High Risk,7,221,458,0,0.02994030682241216,1.2373062425372046
rs9320598,Multiple sclerosis (OCB status),0.9904255319148936,9e-07,6.04575749056068,0.2499694114768139,MMS22L - MIR2113,6,G,1.511254441846991,High Risk,21,797,349,2,0.2475760873243763,1.5112544418469924
rs16898029,Response to interferon beta in multiple sclerosis,0.9146808510638298,2e-06,5.69897000433602,0.5583017251927078,LCORL - LINC02438,4,G,3.1817447852422927,Medium Risk,53,256,250,2,0.5106678971496704,3.1817447852422935
rs34286592,Multiple sclerosis,0.5000000000000001,5e-07,6.30102999566398,0.12639177780496758,"MVP-DT, MAZ",16,T,0.7963983831543977,High Risk,20,453,363,3,0.0631958889024838,0.7963983831543976
rs17411949,Multiple sclerosis (OCB status),0.39397163120567386,8e-07,6.09691001300806,0.2108161017986052,CLSTN2,3,G,1.2853268019592416,High Risk,21,276,80,2,0.08305556351001787,1.2853268019592423
rs2935183,Multiple sclerosis or amyotrophic lateral sclerosis,0.5141843971631206,5e-07,6.30102999566398,0.12068192014356213,NPEPPS,17,G,0.7604203987589102,High Risk,32,422,390,2,0.06205276035750536,0.7604203987589101
rs12249496,Moderate or severe prolonged lymphopenia in dimethyl fumarate-treated relapsing-remitting multiple sclerosis,0.35496453900709224,1e-06,6.0,0.253640034259146,LINC01163 - LINC02667,10,G,1.5218402055548759,High Risk,19,173,264,2,0.09003321783454084,1.5218402055548759
rs4075958,Multiple sclerosis,0.4326241134751774,5e-07,6.30102999566398,0.11782699131285942,LMAN2 - RGS14,5,A,0.7424314065611666,High Risk,20,494,306,0,0.05097479766017324,0.7424314065611665
rs307896,Multiple sclerosis,0.4326241134751774,5e-07,6.30102999566398,0.11782699131285942,SAE1,19,G,0.7424314065611666,High Risk,20,431,479,2,0.05097479766017324,0.7424314065611665
rs806321,Multiple sclerosis,0.36879432624113484,5e-07,6.30102999566398,0.1166034503854154,DLEU1,13,A,0.7347218384764193,Low Risk,20,747,101,0,0.043002690922280866,0.7347218384764191
rs522127,Multiple sclerosis,0.4361702127659575,5e-07,6.30102999566398,0.11537990945797139,"IL12A-AS1, LINC01100",3,C,0.727012270391672,High Risk,20,554,217,1,0.050325279657200295,0.7270122703916719
rs10832000,Depression in multiple sclerosis (pre-diagnosis),0.21276595744680854,2e-06,5.69897000433602,0.5069130062400587,RASSF10 - BMAL1,11,G,2.888882017369892,Medium Risk,10,87,433,2,0.10785383111490614,2.8888820173698924
rs34299154,Multiple sclerosis,0.36879432624113484,5e-07,6.30102999566398,0.11469472653860271,LINC02929,10,C,0.7226949122642133,Low Risk,20,454,298,1,0.042298764397215194,0.7226949122642132
rs2505509,Multiple sclerosis,0.25886524822695045,5e-07,6.30102999566398,0.11352012724825646,RASGEF1A,10,C,0.715293726902856,Low Risk,20,379,431,1,0.02938641591887491,0.7152937269028559
rs10514650,Depression in multiple sclerosis (pre-diagnosis),0.21276595744680854,2e-06,5.69897000433602,0.49834821974795057,TDRD15 - NUTF2P8,2,A,2.840071556057825,Medium Risk,10,76,529,0,0.10603153611658524,2.8400715560578256
rs17417060,Moderate or severe prolonged lymphopenia in dimethyl fumarate-treated relapsing-remitting multiple sclerosis,0.3904255319148936,1e-06,6.0,0.24140462498470577,"TMEM72, TMEM72-AS1",10,G,1.4484277499082348,High Risk,19,278,544,2,0.09425052911636916,1.4484277499082348
rs9596270,Multiple sclerosis,0.968085106382979,7e-07,6.15490195998574,0.14963905542640404,DLEU1,13,T,0.9210137155343895,High Risk,20,811,101,3,0.14486334089151884,0.921013715534389
rs7191700,Multiple sclerosis,0.6914893617021278,6e-07,6.22184874961636,0.12516823687752354,RMI2,16,C,0.7787778381081037,High Risk,20,668,448,1,0.08655250422381949,0.7787778381081042
kgp3442760,Moderate or severe prolonged lymphopenia in dimethyl fumarate-treated relapsing-remitting multiple sclerosis,0.39397163120567386,1e-06,6.0,0.21693380643582527,TMEM72-AS1,6,G,1.3016028386149516,High Risk,19,50,545,2,0.08546576558517799,1.3016028386149516
rs9807334,Oligoclonal band status in multiple sclerosis,0.5141843971631207,8e-07,6.09691001300806,0.17043925119295242,ELAC1 - SMAD4,18,G,1.039152777207907,High Risk,50,817,116,2,0.08763720362758194,1.0391527772079074
rs756699,Multiple sclerosis,0.3652482269503547,6e-07,6.22184874961636,0.1214976140951915,VDAC1 - TCF7,5,A,0.7559397783395377,High Risk,20,708,583,0,0.04437678812696712,0.7559397783395382
rs4409785,Multiple sclerosis,0.3156028368794327,6e-07,6.22184874961636,0.11905053224030346,LNCRNA-IUR - FAM76B,11,G,0.7407144051604938,Low Risk,20,509,309,2,0.03757268570704613,0.7407144051604941
rs9355260,Multiple sclerosis,0.17021276595744683,6e-07,6.22184874961636,0.1166034503854154,TAGAP - FNDC1-AS1,6,A,0.7254890319814497,Low Risk,20,799,524,0,0.019847395810283476,0.7254890319814501
rs7698247,Multiple sclerosis,0.1666666666666667,6e-07,6.22184874961636,0.1143485990456381,N4BP2 - RHOH,4,G,0.7114596879924855,Low Risk,20,720,369,2,0.019058099840939688,0.7114596879924858
rs290260,Multiple sclerosis,0.1666666666666667,6e-07,6.22184874961636,0.11431542885109507,OR7E108P - SYK,9,C,0.7112533080590434,Low Risk,20,419,394,1,0.019052571475182516,0.7112533080590437
rs7134559,Multiple sclerosis,0.1666666666666667,6e-07,6.22184874961636,0.11410742689342959,RPL13AP21 - SLC38A1,12,C,0.7099591513388247,Low Risk,20,664,466,1,0.019017904482238272,0.709959151338825
rs1059501,Multiple sclerosis,0.1666666666666667,6e-07,6.22184874961636,0.1140185244096415,"CD27, CD27-AS1",12,T,0.7094060135312299,Low Risk,20,79,60,3,0.019003087401606923,0.7094060135312303
rs397020,Multiple sclerosis,0.5319148936170214,8e-07,6.09691001300806,0.15698030099106816,C20orf202 - RAD21L1,20,G,0.9570947689574619,High Risk,20,492,44,2,0.08350016010163201,0.9570947689574625
rs2420518,Multiple sclerosis,0.2836879432624114,6e-07,6.22184874961636,0.11329988988131653,REL-DT,2,C,0.7049347781897402,Low Risk,20,371,438,1,0.03214181273228839,0.7049347781897405
kgp1734375,Severe prolonged lymphopenia in dimethyl fumarate-treated relapsing-remitting multiple sclerosis,0.21276595744680854,2e-06,5.69897000433602,0.40046494555242873,NR,6,G,2.2822377124913484,Medium Risk,55,48,391,2,0.08520530756434655,2.2822377124913484
rs74696548,Depression in multiple sclerosis (pre-diagnosis),0.24822695035461,3e-06,5.52287874528034,0.6084669032179126,SGO1-AS1,3,G,3.360488926988758,Medium Risk,10,700,487,2,0.1510378837774961,3.3604889269887592
rs794185,Multiple sclerosis--Brain Glutamate Levels,0.4255319148936171,6e-07,6.22184874961636,0.10720665606264529,SUMF1,3,G,0.6670235989739204,Low Risk,33,736,519,2,0.045619853643678855,0.6670235989739207
rs10866713,Multiple sclerosis,0.21276595744680854,7e-07,6.15490195998574,0.1276153187324116,LINC01845 - LINC01847,5,A,0.7854597753903255,Low Risk,20,89,270,0,0.027152195474981197,0.7854597753903252
chr1:32715071,Multiple sclerosis,0.1773049645390071,7e-07,6.15490195998574,0.1273980423345161,FAM167B,6,T,0.7841224604630598,Low Risk,20,26,136,3,0.0225883053784603,0.7841224604630594
rs4271113,Multiple sclerosis,0.34432624113475174,9e-07,6.04575749056068,0.16484647416289414,TMEM47 - FAM47B,23,G,0.996621805962834,High Risk,20,501,543,2,0.05676096681282631,0.9966218059628349
rs1207401,Median relapse-independent longitudinal age-related multiple sclerosis severity score in relapse-onset multiple sclerosis,0.2659574468085107,3e-07,6.52287874528034,0.044414535666218044,SEZ6L,22,A,0.28971063067866915,Low Risk,18,163,485,0,0.011812376506972887,0.28971063067866926
rs7289446,Median relapse-independent longitudinal age-related multiple sclerosis severity score in relapse-onset multiple sclerosis,0.2659574468085107,3e-07,6.52287874528034,0.044169827480729215,SEZ6L,22,G,0.28811442885674793,Low Risk,18,685,485,2,0.011747294542747134,0.28811442885674804
rs9568281,Multiple sclerosis,0.2659574468085107,3e-07,6.52287874528034,0.043884334597658975,RCBTB1 - ARL11,13,G,0.28625219339784025,Low Risk,20,808,434,2,0.011671365584483772,0.2862521933978404
rs338610,Multiple sclerosis and HDL levels (pleiotropy),0.2659574468085107,3e-07,6.52287874528034,0.043884334597658975,LINC01967,3,G,0.28625219339784025,Low Risk,25,451,274,2,0.011671365584483772,0.2862521933978404
rs733724,Multiple sclerosis,0.2659574468085107,3e-07,6.52287874528034,0.043884334597658975,HACE1,6,G,0.28625219339784025,Low Risk,20,695,170,2,0.011671365584483772,0.2862521933978404
rs1207401,Median relapse-independent longitudinal Multiple Sclerosis Severity Scale score in relapse-onset multiple sclerosis,0.2659574468085107,3e-07,6.52287874528034,0.04368041110975163,SEZ6L,22,A,0.284922025212906,Low Risk,17,163,485,0,0.011617130614295647,0.2849220252129061
rs3780792,Multiple sclerosis,0.24113475177304972,1e-06,6.0,0.1802275786125046,VAV2,9,G,1.0813654716750276,High Risk,20,477,580,2,0.0434591324313841,1.0813654716750276
rs7289446,Median relapse-independent longitudinal Multiple Sclerosis Severity Scale score in relapse-onset multiple sclerosis,0.2659574468085107,3e-07,6.52287874528034,0.04306864064602961,SEZ6L,22,G,0.28093152065810334,Low Risk,17,685,485,2,0.011454425703731282,0.28093152065810345
rs12638253,Multiple sclerosis (severity),0.4787234042553192,2e-06,5.69897000433602,0.37307802112647337,LEKR1,3,G,2.126160451676811,Medium Risk,23,192,252,2,0.1786011803265032,2.1261604516768116
rs1386330,Multiple sclerosis (age of onset),0.11702127659574474,2e-06,5.69897000433602,0.37307802112647337,MTCYBP41 - Y_RNA,11,G,2.126160451676811,Medium Risk,22,237,359,2,0.043658066302034136,2.1261604516768116
rs1478091,Multiple sclerosis (severity),0.04255319148936171,2e-06,5.69897000433602,0.37258452628573757,GAPDHP56 - RNU6-224P,4,G,2.1233480393821633,Medium Risk,23,247,152,2,0.01585466069301011,2.1233480393821638
rs1790100,Multiple sclerosis,0.2340425531914894,7e-07,6.15490195998574,0.12027407316774748,MPHOSPH9,12,G,0.7402751286756376,Low Risk,20,292,352,2,0.028149251166919628,0.7402751286756373
rs13260060,Multiple sclerosis,0.08510638297872347,7e-07,6.15490195998574,0.11905053224030346,NCOA2,8,A,0.7327443542231896,Low Risk,20,224,376,0,0.010131960190664133,0.7327443542231893
rs10936599,Multiple sclerosis,0.18794326241134757,7e-07,6.15490195998574,0.11905053224030346,MYNN,3,G,0.7327443542231896,Low Risk,20,98,366,2,0.022374745421049946,0.7327443542231893
rs727098,Multiple sclerosis,0.24468085106382984,7e-07,6.15490195998574,0.11537990945797139,LINC01625 - ATP5PBP6,6,G,0.7101520308658457,Low Risk,20,682,268,2,0.02823125444184407,0.7101520308658453
rs72709458,Multiple sclerosis,0.18794326241134757,7e-07,6.15490195998574,0.1151719075003059,TERT,5,T,0.7088717992089295,Low Risk,20,681,531,3,0.02164578403374544,0.7088717992089292
rs9399125,Multiple sclerosis,0.18794326241134757,7e-07,6.15490195998574,0.11490248378808271,LINC03002 - MEMO1P2,6,C,0.7072135226745003,Low Risk,20,801,302,1,0.02159514766229924,0.7072135226745
rs7620803,Multiple sclerosis,0.18794326241134757,7e-07,6.15490195998574,0.11474366817570048,SIDT1,3,T,0.7062360281505726,Low Risk,20,716,490,3,0.021565299337986264,0.7062360281505723
rs33384,Multiple sclerosis,0.18794326241134757,7e-07,6.15490195998574,0.11419307475835067,ARHGAP26 - NR3C1,5,G,0.702847179646971,Low Risk,20,448,15,2,0.02146181901486733,0.7028471796469707
rs3885012,Median relapse-independent longitudinal age-related multiple sclerosis severity score in relapse-onset multiple sclerosis,0.04255319148936171,1e-06,6.0,0.16786981524531996,SNORA70 - RN7SL734P,12,G,1.0072188914719198,High Risk,18,489,508,2,0.007143396393417872,1.0072188914719198
rs8074980,Multiple sclerosis--Brain Glutamate Levels,0.4503546099290781,2e-06,5.69897000433602,0.34936171948285,CUEDC1,17,G,1.9910019599960167,Medium Risk,33,751,93,2,0.15733666090185092,1.991001959996017
rs2038256,Multiple sclerosis--Brain Glutamate Levels,0.4503546099290781,2e-06,5.69897000433602,0.34936171948285,LINC01551,14,G,1.9910019599960167,Medium Risk,33,313,266,2,0.15733666090185092,1.991001959996017
rs11026091,Multiple sclerosis,0.4503546099290781,2e-06,5.69897000433602,0.34936171948285,MRGPRE - NDUFA5P8,11,G,1.9910019599960167,Medium Risk,20,107,355,2,0.15733666090185092,1.991001959996017
rs28758178,Depression in multiple sclerosis (pre-diagnosis),0.24822695035461,3e-06,5.52287874528034,0.5277132020066071,TM2D3,15,A,2.9144960269661193,Medium Risk,10,416,540,0,0.13099263879596634,2.9144960269661206
rs73060045,Multiple sclerosis,0.26950354609929084,8e-07,6.09691001300806,0.12167544353358621,ETV6 - BCL2L14,12,G,0.7418442300171181,Low Risk,20,690,130,2,0.03279196350550551,0.7418442300171185
rs2069852,Multiple sclerosis,0.26950354609929084,8e-07,6.09691001300806,0.1211672580447816,IL6 - MTCYBP42,7,G,0.7387458688219599,Low Risk,20,319,222,2,0.03265500571419647,0.7387458688219602
rs9523762,Multiple sclerosis,0.35106382978723405,1e-06,6.0,0.15086259635384805,GPC5,13,G,0.9051755781230884,High Risk,20,807,163,2,0.05296240084762751,0.9051755781230884
rs1857996,Multiple sclerosis,0.2730496453900709,8e-07,6.09691001300806,0.11612626942371224,DOCK10,2,C,0.7080114148227025,Low Risk,20,302,105,1,0.03170823668661646,0.7080114148227028
chr16:68694818,Multiple sclerosis,0.2730496453900709,8e-07,6.09691001300806,0.11575633182429952,CDH3,6,C,0.7057559385686548,Low Risk,20,20,70,1,0.03160722535628037,0.7057559385686553
rs11845242,Median relapse-independent longitudinal age-related multiple sclerosis severity score in relapse-onset multiple sclerosis,0.41489361702127664,6e-07,6.22184874961636,0.08234430441698276,LINC00520,14,G,0.5123338074748328,Low Risk,18,150,257,2,0.03416412630066307,0.512333807474833
rs806349,Multiple sclerosis,0.4893617021276596,8e-07,6.09691001300806,0.11415636853052735,DLEU1,13,A,0.69600110634241,High Risk,20,748,101,0,0.055863754812811264,0.6960011063424104
rs9844930,Multiple sclerosis,0.2730496453900709,8e-07,6.09691001300806,0.11400479628043558,ARHGEF3,3,A,0.6950769839731313,Low Risk,20,823,17,0,0.031128969197140213,0.6950769839731317
rs10918297,Multiple sclerosis,0.2730496453900709,8e-07,6.09691001300806,0.11377205432521718,UCK2,1,G,0.6936579772159132,Low Risk,20,95,574,2,0.031065419088800436,0.6936579772159136
rs62189580,Multiple sclerosis,0.2730496453900709,8e-07,6.09691001300806,0.11374036461519638,IKZF2 - LINC01953,2,G,0.693464767905578,Low Risk,20,595,212,2,0.03105676622471674,0.6934647679055784
rs11629690,Multiple sclerosis,0.2730496453900709,8e-07,6.09691001300806,0.11364248134100087,"LINC02883, AKAP13",15,G,0.6928679823910294,Low Risk,20,136,297,2,0.03103003923140804,0.6928679823910298
rs113116201,Multiple sclerosis,0.0,1e-06,6.0,0.1422978098617399,MIR181A1HG,1,G,0.8537868591704394,Low Risk,20,126,340,2,0.0,0.8537868591704394
rs17157903,Multiple sclerosis (age of onset),0.12765957446808512,3e-06,5.52287874528034,0.4551164403115951,RELN,7,G,2.513552914824556,Medium Risk,22,268,439,2,0.05809997110360789,2.5135529148245572
rs17090640,Multiple sclerosis,0.1702127659574469,3e-06,5.52287874528034,0.4551164403115951,RNA5SP173 - NDUFB5P1,4,G,2.513552914824556,Medium Risk,20,263,452,2,0.07746662813814388,2.5135529148245572
rs17123757,Multiple sclerosis and C-reactive protein levels (pleiotropy),0.1702127659574469,3e-06,5.52287874528034,0.4551164403115951,DPH5-DT - S1PR1-DT,1,G,2.513552914824556,Medium Risk,24,266,106,2,0.07746662813814388,2.5135529148245572
rs2116078,Multiple sclerosis (age of onset),0.4893617021276596,3e-06,5.52287874528034,0.4551164403115951,RNA5SP271 - KCNB2,8,G,2.513552914824556,Medium Risk,22,325,453,2,0.22271655589716358,2.5135529148245572
chr18:60902282,Multiple sclerosis,0.25886524822695045,9e-07,6.04575749056068,0.1255194787715649,BCL2,6,G,0.7588603289944602,Low Risk,20,21,32,2,0.03249263102951859,0.7588603289944609
rs60733400,Multiple sclerosis,0.725531914893617,1e-06,6.0,0.13985072800685183,TNFRSF14 - PRXL2B,1,G,0.839104368041111,High Risk,20,585,547,2,0.1014661664900776,0.839104368041111
rs290986,Multiple sclerosis,0.372340425531915,9e-07,6.04575749056068,0.11905053224030346,OR7E108P - SYK,9,A,0.7197506470470497,High Risk,20,420,394,0,0.04432732583415555,0.7197506470470504
rs8049603,Multiple sclerosis,0.19148936170212774,1e-06,6.0,0.13006240058729965,HS3ST2 - USP31,16,T,0.7803744035237978,Low Risk,20,745,202,3,0.024905566069908455,0.7803744035237978
rs1684468,Multiple sclerosis,0.5460992907801419,9e-07,6.04575749056068,0.11393613116358743,LINC01063 - NRROS,3,T,0.6888302184277623,High Risk,20,254,260,3,0.06222044042266831,0.6888302184277628
rs10157709,Decreased low contrast letter acuity in multiple sclerosis,0.03191489361702132,2e-06,5.69897000433602,0.2609812798238101,ZNF692-DT,1,C,1.4873244854091188,High Risk,7,60,608,1,0.008329189781610973,1.487324485409119
chr10:6390285,Multiple sclerosis,0.372340425531915,1e-06,6.0,0.12084913740364617,LOC399715,6,C,0.725094824421877,High Risk,20,11,311,1,0.04499701924603848,0.725094824421877
chr1:150593391,Multiple sclerosis,0.372340425531915,1e-06,6.0,0.11857710754924752,MCL1,6,T,0.7114626452954851,Low Risk,20,22,328,3,0.04415105068323047,0.7114626452954851
rs17066362,Multiple sclerosis,0.372340425531915,1e-06,6.0,0.11805946408907379,LINC02836 - RN7SKP211,6,T,0.7083567845344427,Low Risk,20,262,295,3,0.04395831109699557,0.7083567845344427
rs7255066,Multiple sclerosis,0.372340425531915,1e-06,6.0,0.11782699131285942,CEACAM16-AS1,19,G,0.7069619478771565,Low Risk,20,677,73,2,0.043871752084575326,0.7069619478771565
rs55733613,Multiple sclerosis,0.372340425531915,1e-06,6.0,0.11723969166768627,CBFA2T3 - ACSF3,16,C,0.7034381500061176,Low Risk,20,560,53,1,0.04365307668477682,0.7034381500061176
rs8112449,Multiple sclerosis,0.372340425531915,1e-06,6.0,0.1166034503854154,CDC37,19,G,0.6996207023124924,Low Risk,20,754,69,2,0.04341617833499511,0.6996207023124924
rs233100,Multiple sclerosis,0.372340425531915,1e-06,6.0,0.1166034503854154,BCL10-AS1,1,G,0.6996207023124924,Low Risk,20,365,31,2,0.04341617833499511,0.6996207023124924
rs189139,Multiple sclerosis,0.3297872340425533,1e-06,6.0,0.11537990945797139,SH3BP2,4,A,0.6922794567478283,Low Risk,20,306,489,0,0.038050821204224615,0.6922794567478283
rs4924273,Multiple sclerosis,0.25531914893617025,1e-06,6.0,0.11537990945797139,RASGRP1,15,G,0.6922794567478283,Low Risk,20,547,432,2,0.029458700287141634,0.6922794567478283
rs10102600,Multiple sclerosis,0.372340425531915,1e-06,6.0,0.11526506790652148,"FAM167A, FAM167A-AS1",8,C,0.6915904074391289,Low Risk,20,57,135,1,0.042917844433279284,0.6915904074391289
rs6433892,Multiple sclerosis,0.372340425531915,1e-06,6.0,0.11524531995595252,LINC01934,2,A,0.6914719197357151,Low Risk,20,602,273,0,0.042910491472961054,0.6914719197357151
rs13193860,Multiple sclerosis,0.372340425531915,1e-06,6.0,0.11495814266487214,LINC02541 - MARCKS,6,A,0.6897488559892329,Low Risk,20,219,283,0,0.042803563758197084,0.6897488559892329
rs11762408,Multiple sclerosis,0.372340425531915,1e-06,6.0,0.11495167013336596,GIMAP6 - GIMAP2,7,C,0.6897100208001958,Low Risk,20,144,158,1,0.042801153773061804,0.6897100208001958
rs5756391,Multiple sclerosis,0.3936170212765958,1e-06,6.0,0.11415636853052735,NCF4 - CSF2RB,22,A,0.6849382111831641,Low Risk,20,571,373,0,0.044933889740739495,0.6849382111831641
rs731089,Multiple sclerosis,0.7127659574468086,1e-06,6.0,0.11415636853052735,LINC00423 - TOMM22P3,13,A,0.6849382111831641,High Risk,20,692,256,0,0.08136677331431205,0.6849382111831641
rs2073167,Multiple sclerosis,0.5319148936170214,1e-06,6.0,0.11415636853052735,TEF,22,A,0.6849382111831641,High Risk,20,321,530,0,0.060721472622620946,0.6849382111831641
rs10931933,Multiple sclerosis,0.5460992907801419,1e-06,6.0,0.11382601248011745,CASP8,2,G,0.6829560748807046,High Risk,20,96,52,2,0.06216030468772372,0.6829560748807046
chr9:86543849,Multiple sclerosis,0.5460992907801419,1e-06,6.0,0.11328192830050166,KIF27,6,G,0.6796915698030099,High Risk,20,47,241,2,0.06186318070311084,0.6796915698030099
rs6984045,Multiple sclerosis,0.0,2e-06,5.69897000433602,0.1790040376850606,ASAP1,8,C,1.0201386414221947,High Risk,20,653,18,1,0.0,1.020138641422195
rs12957214,Response to interferon beta in multiple sclerosis,0.11755319148936177,6e-06,5.22184874961636,0.4887923651046128,MIR924HG,18,C,2.5523998005435438,Medium Risk,53,210,345,1,0.05745910249368059,2.5523998005435455
rs1529316,Multiple sclerosis,0.4787234042553192,2e-06,5.69897000433602,0.15086259635384805,CSMD1,8,G,0.8597614113968325,High Risk,20,250,90,2,0.07222145570131024,0.8597614113968326
rs1458175,Multiple sclerosis,0.5,2e-06,5.69897000433602,0.14841551449896,PDZRN4,12,G,0.8458155653076705,High Risk,20,245,402,2,0.07420775724948,0.8458155653076708
kgp5383559,Moderate or severe prolonged lymphopenia in dimethyl fumarate-treated relapsing-remitting multiple sclerosis,0.4361702127659575,3e-06,5.52287874528034,0.2291692157102655,"ERVMER34-1, LOC152578, RASL11B, SCFD2",6,G,1.26567379051879,High Risk,19,53,124,2,0.09995678557575412,1.2656737905187907
rs12612334,Depression in multiple sclerosis (post-diagnosis),0.2517730496453901,3e-06,5.52287874528034,0.2181573473632693,GCFC2 - SUCLA2P2,2,C,1.2048565768793396,High Risk,9,189,155,1,0.054926140648199014,1.20485657687934
kgp6724547,Severe prolonged lymphopenia in dimethyl fumarate-treated relapsing-remitting multiple sclerosis,0.1702127659574469,6e-06,5.22184874961636,0.4494065826501896,NR,6,G,2.346733201681252,Medium Risk,55,54,391,2,0.07649473747237273,2.346733201681254
rs78077440,Multiple sclerosis,0.7404255319148937,2e-06,5.69897000433602,0.13862718707940783,RNU1-150P - TTC33,5,G,0.7900321809510229,High Risk,20,729,457,2,0.10264310873113602,0.790032180951023
rs3003482,Depression in multiple sclerosis,0.2517730496453901,3e-06,5.52287874528034,0.20836901994371715,PADI1,1,G,1.1507968314220502,High Risk,8,428,396,2,0.052461703602850775,1.1507968314220507
rs73277163,Multiple sclerosis,0.21276595744680854,2e-06,5.69897000433602,0.13169821363024595,ETV6,12,G,0.7505441691034087,Low Risk,20,694,129,2,0.02802089651707361,0.7505441691034088
kgp4348860,Moderate or severe prolonged lymphopenia in dimethyl fumarate-treated relapsing-remitting multiple sclerosis,0.35106382978723416,4e-06,5.39794000867204,0.2781108528080264,MN1,6,G,1.5012256992183457,Medium Risk,19,52,350,2,0.09763466109217951,1.5012256992183464
rs12094392,Multiple sclerosis,0.21276595744680854,2e-06,5.69897000433602,0.1283562461764346,PHGDH,1,C,0.7314983968286706,Low Risk,20,165,404,1,0.027309839612007364,0.7314983968286707
rs10980055,Decreased low contrast letter acuity in multiple sclerosis,0.13829787234042556,3e-06,5.52287874528034,0.19980423345160897,PALM2AKAP2,9,G,1.1034945541469217,High Risk,7,104,397,2,0.027632500370967206,1.1034945541469223
kgp4224365,Severe prolonged lymphopenia in dimethyl fumarate-treated relapsing-remitting multiple sclerosis,0.18794326241134757,5e-06,5.30102999566398,0.3392878991802276,NR,6,G,1.7985753307202033,Medium Risk,55,51,391,2,0.06376687466862435,1.798575330720203
chr3:100656795,Multiple sclerosis,0.21276595744680854,2e-06,5.69897000433602,0.12355316285329745,ABI3BP,6,T,0.7041257690417855,Low Risk,20,31,0,3,0.02628790699006329,0.7041257690417856
rs4364506,Multiple sclerosis,0.21276595744680854,2e-06,5.69897000433602,0.12193753823565398,L3MBTL3,6,G,0.6949183728075684,Low Risk,20,505,246,2,0.025944157071415744,0.6949183728075685
rs1250540,Multiple sclerosis,0.35106382978723405,2e-06,5.69897000433602,0.1214976140951915,ZMIZ1,10,G,0.6924112583268894,High Risk,20,182,604,2,0.04265341771426936,0.6924112583268895
rs6897932,Multiple sclerosis,0.7765957446808511,2e-06,5.69897000433602,0.1214976140951915,IL7R,5,C,0.6924112583268894,High Risk,20,645,224,1,0.09435453009520192,0.6924112583268895
chr3:5035903,Multiple sclerosis,0.21276595744680854,2e-06,5.69897000433602,0.12083690199437172,BHLHE40,6,C,0.6886458798828157,Low Risk,20,37,35,1,0.025709979147738666,0.6886458798828158
rs9321490,Multiple sclerosis,0.21276595744680854,2e-06,5.69897000433602,0.11905053224030346,HBS1L - MYB,6,G,0.6784654122377275,Low Risk,20,798,171,2,0.025329900476660314,0.6784654122377276
rs1062158,Multiple sclerosis,0.21276595744680854,2e-06,5.69897000433602,0.1166034503854154,NDFIP1,5,A,0.6645195661485656,Low Risk,20,80,380,0,0.024809244762854343,0.6645195661485657
rs281380,Multiple sclerosis,0.21276595744680854,2e-06,5.69897000433602,0.1166034503854154,FUT2 - MAMSTR,19,G,0.6645195661485656,Low Risk,20,406,149,2,0.024809244762854343,0.6645195661485657
chr20:52783991,Multiple sclerosis,0.21276595744680854,2e-06,5.69897000433602,0.11633653493209348,CYP24A1,6,G,0.6629984229863901,Low Risk,20,29,96,2,0.024752454240870955,0.6629984229863902
rs10789825,Multiple sclerosis,0.21276595744680854,2e-06,5.69897000433602,0.11425425180472287,POU2AF1,11,G,0.6511315539029701,Low Risk,20,84,419,2,0.024309415277600614,0.6511315539029702
rs4661089,Multiple sclerosis,0.21276595744680854,2e-06,5.69897000433602,0.11422461764346017,ETV3L - ETV3,1,T,0.6509626697068304,Low Risk,20,518,128,3,0.024303110136906423,0.6509626697068304
rs223889,Multiple sclerosis,0.2872340425531915,2e-06,5.69897000433602,0.11415636853052735,RPL23AP91 - CCL22,16,A,0.6505737200594036,Low Risk,20,337,468,0,0.03278959521621531,0.6505737200594037
rs7993214,Multiple sclerosis,0.6702127659574468,2e-06,5.69897000433602,0.11415636853052735,COG6,13,G,0.6505737200594036,High Risk,20,739,83,2,0.07650905550450238,0.6505737200594037
rs6716355,Multiple sclerosis,0.3085106382978724,2e-06,5.69897000433602,0.11415636853052735,LINC01934,2,C,0.6505737200594036,Low Risk,20,631,273,1,0.035218454121120145,0.6505737200594037
rs335123,Multiple sclerosis,0.21276595744680854,2e-06,5.69897000433602,0.11397283739141074,"ANKRD36BP2, ANKRD36BP2",2,T,0.6495277816027164,Low Risk,20,449,13,3,0.024249539870512926,0.6495277816027165
rs2724416,Multiple sclerosis,0.21276595744680854,2e-06,5.69897000433602,0.1138814755903585,LINC02732,11,T,0.6490071134389775,Low Risk,20,395,294,3,0.02423010118943798,0.6490071134389777
rs2960172,Multiple sclerosis,0.21276595744680854,2e-06,5.69897000433602,0.11381306741710512,"FLJ40194, ZNF652",17,A,0.6486172573115552,Low Risk,20,424,143,0,0.02421554625895854,0.6486172573115553
rs11008218,Multiple sclerosis,0.21276595744680854,2e-06,5.69897000433602,0.11371589379664751,LINC02644 - ZNF438,10,G,0.6480634677633546,Low Risk,20,106,291,2,0.024194871020563304,0.6480634677633547
rs1877721,Multiple sclerosis,0.21276595744680854,2e-06,5.69897000433602,0.11329988988131653,TNIP2 - SH3BP2,4,G,0.645692673928197,Low Risk,20,304,551,2,0.024106359549216288,0.6456926739281971
rs10853845,Multiple sclerosis,0.21276595744680854,2e-06,5.69897000433602,0.11274168603939803,FPR1,19,G,0.6425114869767983,Low Risk,20,88,147,2,0.02398759277434001,0.6425114869767984
rs35280661,Multiple sclerosis,0.21276595744680854,2e-06,5.69897000433602,0.11249235286920348,SGSM2,17,G,0.6410905447187735,Low Risk,20,462,488,2,0.023934543163660317,0.6410905447187736
rs12644284,Multiple sclerosis,0.6914893617021278,4e-06,5.39794000867204,0.23406337942004163,TRIM2,4,G,1.263460080336426,High Risk,20,194,560,2,0.16185233683300754,1.2634600803364264
rs898,Depression in multiple sclerosis (post-diagnosis),0.35106382978723416,4e-06,5.39794000867204,0.23161629756515356,PTGFR,1,C,1.2502508792874303,High Risk,9,761,426,1,0.08131210446436245,1.250250879287431
rs908821,Multiple sclerosis,0.7340425531914894,3e-06,5.52287874528034,0.15208613728129208,TRIM42 - RPL23AP41,3,G,0.8399532950426356,High Risk,20,762,562,2,0.111637696514991,0.8399532950426359
rs1755289,Multiple sclerosis,0.6276595744680852,3e-06,5.52287874528034,0.14963905542640404,ADAMTSL1,9,G,0.8264383586783133,High Risk,20,282,1,2,0.09392238585274297,0.8264383586783136
rs6691722,Response to interferon beta in multiple sclerosis,0.5309574468085106,6e-06,5.22184874961636,0.2744402300256944,GRHL3,1,G,1.4330853720040975,Medium Risk,53,628,166,2,0.14571608383598306,1.4330853720040984
rs6604026,Multiple sclerosis,0.27659574468085113,3e-06,5.52287874528034,0.1276153187324116,"RPL5, DIPK1A",1,G,0.7048039313994118,Low Risk,20,618,471,2,0.03529785411747556,0.7048039313994121
rs793108,Multiple sclerosis,0.3262411347517731,3e-06,5.52287874528034,0.1166034503854154,LINC02664,10,A,0.6439867177599611,Low Risk,20,734,292,0,0.03804084196970999,0.6439867177599614
rs3761959,Multiple sclerosis,0.3262411347517731,3e-06,5.52287874528034,0.1166034503854154,FCRL3,1,G,0.6439867177599611,Low Risk,20,474,140,2,0.03804084196970999,0.6439867177599614
rs11755724,Multiple sclerosis,0.3262411347517731,3e-06,5.52287874528034,0.1166034503854154,RREB1,6,A,0.6439867177599611,Low Risk,20,143,477,0,0.03804084196970999,0.6439867177599614
rs4792814,Multiple sclerosis,0.3262411347517731,3e-06,5.52287874528034,0.1166034503854154,MAP3K14 - RNA5SP443,17,G,0.6439867177599611,Low Risk,20,531,322,2,0.03804084196970999,0.6439867177599614
rs2273215,Multiple sclerosis,0.3262411347517731,3e-06,5.52287874528034,0.11620873608222194,LINC01624,6,G,0.6418067585243958,Low Risk,20,348,267,2,0.037912069927533404,0.6418067585243961
rs62059189,Multiple sclerosis,0.3262411347517731,3e-06,5.52287874528034,0.11602455646641381,Y_RNA - SLC2A4,17,T,0.6407895568389351,Low Risk,20,593,596,3,0.03785198296067401,0.6407895568389355
rs4812492,Multiple sclerosis,0.3262411347517731,3e-06,5.52287874528034,0.11494423100452711,ZHX3,20,C,0.634823050307496,Low Risk,20,537,603,1,0.03749953635608686,0.6348230503074962
rs31220,Multiple sclerosis,0.3262411347517731,3e-06,5.52287874528034,0.11474971246788204,"ITK, GARIN3",5,G,0.6337487480158959,Low Risk,20,435,231,2,0.03743607640796152,0.6337487480158962
rs2725556,Median relapse-independent longitudinal Multiple Sclerosis Severity Scale score in relapse-onset multiple sclerosis,0.06382978723404259,2e-06,5.69897000433602,0.07121008197724214,RNU6-449P - UNC13C,15,A,0.4058241211946119,Low Risk,17,396,459,0,0.004545324381526097,0.405824121194612
chr16:30171625,Multiple sclerosis,0.3262411347517731,3e-06,5.52287874528034,0.11422978098617399,MAPK3,6,C,0.6308772294865683,Low Risk,20,18,325,1,0.037266453371375914,0.6308772294865687
rs7260516,Multiple sclerosis,0.3617021276595745,3e-06,5.52287874528034,0.11415636853052735,FPR1,19,A,0.6304717813956386,Low Risk,20,679,147,0,0.04129060138338224,0.630471781395639
rs10905353,Multiple sclerosis,0.3262411347517731,3e-06,5.52287874528034,0.11374036461519638,LINC00708 - KRT8P37,10,G,0.6281742422137039,Low Risk,20,94,259,2,0.03710678561914208,0.6281742422137041
rs1567526,Multiple sclerosis,0.3262411347517731,3e-06,5.52287874528034,0.11372812920592194,MYO5B,18,G,0.6281066675318823,Low Risk,20,253,367,2,0.03710279392533624,0.6281066675318826
chr6:130348257,Multiple sclerosis,0.3262411347517731,3e-06,5.52287874528034,0.11350789183898201,L3MBTL3,6,T,0.6268903232590932,Low Risk,20,41,246,3,0.03703094343683101,0.6268903232590936
rs6492971,Multiple sclerosis,0.3262411347517731,3e-06,5.52287874528034,0.11341769240181085,DLL4 - ISCA1P4,15,A,0.6263921627047043,Low Risk,20,605,102,0,0.037001516670094325,0.6263921627047047
rs4543864,Multiple sclerosis,0.3262411347517731,3e-06,5.52287874528034,0.11333659610913985,LINC01353 - BTG2-DT,1,T,0.6259442777135906,Low Risk,20,512,265,3,0.036975059723549177,0.625944277713591
rs7565445,Multiple sclerosis,0.3262411347517731,3e-06,5.52287874528034,0.11329988988131653,MIR4435-2HG,2,C,0.6257415536681259,Low Risk,20,707,343,1,0.03696308464213164,0.6257415536681261
rs10893900,Multiple sclerosis,0.3262411347517731,3e-06,5.52287874528034,0.11271479260981282,ETS1 - FLI1,11,G,0.6225101323834165,Low Risk,20,92,127,2,0.0367722018443361,0.6225101323834168
rs4941702,Multiple sclerosis,0.3262411347517731,3e-06,5.52287874528034,0.11261470696194789,LINC00423 - TOMM22P3,13,G,0.6219573714861156,Low Risk,20,551,256,2,0.03673954978900428,0.621957371486116
chr1:1682374,Multiple sclerosis,0.3262411347517731,3e-06,5.52287874528034,0.1124197234797504,NADK,6,A,0.6208805013566064,Low Risk,20,24,371,0,0.03667593815651432,0.6208805013566067
rs11066320,Multiple sclerosis,0.3262411347517731,3e-06,5.52287874528034,0.11241894041355685,PTPN11,12,A,0.6208761765769699,Low Risk,20,110,427,0,0.03667568268811075,0.6208761765769701
rs2842483,Multiple sclerosis (age of onset),0.2872340425531915,5e-06,5.30102999566398,0.18867001101186834,PCSK5,9,G,1.0001453876561677,High Risk,22,411,398,2,0.054192449971494104,1.0001453876561675
rs4149584,Multiple sclerosis,0.0021276595744681437,5e-06,5.30102999566398,0.17778049675761656,TNFRSF1A,12,T,0.9424197459561685,High Risk,20,498,548,3,0.0003782563760800457,0.9424197459561684
rs7789940,Multiple sclerosis,0.1808510638297873,6e-06,5.22184874961636,0.21326318365349323,FPASL,7,G,1.1136280889001968,High Risk,20,728,146,2,0.03856887363946156,1.1136280889001977
rs17149161,Multiple sclerosis,0.19148936170212774,6e-06,5.22184874961636,0.21326318365349323,YWHAG,7,A,1.1136280889001968,High Risk,20,267,592,0,0.04083763091237106,1.1136280889001977
kgp2538268,Moderate or severe prolonged lymphopenia in dimethyl fumarate-treated relapsing-remitting multiple sclerosis,0.1702127659574469,6e-06,5.22184874961636,0.20469839716138505,LOC101928519,6,G,1.0689040692656508,High Risk,19,49,310,2,0.03484228036789534,1.0689040692656515
rs6498169,Multiple sclerosis,0.37234042553191493,4e-06,5.39794000867204,0.12394469595007952,CLEC16A,16,G,0.6690460331316254,High Risk,20,610,77,2,0.04614962083247642,0.6690460331316256
chr16:68335911,Multiple sclerosis,0.35106382978723416,4e-06,5.39794000867204,0.1205158448550104,SLC7A6OS,6,C,0.6505373006217728,Low Risk,20,19,502,1,0.04230875404484409,0.6505373006217732
rs17594362,Multiple sclerosis,0.35106382978723416,4e-06,5.39794000867204,0.12027407316774748,RGCC - VWA8,13,A,0.6492322315581321,Low Risk,20,284,442,0,0.04222387675037945,0.6492322315581324
rs12456021,Multiple sclerosis,0.35106382978723416,4e-06,5.39794000867204,0.11905053224030346,ALPK2,18,A,0.6426276310336343,Low Risk,20,179,12,0,0.04179433578648953,0.6426276310336346
rs2602397,Brain lesion load,0.45744680851063835,4e-06,5.39794000867204,0.11817821281455201,UGT1A12P - UGT1A11P,2,G,0.6379189031050287,High Risk,5,388,575,2,0.05406024628750784,0.6379189031050291
rs10518025,Multiple sclerosis (severity),0.12765957446808512,4e-06,5.39794000867204,0.11817821281455201,RNU6-699P - RNU1-63P,4,G,0.6379189031050287,Low Risk,23,77,460,2,0.015086580359304514,0.6379189031050291
rs386965,Multiple sclerosis,0.35106382978723416,4e-06,5.39794000867204,0.11782699131285942,MAFTRR,16,G,0.6360230305091364,Low Risk,20,487,319,2,0.041364794822599596,0.6360230305091368
rs10414065,Multiple sclerosis,0.35106382978723416,4e-06,5.39794000867204,0.11764281169705128,SLC7A10 - CEBPA,19,T,0.6350288399921838,Low Risk,20,72,501,3,0.04130013602130525,0.6350288399921842
rs1557351,Multiple sclerosis (age of onset),0.21276595744680854,4e-06,5.39794000867204,0.11728192830050167,LINC-ROR - BOD1L2,18,G,0.6330808130674833,Low Risk,22,252,254,2,0.02495360176606419,0.6330808130674835
rs10259085,Multiple sclerosis (severity),0.4680851063829788,4e-06,5.39794000867204,0.11687408132468699,C1GALT1,7,G,0.6308792795593173,High Risk,23,67,41,2,0.05470701679027903,0.6308792795593177
rs299175,Multiple sclerosis (severity),0.4680851063829788,4e-06,5.39794000867204,0.11687408132468699,NLRP11,19,G,0.6308792795593173,High Risk,23,427,388,2,0.05470701679027903,0.6308792795593177
rs261902,Normalized brain volume,0.148936170212766,4e-06,5.39794000867204,0.11687408132468699,BICD1,12,G,0.6308792795593173,Low Risk,49,390,36,2,0.017406778069634237,0.6308792795593177
rs6952809,Multiple sclerosis,0.35106382978723416,4e-06,5.39794000867204,0.1166034503854154,CHST12,7,A,0.6294184299846387,Low Risk,20,652,75,0,0.04093525385870968,0.629418429984639
rs9821630,Multiple sclerosis,0.35106382978723416,4e-06,5.39794000867204,0.1166034503854154,PLCL2,3,G,0.6294184299846387,Low Risk,20,819,411,2,0.04093525385870968,0.629418429984639
rs27002,Multiple sclerosis,0.35106382978723416,4e-06,5.39794000867204,0.11374472042089807,MCTP1,5,C,0.613987177135181,Low Risk,20,393,329,1,0.0399316571690387,0.6139871771351814
chr10:21867179,Multiple sclerosis,0.35106382978723416,4e-06,5.39794000867204,0.11371589379664751,MLLT10,6,T,0.613831572746824,Low Risk,20,10,346,3,0.03992153718392946,0.6138315727468242
rs471942,Multiple sclerosis and waist-to-hip-ratio (pleiotropy),0.21985815602836883,5e-06,5.30102999566398,0.14596843264407194,IP6K3,6,G,0.7737830398662828,High Risk,31,525,228,2,0.032092350439476815,0.7737830398662827
rs4792814,Multiple sclerosis and LDL levels (pleiotropy),0.21985815602836883,5e-06,5.30102999566398,0.14596843264407194,MAP3K14 - RNA5SP443,17,G,0.7737830398662828,High Risk,26,531,322,2,0.032092350439476815,0.7737830398662827
rs4669226,Multiple sclerosis,0.21985815602836883,5e-06,5.30102999566398,0.14596843264407194,LINC01871 - LINC00299,2,G,0.7737830398662828,High Risk,20,520,271,2,0.032092350439476815,0.7737830398662827
rs12513380,Multiple sclerosis,0.21985815602836883,5e-06,5.30102999566398,0.14596843264407194,TLL1,4,G,0.7737830398662828,High Risk,20,186,539,2,0.032092350439476815,0.7737830398662827
rs566267,Multiple sclerosis,0.35106382978723416,4e-06,5.39794000867204,0.11326318365349321,PDE4B,1,G,0.6113878705527597,Low Risk,20,569,401,2,0.03976260702729018,0.61138787055276
rs7758683,Median relapse-independent longitudinal age-related multiple sclerosis severity score in relapse-onset multiple sclerosis,0.22340425531914898,2e-06,5.69897000433602,0.04282393246054081,EPHA7 - MTCYBP36,6,T,0.24405230656033364,Low Risk,18,725,120,3,0.00956704874118465,0.24405230656033366
rs698805,Median relapse-independent longitudinal age-related multiple sclerosis severity score in relapse-onset multiple sclerosis,0.058297872340425605,6e-06,5.22184874961636,0.15819160650923775,CAMKMT,2,G,0.8260526426500657,High Risk,18,654,48,2,0.009222234081602382,0.8260526426500663
rs5978649,Multiple sclerosis,0.18085106382978725,4e-06,5.39794000867204,0.09974450834047068,EGFL6,23,G,0.5384148722163484,Low Risk,20,578,113,2,0.018038900444553207,0.5384148722163487
rs7255066,Multiple sclerosis and HDL levels (pleiotropy),0.18085106382978725,4e-06,5.39794000867204,0.09974450834047068,CEACAM16-AS1,19,G,0.5384148722163484,Low Risk,25,677,73,2,0.018038900444553207,0.5384148722163487
rs806321,Multiple sclerosis and triglyceride levels (pleiotropy),0.18085106382978725,4e-06,5.39794000867204,0.09974450834047068,DLEU1,13,G,0.5384148722163484,Low Risk,29,747,101,2,0.018038900444553207,0.5384148722163487
rs12756986,Multiple sclerosis and HDL levels (pleiotropy),0.18085106382978725,4e-06,5.39794000867204,0.09974450834047068,DPH5-DT - S1PR1-DT,1,G,0.5384148722163484,Low Risk,25,202,106,2,0.018038900444553207,0.5384148722163487
rs2072711,Multiple sclerosis and triglyceride levels (pleiotropy),0.18085106382978725,4e-06,5.39794000867204,0.09974450834047068,NCF4,22,G,0.5384148722163484,Low Risk,29,320,372,2,0.018038900444553207,0.5384148722163487
rs9643199,Median relapse-independent longitudinal Multiple Sclerosis Severity Scale score in relapse-onset multiple sclerosis,0.25531914893617025,2e-06,5.69897000433602,0.041355683347607974,MTSS1,8,A,0.23568479890683644,Low Risk,17,814,361,0,0.010558897875985017,0.23568479890683647
rs6074022,Multiple sclerosis,0.2659574468085107,5e-06,5.30102999566398,0.12516823687752354,RPL13P2 - CD40,20,C,0.6635205781921268,Low Risk,20,586,467,1,0.033289424701469034,0.6635205781921267
rs4409785,Multiple sclerosis and LDL levels (pleiotropy),0.2411347517730497,6e-06,5.22184874961636,0.15004690240221868,LNCRNA-IUR - FAM76B,11,G,0.783522229692833,High Risk,26,509,309,2,0.036181522565074016,0.7835222296928336
rs1500710,Multiple sclerosis and triglyceride levels (pleiotropy),0.2411347517730497,6e-06,5.22184874961636,0.15004690240221868,ARHGEF3,3,G,0.783522229692833,High Risk,29,248,17,2,0.036181522565074016,0.7835222296928336
rs62208470,Multiple sclerosis,0.45744680851063835,5e-06,5.30102999566398,0.12012724825645418,ZHX3,20,G,0.6367981463040373,High Risk,20,596,603,2,0.05495182633008011,0.6367981463040372
rs56089601,Median relapse-independent longitudinal age-related multiple sclerosis severity score in relapse-onset multiple sclerosis,0.08510638297872347,3e-06,5.52287874528034,0.06460296096904442,STK32B,4,C,0.3567943200181106,Low Risk,18,564,518,1,0.005498124337791018,0.3567943200181108
rs10243024,Multiple sclerosis (severity),0.22340425531914898,6e-06,5.22184874961636,0.14396384028712428,"MET, COMETT",7,G,0.7517573993932887,High Risk,23,65,334,2,0.0321621345322299,0.7517573993932892
rs12047808,Multiple sclerosis (age of onset),0.11702127659574474,6e-06,5.22184874961636,0.14396384028712428,AXDND1,1,G,0.7517573993932887,Low Risk,22,161,25,2,0.01684683237402519,0.7517573993932892
rs7191888,Multiple sclerosis (severity),0.15957446808510645,6e-06,5.22184874961636,0.14396384028712428,ZFHX3,16,G,0.7517573993932887,High Risk,23,669,601,2,0.022972953237307074,0.7517573993932892
rs2039485,Brain lesion load,0.21276595744680854,6e-06,5.22184874961636,0.14396384028712428,NUBPL - LINC02313,14,G,0.7517573993932887,High Risk,5,314,393,2,0.030630604316409425,0.7517573993932892
rs6941421,Multiple sclerosis (severity),0.2340425531914894,6e-06,5.22184874961636,0.14396384028712428,RNU6-793P - RPL6P17,6,G,0.7517573993932887,High Risk,23,650,461,2,0.03369366474805037,0.7517573993932892
rs180358,Multiple sclerosis (severity),0.22340425531914898,6e-06,5.22184874961636,0.14396384028712428,LINC02702 - BUD13,11,G,0.7517573993932887,High Risk,23,295,293,2,0.0321621345322299,0.7517573993932892
rs11810158,Multiple sclerosis,0.45744680851063835,5e-06,5.30102999566398,0.11660715771442555,FTH1P22 - PTGFRN,1,T,0.6181380407532905,High Risk,20,148,148,3,0.05334157214596063,0.6181380407532904
rs11150602,Multiple sclerosis,0.45744680851063835,5e-06,5.30102999566398,0.11574224886822465,SETD1A,16,G,0.6135531330160644,High Risk,20,119,484,2,0.05294592235461341,0.6135531330160643
rs17371986,Multiple sclerosis,0.8191489361702129,5e-06,5.30102999566398,0.11537990945797139,VANGL2 - SLAMF6,1,A,0.6116323609337007,High Risk,20,274,579,0,0.09451333008791274,0.6116323609337005
rs2888449,Decreased low contrast letter acuity in multiple sclerosis,0.2872340425531915,3e-06,5.52287874528034,0.06276764957787838,TESHL,2,C,0.3466581177448688,Low Risk,7,418,532,1,0.018029005729816132,0.346658117744869
rs2045769,Multiple sclerosis,0.45744680851063835,5e-06,5.30102999566398,0.11461109751621192,KLF3 - RNA5SP158,4,C,0.607556865769409,High Risk,20,316,242,1,0.05242848077869269,0.6075568657694089
rs13330176,Multiple sclerosis,0.45744680851063835,5e-06,5.30102999566398,0.11349565642970758,LINC02132 - LINC01082,16,A,0.6016438791114535,High Risk,20,227,280,0,0.05191822581358964,0.6016438791114533
rs61909096,Multiple sclerosis,0.40780141843971635,5e-06,5.30102999566398,0.11326838370243483,ETS1,11,G,0.6004390995669843,Low Risk,20,591,126,2,0.046191007538226976,0.6004390995669842
rs16903340,Multiple sclerosis,0.40780141843971635,5e-06,5.30102999566398,0.1132264774256699,"MEF2C-AS2, MEF2C",5,A,0.6002169531368468,Low Risk,20,257,332,0,0.046173918099120706,0.6002169531368466
rs12713638,Decreased low contrast letter acuity in multiple sclerosis,0.37234042553191493,3e-06,5.52287874528034,0.06154410865043436,DTNB - Y_RNA,2,G,0.33990064956270766,Low Risk,7,196,111,2,0.022915359603885136,0.3399006495627078
rs651477,Multiple sclerosis,0.25531914893617025,7e-06,5.15490195998574,0.1533096782087361,THORLNC - LINC01956,2,G,0.7902963606829972,High Risk,20,613,537,2,0.039142896563932626,0.7902963606829968
rs3817963,Multiple sclerosis (OCB status),0.25886524822695034,8e-06,5.09691001300806,0.17043925119295242,"TSBP1-AS1, BTNL2",6,G,0.8687135260149544,High Risk,21,482,567,2,0.04412079906767917,0.8687135260149551
rs61578937,Median relapse-independent longitudinal Multiple Sclerosis Severity Scale score in relapse-onset multiple sclerosis,0.11702127659574474,3e-06,5.52287874528034,0.05322403034381501,NCOA2 - LINC03020,8,G,0.2939498659240116,Low Risk,17,587,377,2,0.006228343976403887,0.2939498659240118
rs4680534,Multiple sclerosis,0.37234042553191493,6e-06,5.22184874961636,0.1214976140951915,IL12A-AS1,3,C,0.6344421642443463,High Risk,20,522,216,1,0.04523847333331599,0.6344421642443467
rs13257990,Multiple sclerosis,0.1702127659574469,6e-06,5.22184874961636,0.11797381622415269,IFITM3P8 - NASPP1,8,C,0.6160414247375615,Low Risk,20,223,207,1,0.020080649570068554,0.616041424737562
rs16917546,Multiple sclerosis,0.1702127659574469,6e-06,5.22184874961636,0.11474971246788204,LINC02929,10,T,0.5992056425692462,Low Risk,20,258,298,3,0.01953186595197993,0.5992056425692467
rs929566,Multiple sclerosis,0.1702127659574469,6e-06,5.22184874961636,0.11375260002447082,NAB1,2,C,0.5939988722033924,Low Risk,20,793,370,1,0.01936214468501632,0.5939988722033929
rs2253675,Multiple sclerosis,0.1702127659574469,6e-06,5.22184874961636,0.11244341123210572,RFT1,3,C,0.5871624863449689,Low Risk,20,343,440,1,0.019139304039507365,0.5871624863449694
rs2776741,Median relapse-independent longitudinal age-related multiple sclerosis severity score in relapse-onset multiple sclerosis,0.3085106382978724,3e-06,5.52287874528034,0.0475957420775725,NIPAL3 - NCMAP-DT,1,A,0.2628655122860702,Low Risk,18,402,386,0,0.014683792768612796,0.2628655122860703
rs7672826,Multiple sclerosis,0.34042553191489366,8e-06,5.09691001300806,0.15208613728129208,LINC02500 - TENM3-AS1,4,G,0.7751693559487355,High Risk,20,718,282,2,0.0517740041808654,0.775169355948736
rs73091975,Median relapse-independent longitudinal age-related multiple sclerosis severity score in relapse-onset multiple sclerosis,0.07446808510638303,4e-06,5.39794000867204,0.06766181328765448,NEUROD6 - ITPRID1,7,G,0.3652344090047274,Low Risk,18,691,382,2,0.005038645670357253,0.3652344090047276
rs1841770,Multiple sclerosis,0.5425531914893618,8e-06,5.09691001300806,0.14841551449896,LINC02032,3,G,0.7564605219354916,High Risk,20,300,277,2,0.0805233110579464,0.7564605219354922
rs2104286,Multiple sclerosis,0.7553191489361702,7e-06,5.15490195998574,0.12639177780496758,IL2RA,10,A,0.6515372231329098,High Risk,20,324,220,0,0.09546613004417764,0.6515372231329095
rs4572384,Median relapse-independent longitudinal age-related multiple sclerosis severity score in relapse-onset multiple sclerosis,0.40425531914893625,3e-06,5.52287874528034,0.04404747338798483,USP10 - CRISPLD2,16,A,0.2432688545578027,Low Risk,18,514,577,0,0.017806425412164085,0.2432688545578028
rs56194930,Median relapse-independent longitudinal age-related multiple sclerosis severity score in relapse-onset multiple sclerosis,0.09574468085106386,4e-06,5.39794000867204,0.0637464823198336,MTCO3P30 - HMGB3P23,9,G,0.34409968732633445,Low Risk,18,566,358,2,0.006103386605090452,0.3440996873263346
rs2243123,Multiple sclerosis,0.15957446808510645,7e-06,5.15490195998574,0.1166034503854154,"IL12A, IL12A-AS1",3,G,0.6010793549328782,Low Risk,20,340,215,2,0.018606933572140764,0.6010793549328779
rs1109670,Multiple sclerosis,0.25531914893617025,9e-06,5.04575749056068,0.1533096782087361,RPL30P3 - ASAP2,2,G,0.7735634571971768,High Risk,20,114,469,2,0.039142896563932626,0.7735634571971776
rs67457628,Multiple sclerosis,0.15957446808510645,7e-06,5.15490195998574,0.1145281047351034,"SMG6, HIC1",17,T,0.590381151572437,Low Risk,20,636,506,3,0.018275761393899487,0.5903811515724366
rs12953974,Median relapse-independent longitudinal age-related multiple sclerosis severity score in relapse-onset multiple sclerosis,0.1063829787234043,4e-06,5.39794000867204,0.058729964517313105,CTIF,18,A,0.31702082517589353,Low Risk,18,209,91,0,0.0062478685656716096,0.3170208251758937
rs4755450,Multiple sclerosis,0.6808510638297873,7e-06,5.15490195998574,0.11415636853052735,PRR5L,11,G,0.5884648878828702,High Risk,20,527,424,2,0.0777234849569548,0.58846488788287
rs62088246,Multiple sclerosis,0.15957446808510645,7e-06,5.15490195998574,0.11385048329866636,UNK,17,G,0.5868880795016194,Low Risk,20,594,576,2,0.01816763031361698,0.586888079501619
rs1437898,Multiple sclerosis (age of onset),0.40425531914893625,8e-06,5.09691001300806,0.1322035972103267,NCKAP5,2,G,0.6738298383769982,High Risk,22,242,375,2,0.05344400738289804,0.6738298383769986
rs9480865,Normalized brain volume,0.148936170212766,7e-06,5.15490195998574,0.11345487173212611,FOXO3,6,G,0.584848740661868,Low Risk,49,805,144,2,0.01689753408776347,0.5848487406618676
rs11666377,Brain lesion load,0.12765957446808512,7e-06,5.15490195998574,0.11345487173212611,CPAMD8,19,G,0.584848740661868,Low Risk,5,137,84,2,0.0144836006466544,0.5848487406618676
rs4704970,Multiple sclerosis (age of onset),0.19148936170212774,7e-06,5.15490195998574,0.11345487173212611,SGCD,5,G,0.584848740661868,Low Risk,22,523,486,2,0.021725400969981604,0.5848487406618676
rs2741190,Multiple sclerosis,0.15957446808510645,7e-06,5.15490195998574,0.11331212529059097,"SLA, TG",8,C,0.5841128967506175,Low Risk,20,400,492,1,0.018081722120838993,0.5841128967506172
rs2811727,Multiple sclerosis,0.15957446808510645,7e-06,5.15490195998574,0.11320200660712101,LCN6,9,A,0.5835452457333672,Low Risk,20,404,249,0,0.018064149990498043,0.5835452457333669
rs10984447,Multiple sclerosis,0.797872340425532,8e-06,5.09691001300806,0.1276153187324116,BRINP1,9,A,0.6504437958604433,High Risk,20,105,38,0,0.10182073303117949,0.6504437958604438
rs6604026,Multiple sclerosis,0.2872340425531915,8e-06,5.09691001300806,0.12516823687752354,"RPL5, DIPK1A",1,C,0.637971239851614,Low Risk,20,618,471,1,0.035952578677586555,0.6379712398516144
rs2727790,Multiple sclerosis,0.1453900709219858,9e-06,5.04575749056068,0.1377101553896978,LNC-RHL1 - APOA4,11,A,0.6948520480838422,Low Risk,20,399,307,0,0.02002168925878585,0.6948520480838429
chr5:1519833,Multiple sclerosis,0.25886524822695034,8e-06,5.09691001300806,0.12004160039153311,LPCAT1,6,T,0.6118412350131169,Low Risk,20,38,312,3,0.0310745986829146,0.6118412350131174
rs71314176,Multiple sclerosis,0.25886524822695034,8e-06,5.09691001300806,0.11726416248623515,IL10RB - IFNAR1,21,G,0.5976848839430956,Low Risk,20,662,214,2,0.030355616530124703,0.597684883943096
rs1442118,Multiple sclerosis,0.25886524822695034,8e-06,5.09691001300806,0.11498837636118928,NIHCOLE,5,A,0.5860854068548845,Low Risk,20,243,385,0,0.02976649458995325,0.5860854068548849
rs2333227,Multiple sclerosis,0.25886524822695034,8e-06,5.09691001300806,0.11437660589746729,MPO - TSPOAP1,17,C,0.5829672678526773,Low Risk,20,367,353,1,0.02960812847700394,0.5829672678526777
rs1152430,Multiple sclerosis,0.25886524822695034,8e-06,5.09691001300806,0.1140829560748807,RPS6KA5,14,C,0.5814705611316177,Low Risk,20,129,474,1,0.029532112742788264,0.5814705611316181
rs716595,Normalized brain volume,0.06382978723404259,8e-06,5.09691001300806,0.11371997226640565,MXI1,10,G,0.5796204653236414,Low Risk,49,667,364,2,0.007258721634025897,0.5796204653236419
rs1927457,Normalized brain volume,0.3085106382978724,8e-06,5.09691001300806,0.11364822382642034,SVIL,10,G,0.5792547699814626,Low Risk,49,309,520,2,0.03506168607410841,0.579254769981463
rs72665771,Multiple sclerosis,0.25886524822695034,8e-06,5.09691001300806,0.11362190138260125,MAPK10,4,A,0.5791206068539942,Low Risk,20,680,324,0,0.029412761705425144,0.5791206068539947
rs12909611,Multiple sclerosis,0.25886524822695034,8e-06,5.09691001300806,0.1132264774256699,RORA,15,C,0.5771051665285275,Low Risk,20,204,464,1,0.029310400184659226,0.577105166528528
rs11669861,Multiple sclerosis,0.25886524822695034,8e-06,5.09691001300806,0.11301123210571394,"MEF2B, BORCS8-MEF2B",19,C,0.5760080805019909,Low Risk,20,138,331,1,0.02925468065147914,0.5760080805019913
rs2295799,Multiple sclerosis,0.25886524822695034,8e-06,5.09691001300806,0.11294506301235777,"FAM221B, TMEM8B",9,G,0.5756708225875121,Low Risk,20,359,137,2,0.02923755177270254,0.5756708225875126
rs56089601,Median relapse-independent longitudinal Multiple Sclerosis Severity Scale score in relapse-onset multiple sclerosis,0.08510638297872347,5e-06,5.30102999566398,0.06166646274317876,STK32B,4,C,0.32689576872808596,Low Risk,17,564,518,1,0.005248209595164154,0.3268957687280859
rs6917747,Brain lesion load,0.13829787234042556,7e-06,5.15490195998574,0.09136995799176148,IGF2R,6,G,0.47100317553554627,Low Risk,5,648,209,2,0.012636270786094675,0.471003175535546
rs337718,Multiple sclerosis (severity),0.2872340425531915,9e-06,5.04575749056068,0.12168519515477792,LINC01899 - CBLN2,18,G,0.6139939849425582,Low Risk,23,450,272,2,0.03495213052318089,0.6139939849425589
rs11957313,Normalized brain volume,0.11702127659574474,9e-06,5.04575749056068,0.12168519515477792,KCNIP1,5,G,0.6139939849425582,Low Risk,49,158,238,2,0.014239756879814445,0.6139939849425589
rs7253363,Multiple sclerosis (severity),0.03191489361702132,9e-06,5.04575749056068,0.12168519515477792,ZNF627,19,G,0.6139939849425582,Low Risk,23,676,607,2,0.003883570058131216,0.6139939849425589
rs62626325,Multiple sclerosis,0.8617021276595744,9e-06,5.04575749056068,0.11905053224030346,RPL32P23 - RBM17,10,G,0.6007001148067462,High Risk,20,598,470,2,0.10258609693047425,0.6007001148067469
rs75637965,Multiple sclerosis,0.11702127659574474,9e-06,5.04575749056068,0.1166034503854154,FAM167A,8,C,0.5883527332074298,Low Risk,20,706,134,1,0.013645084619569895,0.5883527332074304
rs3747562,Multiple sclerosis,0.1453900709219858,9e-06,5.04575749056068,0.11381306741710512,PRICKLE1,12,G,0.5742731374435452,Low Risk,20,471,422,2,0.016547289943621663,0.5742731374435458
rs8078776,Multiple sclerosis,0.1453900709219858,9e-06,5.04575749056068,0.11353236265753089,MINK1,17,A,0.5728567693002875,Low Risk,20,752,338,0,0.016506478258719027,0.5728567693002882
rs7295386,Multiple sclerosis,0.1453900709219858,9e-06,5.04575749056068,0.11341769240181085,ATF1 - RN7SL519P,12,C,0.5722781709985436,Low Risk,20,688,20,1,0.016489806342107248,0.5722781709985443
rs7758683,Median relapse-independent longitudinal Multiple Sclerosis Severity Scale score in relapse-onset multiple sclerosis,0.22340425531914898,4e-06,5.39794000867204,0.040254496512908355,EPHA7 - MTCYBP36,6,T,0.21729135725597704,Low Risk,17,725,120,3,0.00899302581671357,0.21729135725597715
rs2413436,Multiple sclerosis and LDL levels (pleiotropy),0.14326241134751777,9e-06,5.04575749056068,0.10687222154247726,CSF2RB,22,G,0.5392513123808146,Low Risk,26,370,88,2,0.015310772164241428,0.5392513123808151
rs8007846,Multiple sclerosis--Brain Glutamate Levels,0.14326241134751777,9e-06,5.04575749056068,0.10687222154247726,FUT8 - NCOA4P1,14,G,0.5392513123808146,Low Risk,33,740,150,2,0.015310772164241428,0.5392513123808151
rs11704853,Median relapse-independent longitudinal Multiple Sclerosis Severity Scale score in relapse-onset multiple sclerosis,0.07446808510638303,7e-06,5.15490195998574,0.06525143766058975,ZNF74 - RNU6-225P,22,T,0.3363647638884616,Low Risk,17,139,609,3,0.004859149613022644,0.3363647638884614
rs11962089,Multiple sclerosis,0.148936170212766,8e-06,5.09691001300806,0.06888535421509849,"POPDC3, BVES-AS1",6,G,0.3511024516485422,Low Risk,20,159,418,2,0.010259520840546587,0.3511024516485425
rs2274333,Median relapse-independent longitudinal age-related multiple sclerosis severity score in relapse-onset multiple sclerosis,0.2872340425531915,5e-06,5.30102999566398,0.0369509360088095,CA6,1,G,0.19587802015055947,Low Risk,18,349,46,2,0.010613566725934644,0.19587802015055944
rs13117816,Multiple sclerosis--Brain Glutamate Levels,0.11702127659574474,7e-06,5.15490195998574,0.054215098495044675,LINC02616,4,G,0.2794735174929259,Low Risk,33,215,288,2,0.006344320036654167,0.27947351749292576
rs1821625,Multiple sclerosis,0.11702127659574474,7e-06,5.15490195998574,0.054215098495044675,NCKAP5,2,G,0.2794735174929259,Low Risk,20,299,375,2,0.006344320036654167,0.27947351749292576
rs4916321,Multiple sclerosis,0.11702127659574474,7e-06,5.15490195998574,0.054215098495044675,TNFSF4,1,G,0.2794735174929259,Low Risk,20,546,550,2,0.006344320036654167,0.27947351749292576
rs111399831,Median relapse-independent longitudinal Multiple Sclerosis Severity Scale score in relapse-onset multiple sclerosis,0.13829787234042556,7e-06,5.15490195998574,0.04979811574697174,GNG5P5 - RN7SL700P,13,A,0.2567044044676615,Low Risk,17,118,161,0,0.006886973454368434,0.25670440446766135
rs56363129,Median relapse-independent longitudinal Multiple Sclerosis Severity Scale score in relapse-onset multiple sclerosis,0.13829787234042556,7e-06,5.15490195998574,0.0475957420775725,SEPHS1 - BEND7,10,G,0.2453513841226544,Low Risk,17,567,483,2,0.0065823898617919435,0.24535138412265425
rs17749211,Multiple sclerosis,0.17730496453900715,8e-06,5.09691001300806,0.05175578123088216,SAMD12,8,G,0.2637945595867377,Low Risk,20,287,480,2,0.009176556955830174,0.2637945595867379
rs17267338,Multiple sclerosis,0.17730496453900715,8e-06,5.09691001300806,0.05175578123088216,VTI1A,10,G,0.2637945595867377,Low Risk,20,273,585,2,0.009176556955830174,0.2637945595867379
rs12456021,Multiple sclerosis and systolic blood pressure (pleiotropy),0.17730496453900715,8e-06,5.09691001300806,0.05175578123088216,ALPK2,18,G,0.2637945595867377,Low Risk,28,179,12,2,0.009176556955830174,0.2637945595867379
rs11864333,Multiple sclerosis and type 2 diabetes (pleiotropy),0.17730496453900715,8e-06,5.09691001300806,0.05175578123088216,RMI2 - LITAF,16,G,0.2637945595867377,Low Risk,30,153,449,2,0.009176556955830174,0.2637945595867379
rs9821630,Multiple sclerosis and HDL levels (pleiotropy),0.17730496453900715,8e-06,5.09691001300806,0.05175578123088216,PLCL2,3,G,0.2637945595867377,Low Risk,25,819,411,2,0.009176556955830174,0.2637945595867379
rs7941030,Multiple sclerosis and HDL levels (pleiotropy),0.17730496453900715,8e-06,5.09691001300806,0.05175578123088216,GLULP3 - UBASH3B,11,G,0.2637945595867377,Low Risk,25,735,159,2,0.009176556955830174,0.2637945595867379
rs111399831,Median relapse-independent longitudinal age-related multiple sclerosis severity score in relapse-onset multiple sclerosis,0.20212765957446813,7e-06,5.15490195998574,0.041722745625841176,GNG5P5 - RN7SL700P,13,A,0.21507666320263527,Low Risk,18,118,161,0,0.008433320924372155,0.21507666320263516
rs4495680,Median relapse-independent longitudinal Multiple Sclerosis Severity Scale score in relapse-onset multiple sclerosis,0.41489361702127664,6e-06,5.22184874961636,0.03217912639177781,RGS1 - RGS13,1,G,0.16803453091265164,Low Risk,17,511,444,2,0.013350914141269517,0.16803453091265175
rs11057374,Median relapse-independent longitudinal age-related multiple sclerosis severity score in relapse-onset multiple sclerosis,0.35106382978723405,6e-06,5.22184874961636,0.03217912639177781,DNAH10,12,G,0.16803453091265164,Low Risk,18,109,103,2,0.011296927350304974,0.16803453091265175
rs295254,Median relapse-independent longitudinal age-related multiple sclerosis severity score in relapse-onset multiple sclerosis,0.3829787234042554,6e-06,5.22184874961636,0.03193441820628899,RCL1,9,G,0.16675670178023597,Low Risk,18,423,435,2,0.012230202717302168,0.16675670178023608
rs58352802,Median relapse-independent longitudinal age-related multiple sclerosis severity score in relapse-onset multiple sclerosis,0.11063829787234042,9e-06,5.04575749056068,0.05377462376116482,"DSG1-AS1, DSG4",18,A,0.2713337106449794,Low Risk,18,574,110,0,0.005949532841660788,0.27133371064497974
rs758944,Multiple sclerosis,0.19148936170212774,8e-06,5.09691001300806,0.04319099473877401,FPASL,7,T,0.22014061355583553,Low Risk,20,710,146,3,0.008270616013807793,0.2201406135558357
rs7779014,Multiple sclerosis,0.19148936170212774,8e-06,5.09691001300806,0.04319099473877401,YWHAG,7,T,0.22014061355583553,Low Risk,20,727,592,3,0.008270616013807793,0.2201406135558357
rs7583400,Median relapse-independent longitudinal age-related multiple sclerosis severity score in relapse-onset multiple sclerosis,0.35000000000000003,8e-06,5.09691001300806,0.03308454667808637,TMEM17,2,G,0.16862895723937085,Low Risk,18,709,541,2,0.011579591337330232,0.16862895723937096
rs12976899,Median relapse-independent longitudinal age-related multiple sclerosis severity score in relapse-onset multiple sclerosis,0.4617021276595745,1e-05,5.0,0.031310412333292556,RPL7AP69 - USP29,19,G,0.1565520616664628,Low Risk,18,212,472,2,0.014456083992179757,0.1565520616664628
